
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152539AC8AF201630539AC000F310C4C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="npjregmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="NPJ Regenerative Medicine">
<meta name="citation_title" content="Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways">
<meta name="citation_author" content="Siavash Rahimi">
<meta name="citation_author_institution" content="Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland">
<meta name="citation_author_institution" content="Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland">
<meta name="citation_author_institution" content="Department of Emergency Medicine, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland">
<meta name="citation_author" content="William V J Hariton">
<meta name="citation_author_institution" content="Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland">
<meta name="citation_author_institution" content="Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland">
<meta name="citation_author" content="Fattaneh Khalaj">
<meta name="citation_author_institution" content="Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran">
<meta name="citation_author" content="Ralf J Ludwig">
<meta name="citation_author_institution" content="Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany">
<meta name="citation_author_institution" content="Department of Dermatology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany">
<meta name="citation_author_institution" content="Institute and Comprehensive Centre for Inflammation Medicine, University-Hospital Schleswig-Holstein, Lübeck, Germany">
<meta name="citation_author" content="Luca Borradori">
<meta name="citation_author_institution" content="Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland">
<meta name="citation_author" content="Eliane J Müller">
<meta name="citation_author_institution" content="Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland">
<meta name="citation_author_institution" content="Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="10">
<meta name="citation_firstpage" content="39">
<meta name="citation_doi" content="10.1038/s41536-025-00426-x">
<meta name="citation_pmid" content="40846710">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/pdf/41536_2025_Article_426.pdf">
<meta name="description" content="Epithelial tissue integrity is maintained through specialized intercellular junctions known to coordinate homeostatic processes. In this context, outside-in signaling and mechanotransduction through desmosomal cadherins, the building blocks of ...">
<meta name="og:title" content="Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Epithelial tissue integrity is maintained through specialized intercellular junctions known to coordinate homeostatic processes. In this context, outside-in signaling and mechanotransduction through desmosomal cadherins, the building blocks of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373888">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41536-025-00426-x"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41536_2025_Article_426.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373888%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373888/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373888/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-npjregmed.jpg" alt="NPJ Regenerative Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to NPJ Regenerative Medicine" title="Link to NPJ Regenerative Medicine" shape="default" href="https://www.nature.com/npjregenmed/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">NPJ Regen Med</button></div>. 2025 Aug 22;10:39. doi: <a href="https://doi.org/10.1038/s41536-025-00426-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41536-025-00426-x</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22NPJ%20Regen%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22NPJ%20Regen%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22NPJ%20Regen%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22NPJ%20Regen%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Desmoglein-driven dynamic signaling in pemphigus vulgaris: a systematic review of pathogenic pathways</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rahimi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Siavash Rahimi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Siavash Rahimi</span></h3>
<div class="p">
<sup>1</sup>Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland </div>
<div class="p">
<sup>2</sup>Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland </div>
<div class="p">
<sup>3</sup>Department of Emergency Medicine, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rahimi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Siavash Rahimi</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hariton%20WVJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">William V J Hariton</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">William V J Hariton</span></h3>
<div class="p">
<sup>1</sup>Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland </div>
<div class="p">
<sup>2</sup>Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hariton%20WVJ%22%5BAuthor%5D" class="usa-link"><span class="name western">William V J Hariton</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khalaj%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Fattaneh Khalaj</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Fattaneh Khalaj</span></h3>
<div class="p">
<sup>4</sup>Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khalaj%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fattaneh Khalaj</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ludwig%20RJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ralf J Ludwig</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ralf J Ludwig</span></h3>
<div class="p">
<sup>5</sup>Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany </div>
<div class="p">
<sup>6</sup>Department of Dermatology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany </div>
<div class="p">
<sup>7</sup>Institute and Comprehensive Centre for Inflammation Medicine, University-Hospital Schleswig-Holstein, Lübeck, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ludwig%20RJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Ralf J Ludwig</span></a>
</div>
</div>
<sup>5,</sup><sup>6,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borradori%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Luca Borradori</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Luca Borradori</span></h3>
<div class="p">
<sup>1</sup>Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borradori%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Luca Borradori</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%BCller%20EJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Eliane J Müller</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Eliane J Müller</span></h3>
<div class="p">
<sup>1</sup>Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland </div>
<div class="p">
<sup>2</sup>Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%BCller%20EJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Eliane J Müller</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland </div>
<div id="Aff2">
<sup>2</sup>Department for BioMedical Research, Molecular Dermatology and Stem Cell Research, University of Bern, Bern, Switzerland </div>
<div id="Aff3">
<sup>3</sup>Department of Emergency Medicine, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland </div>
<div id="Aff4">
<sup>4</sup>Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran </div>
<div id="Aff5">
<sup>5</sup>Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany </div>
<div id="Aff6">
<sup>6</sup>Department of Dermatology, University Hospital Schleswig-Holstein Lübeck, Lübeck, Germany </div>
<div id="Aff7">
<sup>7</sup>Institute and Comprehensive Centre for Inflammation Medicine, University-Hospital Schleswig-Holstein, Lübeck, Germany </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 20; Accepted 2025 Aug 5; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373888  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846710/" class="usa-link">40846710</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Epithelial tissue integrity is maintained through specialized intercellular junctions known to coordinate homeostatic processes. In this context, outside-in signaling and mechanotransduction through desmosomal cadherins, the building blocks of desmosomes and main stress bearers in epithelial tissue, are only starting to emerge. To better understand the dual function of desmosomal cadherins in structural integrity and cellular signaling, we here performed a systematic, unbiased review on pathogenic signaling effectors identified in models and patients with pemphigus vulgaris (PV). PV is an autoimmune blistering disorder characterized by disruption of desmosomal transadhesion through autoantibodies mainly targeting the desmosomal cadherins desmoglein (Dsg) 3 or Dsg1 and Dsg3. The survey of functionally validated pathogenic pathways published since inception in 1977 up to mid-2024 identifies 128 studies and 128 signaling molecules, highlighting a coherent network of biomechanical, bioelectrical, and biochemical signaling events. This in-depth analysis will stimulate future research as well as development of potential therapeutic applications beyond PV.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Immunological disorders, Autoimmune diseases, Stem-cell research, Cell adhesion, Adherens junctions, Cadherins, Desmosomes, Mechanotransduction, Calcium signalling, Growth factor signalling, Ion channel signalling, RHO signalling, Stress signalling, Adult stem cells, Multipotent stem cells, Regeneration, Skin stem cells, Stem-cell niche, Transdifferentiation</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Intercellular adhesion is essential to maintain tissue integrity and intercellular communication in epithelial homeostasis<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. Structurally, junctional cell-cell adhesion is mediated by adherens junctions and desmosomes. The adhesive building blocks of adherens junctions are classical cadherins that communicate through their plaque proteins to the actin cytoskeleton. Desmosomes are robust, tightly packed, knob-like structures that confer strongest adhesion and are built by desmosomal cadherins which act as anchoring sites for intermediate filaments. It is well established that classical cadherins detect external mechanical forces through plasma membrane deformation and molecular conformational changes, transmitted intracellularly in a process known as mechanotransduction, ultimately leading to changes in cell behavior during homeostasis and regenerative processes<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>. These outside-in mechanotransduction mechanisms are less well understood for desmosomal cadherins.</p>
<p id="Par3">In the epidermis, the outermost layer of the skin, desmosomal cadherins, particularly Dsg3 and Dsg1 have been studied most extensively for their role as the predominant targets in the autoimmune blistering disease pemphigus vulgaris (PV). Dsg3 is mainly expressed in the basal and suprabasal layer of stratified epithelia, from where the highly complex homeostatic processes are governed<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>, whereas Dsg1 expression is low in basal layers and gradually increases up to the granular layer beneath the stratum corneum<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. Antibody binding to these desmosomal cadherins in PV results in potentially life-threatening, basal-suprabasal loss of intercellular adhesion (acantholysis) and skin blistering<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. It is noteworthy that anti-Dsg3 antibodies are sufficient to induce blisters in tissues lacking Dsg1 expression, suggesting that Dsg1 has a compensatory function in this disease. Whether this function pertains to interfering signaling with Dsg3 or to structurally more resilient desmosomes, or both, will be an interesting topic for future investigations. Complementing these findings, a milder and cutaneous-limited variant of pemphigus named pemphigus foliaceus (PF), which is characterized by autoantibodies targeting Dsg1 without Dsg3, results in superficial epidermal blistering within the granular and upper spinous layers where Dsg1 is the main desmoglein isoform<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. The distinct expression patterns and clinical phenotypes of PV and PF underscore functional redundancies between these adhesion molecules while simultaneously highlighting Dsg-specific functions required for the homeostatic balance within different layers of the epidermis<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Studies on functional disruption of Dsg3 transadhesion by PV antibodies<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup> have highlighted that desmosomal cadherins not only provide mechanical resilience, but also participate in outside-in signaling that is critical in the homeostasis of stratified epithelia in terms of stem cell maintenance, control of proliferation and differentiation as well as tissue regeneration<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. This underlines the significance of Dsg3 and potentially Dsg1 beyond mere adhesion functions.</p>
<p id="Par4">Seminal work on the turnover of desmosomal cadherins has indicated that upon plasma membrane delivery through the Golgi apparatus, desmosomal cadherins are stabilized by transadhesion prior to lateral incorporation into tightly packed desmosomes<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>–<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. This extra-desmosomal cadherin pool, which can be fractionated biochemically (with 0.5–1% Triton-X 100), is characterized by absence of desmoplakin and presence of associated junctional plakoglobin (JUP), plakophilins and actin. It is believed to serve as an intermediate regulatory adhesive signaling structure during the transport to and from desmosomes<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>–<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Early research has further demonstrated that PV autoantibodies predominantly target Dsg3 expressed in the more accessible extra-desmosomal compartment at the cell surface<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>, while antibody binding to desmosomes occurs at later stages when these structures become functionally defective<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>,<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. The implication of cell signaling in PV started to be studied three decades ago by the group of Dr Kitajima. Seconds after antibody binding, cytosolic calcium influx was recorded as the first pathogenic signaling event<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. Within the first hour, the turn-over of plasma membrane exposed, antibody-targeted extra-desmosomal Dsg3 as well as JUP, a plaque protein of Dsg1 and Dsg3 and transcription factor in the Wnt pathway<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>, increase significantly, as shown by metabolic labeling, and drive pathogenic PV signaling<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Consistently, JUP knockout keratinocytes failed to respond to PV IgG by means of disruption of the desmosomal plaque and loss of intercellular adhesion, despite defective desmosomes and normal PV IgG binding<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. Furthermore, the actin cytoskeleton machinery, including RhoA, a critical mechanotransductive regulatory molecule mediating the crosstalk between adherens junctions and desmosomes to support homeostatic processes<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>, was suggested to contribute to PV pathogenesis and regeneration<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. Although these results highlight outside-in signal transduction by antibody-mediated disruption of Dsg3 transadhesion in conjunction with Dsg1<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>, to date there has been no comprehensive analysis of the mechanotransducive effector network in PV. The latter is important to identify existing gaps in our understanding of both the effects of the pathogenic anti-Dsg3/Dsg1 autoantibodies and Dsg3/Dsg1 functions as well as to identify potentially druggable pathways for the first line treatment of PV patients.</p>
<p id="Par5">Here we present the first comprehensive, pathogenic effector signaling network in PV based on the systematic review of literature published since inception in 1977 up to April 2024. The effector framework categorizes in three fundamental signaling modalities mediated by Dsg3 or Dsg3/Dsg1 which also typify classical cadherin and integrin mechanotransduction: biomechanical, bioelectrical, and biochemical signaling<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>. These networks highlight a dynamic and complex interplay of a variety of intricate pathogenic signaling pathways that initiate blister formation in PV and promote tissue regeneration. This proposes a model whereby effector pathways such as calcium influx are activated within seconds to minutes followed by PLC/PKC, EGFR and p38MAPK activation as well as JUP dissociation from its Dsg3 anchor. This results in fate conversion including cortical actin cytoskeletal depolymerization, mitosis, migration, compromised differentiation and junctional reductions, which leads to blistering. This is followed by regenerative processes reminiscent of mechanotransduction of the desmosomal system to adherens junctions to establish force equilibrium and epithelial homeostasis.</p>
<p id="Par6">The systematic review will shed new light on PV and desmosomal cadherin signaling while the established framework allows for identification of unexplored hierarchy and synergies between signaling modalities, with the overarching goal to develop efficient treatment options for PV and potentially other acantholytic disorders while allowing for a more effective translation of findings across disciplinary boundaries.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study characteristics</h3>
<p id="Par7">A comprehensive search was performed with the focus question of “identifying signaling molecules in keratinocytes that are essential for loss of intercellular adhesion and blister formation in PV based on pharmacological or genetic manipulation (inhibition/activation; knockout/knockdown)” (see methods; flow diagram, Supplementary Fig. <a href="#MOESM1" class="usa-link">S1</a> and Table <a href="#MOESM1" class="usa-link">S1</a> and PRISMA checklists, Supplementary Information and Supplementary Data <a href="#MOESM2" class="usa-link">1</a>). The initial search, covering all in vitro and in vivo models for PV<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>, yielded 11,426 articles, from which 128 articles were eligible for final assessment. The PRISMA flow diagram for identification and screening of the studies is shown in Supplementary Fig. <a href="#MOESM1" class="usa-link">S1</a>, Supplementary Information. The literature review identified a total of 332 interventions with 234 unique approaches, which identified 128 signaling molecules. These signaling molecules were categorized according to three main signaling modalities: biomechanical, bioelectrical and biochemical (Figs. <a href="#Fig1" class="usa-link">1</a>–<a href="#Fig3" class="usa-link">3</a>). The most employed models in these studies were human or mouse 2D keratinocyte cultures (83 studies), the passive transfer neonatal mouse model (PTNM, 38 studies), and ex vivo human skin organ culture (30 studies). Additional models included the passive transfer adult mouse model (PTAM, 4 studies), 3D culture (2 studies), ex vivo human oral mucosa culture (1 study), and patient skin samples (1 study). A wide range of pathogenic patients and experimental IgG antibodies or antibody fractions were used to investigate the biological targets. The most commonly used PV induction methods were IgG purified from PV patients’ sera (PV IgG) (88 studies), the experimental anti-mouse Dsg3 IgG antibody AK23 (32 studies), and sera from PV patients (23 studies). Others included enzymatically digested IgG subfragments (Fab or F(ab´)<sub>2</sub> IgG fragments) of PV IgG (4 studies), Px43 scFv or other scFv (single chain variable fragment anti-Dsg1/3 cloned from PV patient; 4 studies), humanized AK23 (1 study), 4B3 (an anti-Dsg1/3 antibody isolated from patient) (1 study), the monoclonal anti-Dsg3 IgG antibody 2G4 (from humanized Dsg3 mice<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup> against the amino terminal region EC5 of human Dsg3; 1 study), a rabbit polyclonal anti-Dsg3 antibody (1 study), and canine PV IgG (1 study). The details of the eligible studies are given in Supplementary Data <a href="#MOESM2" class="usa-link">1</a>. Effectors and key effectors (the latter indicated in bold were confirmed multiple times by several PV models, approaches and laboratories) are depicted in Figs. <a href="#Fig1" class="usa-link">1</a>–<a href="#Fig3" class="usa-link">3</a> and Fig. <a href="#Fig4" class="usa-link">4</a>, respectively.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Schematic representation of the signaling network of biomechanical effectors identified upon PV antibody binding and loss of transadhesion between extra-desmosomal Dsg3 or Dsg1/3 receptors.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373888_41536_2025_426_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a92/12373888/28decb5788e6/41536_2025_426_Fig1_HTML.jpg" loading="lazy" id="d33e509" height="384" width="691" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The diagram illustrates key molecular interactions and pathways which have been involved in loss of intercellular adhesion in PV, with arrows indicating the direction of interaction between molecules. Effector molecules identified and tested across various experimental PV models and antibody types are highlighted in bold, underscoring their roles in downstream signaling events leading to shrinkage of desmosomes (to the right) and blister formation. This figure provides an overview of three main biomechanical signaling cascades initiated upon antibody engagement with Dsg receptors, capturing the critical points of intervention, molecular crosstalk and consequences thereof (boxes at the bottom). This figure was created in BioRender. Hariton, W. (2025) <a href="https://BioRender.com/2iinwlr" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/2iinwlr</a>.</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. Overview of the signaling network of biochemical effectors activated by PV antibody binding to Dsg3 or Dsg1/3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373888_41536_2025_426_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a92/12373888/7357691064cd/41536_2025_426_Fig3_HTML.jpg" loading="lazy" id="d33e535" height="380" width="691" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>This figure illustrates key molecular interactions and highlights the four major signaling pathway families cooperating with Dsg1/3 to induce loss of intercellular adhesion and blistering, with arrows indicating interactions between specific molecules within the signaling cascade. Effector molecules tested across various experimental PV models and antibody types are highlighted in bold, emphasizing their roles in the biomechanical signaling process. The schematic captures the intricate web of biomechanical signaling events and consequences thereof (boxes at the bottom) following antibody engagement with Dsg receptors, identifying critical points for potential intervention and inter-molecular crosstalk. This figure was created in BioRender. Hariton, W. (2025) <a href="https://BioRender.com/opaf5k5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/opaf5k5</a>.</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Summary scheme of major effectors identified in biomechanical, bioelectrical and biochemical signaling leading to desmosome shrinkage and loss of intercellular adhesion in PV.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373888_41536_2025_426_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a92/12373888/6dfe2c1a1b42/41536_2025_426_Fig4_HTML.jpg" loading="lazy" id="d33e548" height="285" width="691" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The model proposes a sequence of events ranging from PV antibody binding to Dsg3 or Dsg1/3 receptors inducing loss of transadhesion, to influx of calcium from extracellular and intracellular stores, activation of cell surface receptors and their effectors through to altered transcription in the nucleus. This figure was created in BioRender. Hariton, W. (2025) <a href="https://BioRender.com/h2vc44h" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/h2vc44h</a>.</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">Biomechanical signaling</h3>
<p id="Par8">Biomechanical signal transducers from the plasma membrane to the nucleus have been identified in many biological systems<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>, of which some can be assigned to PV pathogenicity. These are the extra-desmosomal cell-cell adhesion receptor Dsg3 acting as upstream regulator of Rho GTPases and actin<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>, Dsg3 associated signaling molecules JUP<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>, plakophilin 1–3<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>, growth factor receptors such as EGFR<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup> and the pleotropic, stress responsive p38MAPK<sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>. Characteristics of the 66 eligible studies are compiled in Table <a href="#Tab1" class="usa-link">1</a> and pathogenic effectors in PV are depicted in Fig. <a href="#Fig1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Characteristics of studies included in biomechanical signaling axis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Author</th>
<th colspan="1" rowspan="1">Year</th>
<th colspan="1" rowspan="1">Target molecule</th>
<th colspan="1" rowspan="1">Intervention</th>
<th colspan="1" rowspan="1">Treatment Modality</th>
<th colspan="1" rowspan="1">Model</th>
<th colspan="1" rowspan="1">Antibody</th>
<th colspan="1" rowspan="1">Preventing Pathology</th>
<th colspan="1" rowspan="1">Measured Outcome</th>
</tr></thead>
<tbody>
<tr><td colspan="9" rowspan="1"><strong>Cell adhesion molecules</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Hunziker and Morgenthaler<sup><a href="#CR95" class="usa-link" aria-describedby="CR95">95</a></sup>
</td>
<td colspan="1" rowspan="1">1987</td>
<td colspan="1" rowspan="1">Fibronectin</td>
<td colspan="1" rowspan="1">Fibronectin (20–500 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV serum</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Brightfield microscopy examination of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Caldelari et al.<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>
</td>
<td colspan="1" rowspan="1">2001</td>
<td colspan="1" rowspan="1">JUP</td>
<td colspan="1" rowspan="1">JUP KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA and keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Berkowitz et al.<sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>
</td>
<td colspan="1" rowspan="1">2005</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (100 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Keratin retraction measured by confocal immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Berkowitz et al.<sup><a href="#CR65" class="usa-link" aria-describedby="CR65">65</a></sup>
</td>
<td colspan="1" rowspan="1">2006</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (6.25 µg/injection), SB203580 (12.5 µg/ injection)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h and cotreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis, Nikolsky’s sign, and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">de Bruin et al.<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">JUP</td>
<td colspan="1" rowspan="1">JUP KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG/PV Fab</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR175" class="usa-link" aria-describedby="CR175">175</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">Desmoglein 1/3</td>
<td colspan="1" rowspan="1">IgG depletion from PV serum</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV serum</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Cell-cell detachment and disruption of intercellular contacts were seen after 24 and 48 hours, respectively.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Chernyavsky et al.<sup><a href="#CR84" class="usa-link" aria-describedby="CR84">84</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">p38MAPK, Src</td>
<td colspan="1" rowspan="1">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/PD169316" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PD169316</a> (10 µM), PP2 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">
<a href="https://www.ncbi.nlm.nih.gov/nuccore/PD169316" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PD169316</a> (-), PP2 (+)</td>
<td colspan="1" rowspan="1">Cell volume and keratin aggregation measurements</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lee et al.<sup><a href="#CR66" class="usa-link" aria-describedby="CR66">66</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (6.25 μg)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h or treatment after 3 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Pretreatment (+), Treatment (-)</td>
<td colspan="1" rowspan="1">Keratin retraction measured by confocal immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Plakophilin 3</td>
<td colspan="1" rowspan="1">siRNA PKP3 KD</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA, morphometric analysis of cell-cell detachment and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heupel b et al.<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Desmoglein 3</td>
<td colspan="1" rowspan="1">Tandem peptide (20 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA and keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heupel a et al.<sup><a href="#CR92" class="usa-link" aria-describedby="CR92">92</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG 1–5</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA and keratin or F-actin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Nguyen et al.<sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Perp</td>
<td colspan="1" rowspan="1">Prep KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pretel et al.<sup><a href="#CR86" class="usa-link" aria-describedby="CR86">86</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Clinical activity and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Jolly et al.<sup><a href="#CR67" class="usa-link" aria-describedby="CR67">67</a></sup>
</td>
<td colspan="1" rowspan="1">2010</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (100 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Dsg3 internalization was measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mao et al.<sup><a href="#CR80" class="usa-link" aria-describedby="CR80">80</a></sup>
</td>
<td colspan="1" rowspan="1">2011</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (2 µM), p38α MAPK epidermal KO, p38MAPK siRNA</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro, PTNM</td>
<td colspan="1" rowspan="1">PX43</td>
<td colspan="1" rowspan="1">In vitro (+), PTNM (-)</td>
<td colspan="1" rowspan="1">In vitro: Dsg3 internalization was measured by immunofluorescence microscopy. PTNM: Gross and microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Jennings et al.<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>
</td>
<td colspan="1" rowspan="1">2011</td>
<td colspan="1" rowspan="1">Desmoglein 3</td>
<td colspan="1" rowspan="1">DSG3 overexpression</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Saito et al.<sup><a href="#CR68" class="usa-link" aria-describedby="CR68">68</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (In vitro: 20 µM, ex vivo: 5 µg)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 1 h. Ex vivo: Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro, ex vivo</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">PV IgG (+), AK23 (-)</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gil et al.<sup><a href="#CR87" class="usa-link" aria-describedby="CR87">87</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">FAK, Src</td>
<td colspan="1" rowspan="1">PF-573228 (5 µg/g), PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Espana et al.<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">FAK, Src</td>
<td colspan="1" rowspan="1">PF-573228 (5 µg/g), PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Spindler et al.<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">Desmoglein 3</td>
<td colspan="1" rowspan="1">Tandem peptide (in vitro: 20 µM, PTNM: 20 μM/L in 50 μl PBS for injection, 2 nmol mixed in 100 mg of linimentum aquosum for topical administration</td>
<td colspan="1" rowspan="1">In vitro: Cotreatment and posttreatment at 6 and 24 h. PTNM: Pretreatment for 2 h or posttreatment after 6 h</td>
<td colspan="1" rowspan="1">PTNM/ In vitro</td>
<td colspan="1" rowspan="1">PV IgG/ AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA and Dsg3 immunofluorescence microscopy. PTNM: Gross and microscopic evaluation and scoring of blisters</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bektas et al.<sup><a href="#CR69" class="usa-link" aria-describedby="CR69">69</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Keratin retraction and Dsg3 internalization was visualized with immunofluorescence microscopy. Dsg3 depletion was measured by western blotting</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Dehner et al.<sup><a href="#CR136" class="usa-link" aria-describedby="CR136">136</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">Desmoplakin</td>
<td colspan="1" rowspan="1">Desmoplakin point mutation (S2849G)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG/ AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA and keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Spindler et al.<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">JUP, Desmoplakin</td>
<td colspan="1" rowspan="1">JUP siRNA KD, Desmoplakin siRNA KD</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Tucker et al.<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">Plakophilin 1, JUP</td>
<td colspan="1" rowspan="1">Plakophilin 1 overexpression, JUP overexpression</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">Plakophilin 1 (-), JUP (x)</td>
<td colspan="1" rowspan="1">KDA and desmosome length was measured by electron microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hartlieb et al.<sup><a href="#CR70" class="usa-link" aria-describedby="CR70">70</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (30 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mao et al.<sup><a href="#CR71" class="usa-link" aria-describedby="CR71">71</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (In vitro: 2 µM, PTNM: 5 µg)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro, PTNM</td>
<td colspan="1" rowspan="1">PX43</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: Dsg3 internalization was measured by immunofluorescence microscopy. PTNM: Gross and microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Spindler et al.<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (30 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rötzer et al.<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (30 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Vielmuth et al.<sup><a href="#CR73" class="usa-link" aria-describedby="CR73">73</a></sup>
</td>
<td colspan="1" rowspan="1">2015</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA. Keratin retraction and intercellular widening were visualized with immunofluorescence, and atomic force microscopy, respectively.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR89" class="usa-link" aria-describedby="CR89">89</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">Src inhibitor-1 (1 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Morphometric analysis of cell-cell detachment and KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rötzer et al.<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>
</td>
<td colspan="1" rowspan="1">2015</td>
<td colspan="1" rowspan="1">E-cadherin</td>
<td colspan="1" rowspan="1">E-cadherin overexpression</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egu et al.<sup><a href="#CR74" class="usa-link" aria-describedby="CR74">74</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (50 µL of 30 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">mPV IgG, mcPV IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and light microscopic evaluation of blister formation or electron microscopy for blister size quantification and desmosome size.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR75" class="usa-link" aria-describedby="CR75">75</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">p38MAPK, Src</td>
<td colspan="1" rowspan="1">SB202190 (NA), PP2 (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, mcPV IgG, mPV IgG, atPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Vielmuth et al.<sup><a href="#CR76" class="usa-link" aria-describedby="CR76">76</a></sup>
</td>
<td colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (30 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hofrichter et al.<sup><a href="#CR203" class="usa-link" aria-describedby="CR203">203</a></sup>
</td>
<td colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">Desmoglein 1/3</td>
<td colspan="1" rowspan="1">Anti-Dsg1/3 antibody depletion</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro/ PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA and Dsg3 degradation assay. PTNM: Gross and microscopic histology before and after application of mechanical stress</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">Desmoglein 2/3</td>
<td colspan="1" rowspan="1">Desmoglein 2 KO, Desmoglein 3 KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">mPV IgG, mcPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">Desmoglein 2 (x), Desmoglein 3 (+)</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kugelmann et al.<sup><a href="#CR90" class="usa-link" aria-describedby="CR90">90</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (In vitro: 10 µM, ex vivo and PTNM: 50 µL of 10 µM)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 2 h, ex vivo and PTNM: Cotreatment</td>
<td colspan="1" rowspan="1">PTNM, In vitro, ex vivo</td>
<td colspan="1" rowspan="1">PV1-4 IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo and PTNM: Blister score was counted in H&amp;E stained samples</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ivars et al.<sup><a href="#CR91" class="usa-link" aria-describedby="CR91">91</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation with histological scoring</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Burmester et al.<sup><a href="#CR77" class="usa-link" aria-describedby="CR77">77</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">BIRB 796 (0.1, 1, and 10 µM)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 2 h then discarding supernatant. Ex vivo: Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, ex vivo</td>
<td colspan="1" rowspan="1">In vitro: Immunophresis material from PV patient. ex vivo: PX43 scFv</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Gross and light microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egu et al.<sup><a href="#CR204" class="usa-link" aria-describedby="CR204">204</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (50 µL of 30, 60, 120 µM), SB203580 (30 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">Ex vivo human oral mucosa culture</td>
<td colspan="1" rowspan="1">AK23, mPV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Gross and light microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sigmund et al.<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">JUP</td>
<td colspan="1" rowspan="1">Phosphodeficient mutant of JUP S665</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">p38MAPK</td>
<td colspan="1" rowspan="1">SB202190 (60 µM), EO1428 (40 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, 2G4</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA. Dsg3 internalization, keratin retraction, and desmosome numbers were visualized using STED microscopy.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hariton et al.<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Desmoglein 3</td>
<td colspan="1" rowspan="1">Desmoglein 3 KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, 2G4</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA. Dsg3 internalization, keratin retraction, and desmosome numbers were visualized using STED microscopy.</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Cytoskeleton</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Patel et al.<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>
</td>
<td colspan="1" rowspan="1">1984</td>
<td colspan="1" rowspan="1">Actin, Tubulin</td>
<td colspan="1" rowspan="1">Cytochalasin D (0.5 µg/mL), Colchicine (40 µg/mL), Combination</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Antibody internalization by electron microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sánchez-Carpintero et al.<sup><a href="#CR99" class="usa-link" aria-describedby="CR99">99</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">Calmodulin</td>
<td colspan="1" rowspan="1">W-7 hydrochloride (200 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 3 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Waschke et al.<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>
</td>
<td colspan="1" rowspan="1">2006</td>
<td colspan="1" rowspan="1">Rho A, Rac 1, and Cdc42</td>
<td colspan="1" rowspan="1">CNF-1 (1200 ng/mL), CNFy (HSOC: 1200 ng/mL, 2D Cell culture: 600 ng/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo/ in vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Ex vivo: Gross and microscopic evaluation of tissue. In vitro: F-actin immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heupel a et al.<sup><a href="#CR92" class="usa-link" aria-describedby="CR92">92</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Rho A, Rac 1, and Cdc42</td>
<td colspan="1" rowspan="1">CNF-1 (300 ng/mL), CNFy (900 ng/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA and keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gliem et al.<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>
</td>
<td colspan="1" rowspan="1">2010</td>
<td colspan="1" rowspan="1">Actin, Rho A, Rac 1, and Cdc42</td>
<td colspan="1" rowspan="1">Cytochalasin D (100 nM), Jasplakinolide (100 nM), Actin-RFP overexpression, CNF-1 (300 ng/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 3, 1, and 0.5 h, respectively</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Cytochalasin D and Actin-RFP overexpression (-), Jasplakinolide and CNF-1 (+)</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Jennings et al.<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>
</td>
<td colspan="1" rowspan="1">2011</td>
<td colspan="1" rowspan="1">Actin</td>
<td colspan="1" rowspan="1">Lantraculin A (250 nM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Dsg3 internalization measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rötzer et al.<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">α-adductin</td>
<td colspan="1" rowspan="1">siRNA KD</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sumigray et al.<sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">Myh9</td>
<td colspan="1" rowspan="1">Myosin IIA KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Vielmuth et al.<sup><a href="#CR76" class="usa-link" aria-describedby="CR76">76</a></sup>
</td>
<td colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">Keratin cluster II</td>
<td colspan="1" rowspan="1">Keratin cluster II knockout (KtyII)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, PF IgG, AK23</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kugelmann et al.<sup><a href="#CR90" class="usa-link" aria-describedby="CR90">90</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">Cortactin (CTTN)</td>
<td colspan="1" rowspan="1">CTTN KO</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTNM/In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro: KDA. PTNM: Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Jin et al.<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>
</td>
<td colspan="1" rowspan="1">2021</td>
<td colspan="1" rowspan="1">RhoA</td>
<td colspan="1" rowspan="1">Cyclic mechanical stretch (10% 1 Hz cyclic stretch for 4 h), CN01 (1 unitl/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Plasma membrane and Endocytosis</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Hunziker and Vassalli et al.<sup><a href="#CR116" class="usa-link" aria-describedby="CR116">116</a></sup>
</td>
<td colspan="1" rowspan="1">1987</td>
<td colspan="1" rowspan="1">Plasminogen</td>
<td colspan="1" rowspan="1">Plasminogen (300 µg/mL)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Morioka et al.<sup><a href="#CR117" class="usa-link" aria-describedby="CR117">117</a></sup>
</td>
<td colspan="1" rowspan="1">1987</td>
<td colspan="1" rowspan="1">Urokinase-type plasminogen activator (uPA)</td>
<td colspan="1" rowspan="1">Anti-Urokinase IgG (NA)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hashimoto et al.<sup><a href="#CR118" class="usa-link" aria-describedby="CR118">118</a></sup>
</td>
<td colspan="1" rowspan="1">1989</td>
<td colspan="1" rowspan="1">Urokinase-type plasminogen activator (uPA)</td>
<td colspan="1" rowspan="1">Plasminogen Activator Inhibitor 2 (100 µg/mL)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Wilkinson et al.<sup><a href="#CR119" class="usa-link" aria-describedby="CR119">119</a></sup>
</td>
<td colspan="1" rowspan="1">1989</td>
<td colspan="1" rowspan="1">Urokinase-type plasminogen activator (uPA)</td>
<td colspan="1" rowspan="1">Human placental urokinase inhibitor (50 U/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Canine oral keratinocytes grown at the air-liquid interface on synthetic membranes</td>
<td colspan="1" rowspan="1">Human and canine PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Xue et al.<sup><a href="#CR120" class="usa-link" aria-describedby="CR120">120</a></sup>
</td>
<td colspan="1" rowspan="1">1998</td>
<td colspan="1" rowspan="1">Urokinase-type plasminogen activator (uPA)</td>
<td colspan="1" rowspan="1">Anti-Urokinase-type plasminogen activator receptor (100 µg/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mahoney et al.<sup><a href="#CR123" class="usa-link" aria-describedby="CR123">123</a></sup>
</td>
<td colspan="1" rowspan="1">1999</td>
<td colspan="1" rowspan="1">Tissue type Plasminogen Activator (tPA), Urokinase-type plasminogen activator (uPA)</td>
<td colspan="1" rowspan="1">Tissue type Plasminogen Activator (tPA) KO, Urokinase-type plasminogen activator (uPA) uPA + tPA knockout</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Asano et al.<sup><a href="#CR121" class="usa-link" aria-describedby="CR121">121</a></sup>
</td>
<td colspan="1" rowspan="1">2001</td>
<td colspan="1" rowspan="1">Urokinase-type plasminogen activator receptor, Plasmin and plasminogen</td>
<td colspan="1" rowspan="1">Phosphatidylinositol-specific phospholipase C (PI-PLC) (10 µg/mL), Tranexamic acid (15 mM)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 minu</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">keratin retraction and desmoplakin were measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Feliciani et al.<sup><a href="#CR122" class="usa-link" aria-describedby="CR122">122</a></sup>
</td>
<td colspan="1" rowspan="1">2003</td>
<td colspan="1" rowspan="1">Urokinase-type plasminogen activator (uPA)</td>
<td colspan="1" rowspan="1">Anti-Urokinase IgG (2 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min and cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Acantholysis was measured by cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Delva et al.<sup><a href="#CR113" class="usa-link" aria-describedby="CR113">113</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">Dynamin II, Caveolin-1</td>
<td colspan="1" rowspan="1">Dynamin II (Dyn K44A) mutant, Caveolin-1 (Y14F) mutant</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Dsg3 internalization assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Vielmuth et al.<sup><a href="#CR73" class="usa-link" aria-describedby="CR73">73</a></sup>
</td>
<td colspan="1" rowspan="1">2015</td>
<td colspan="1" rowspan="1">Cholesterol</td>
<td colspan="1" rowspan="1">β-Methylcyclodextrin (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schlögl et al.<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>
</td>
<td colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">Cholesterol</td>
<td colspan="1" rowspan="1">β-Methylcyclodextrin (1 mM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA, keratin retraction was measured by immunofluorescence microscopy. Dsg3 internalization was measured by immunofluorescence microscopy and western blotting.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Choi et al.<sup><a href="#CR114" class="usa-link" aria-describedby="CR114">114</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">RPGRIP1L</td>
<td colspan="1" rowspan="1">RPGRIP1L siRNA KD</td>
<td colspan="1" rowspan="1">Cells were transfected prior to calcium switch</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Dsg3 internalization was measured by immunofluorescence microscopy</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p14"><p>Treatment modalities: Pretreatment, Intervention added before antibody application. Cotreatment, Intervention added simultaneously with the antibody. Posttreatment, Intervention added after antibody application. Model: Ex vivo, human skin organ culture. In vitro, 2D cultured keratinocyte cell lines or primary cells. PTNM, Passive transfer neonatal mouse model. PTAM, Passive transfer adult mouse model. Antibodies: mPV IgG, mucosal PV IgG. mcPV IgG, mucocutaneous PV IgG. atPV IgG, Atypical PV IgG. PF IgG, pemphigus foliaceus IgG. Preventing Pathology: ( + ) effective in preventing antibody-induced pathology, (-) Ineffective in preventing antibody-induced pathology, (x) worsened antibody-induced pathology. <em>KDA</em> Keratinocyte dissociation assay, <em>NA</em> Not Available.</p></div></div></section></section><section id="Sec5"><h3 class="pmc_sec_title">Cell adhesion molecules and associated proteins</h3>
<p id="Par9">Dsg3 and Dsg1 have been identified as major targets in PV. In support of this clinical finding, the pathogenic impact of anti-Dsg3 and anti-Dsg1/3 antibodies can be completely abolished by removal of Dsg3 or Dsg1 antibodies from patients serum<sup><a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>. In line, cultured Dsg3 gene knockout keratinocytes or Dsg3-deficient mice mimic the PV phenotype in terms of blister sites and altered signaling<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. Further supporting the unique functional role of Dsg3 and Dsg1, PV antibodies and to some extent also PF antibodies remained pathogenic after Dsg2 knockout. In agreement with these findings as well as the fact that Dsg3 is endocytosed upon PV antibody binding, Dsg3 overexpression exerted an inhibitory effect on cell sheet fragmentation in vitro<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>. Two other studies have demonstrated that the stabilization of Dsg adhesion, achieved by cross-linking the binding pockets of two trans-interacting Dsg3 or Dsg1 molecules, can partially mitigate the PV phenotype of intercellular gap formation, altered Dsg3 localization, loss of intercellular adhesion, and blister formation in both in vitro and in vivo models<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>,<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Building upon the finding on predominant targeting of extra-desmosomal Dsg3 by PV antibodies<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>, Nguyen et al.<sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup> have proposed that the gene knockout of <em>Perp</em> is associated with a decrease in Dsg3 levels in desmosomes and concurrent increase of Dsg3 in the extra-desmosomal compartment. Consistently, <em>Perp</em> knockout was found to exacerbate the PV antibody-induced weakening of intercellular adhesion, an effect that was attributed to elevated levels in the extra-desmosomal Dsg3 pool (conceivably increasing the number of antibody targets). These observations also suggested that Perp plays an integral role in modulating the distribution of Dsg3 between the desmosomal and non-desmosomal compartments.</p>
<p id="Par10">Other than desmosomal cadherins, the role of E-cadherin has also been investigated in PV. Multiple laboratories reported that the plasma membrane-bound expression and localization as well as related Wnt/β-catenin signaling were unaffected during blister initiation<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>, while a considerable increase in E-cadherin, β-catenin and JUP expression at the plasma membrane marked regenerative processes of morphological repair in a mouse model for hair follicle blistering<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>, suggesting mechanosensitive feedback mechanisms. Rötzer et al.<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup> further reported that overexpression of E-cadherin was able to mitigate the PV IgG-induced fragmentation in HaCaT keratinocytes, by so far unknown mechanisms, while E-cadherin knockdown decreased desmosome formation and intercellular adhesive strength<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>, supporting a mutual crosstalk and direct association of these adhesion receptors<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>,<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>–<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>.</p>
<p id="Par11">Signaling through extra-desmosomal Dsg3, described and investigated in PV by means of biochemical and electron microscopical approaches since more than three decades<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>–<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>, presumably occur in main conjunction with associated plaque proteins JUP and plakophilin 1–3, as well as p38MAPK, and actin<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a></sup>. Once integrated into desmosomes, the desmosomal cadherins and their plaque proteins anchor to the keratin filament cytoskeleton through association with desmoplakin<sup><a href="#CR55" class="usa-link" aria-describedby="CR55">55</a></sup>. The plaque proteins are also known transducers of mechanical signals as further discussed below<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>,<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>,<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a></sup>. Studies have demonstrated that PV IgG or Fab-induced keratin retraction, disruption of the desmosomal plaque and loss of cell-cell adhesion were eliminated in JUP knockout keratinocytes, supporting the implication of JUP in the process, while pathogenic effects were rescued upon moderate ectopic expression of JUP<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>. However, conflicting findings have been reported, indicating that both knockdown or overexpression of JUP exacerbate antibody-induced fragmentation<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>. Given the functional implication of JUP at the plasma membrane, in the cytoplasm and in the nucleus in PV<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>, alterations in its distribution resulting from knockdown or overexpression may contribute to the observed discrepancies which prompt further investigations. Notably, a recent study by Sigmund et al.<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup> unveiled that intracellular adhesion is impaired in keratinocytes with S665 phospho-deficient JUP, and the exposure to PV antibodies do not result in further alteration. This highlights the importance of JUP phosphorylation in PV pathogenesis and loss of desmosomal integrity. In addition to JUP, the role of other desmosomal plaque proteins has also been investigated in PV pathogenesis. Specifically, studies have shown that the knockout of plakophilin 3<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup> or the overexpression of plakophilin 1<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup> attenuated the antibody-induced loss of intercellular adhesion. Conceivably, the knockdown of desmoplakin was found to facilitate and thus enhance the AK23 antibody-induced fragmentation of keratinocytes<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup>. These findings highlight the complex and variable roles that different desmosomal cadherin components in transmitting the pathological effects of PV autoantibodies to cell-cell adhesion, which is still largely unresolved</p>
<p id="Par12">In mouse and human keratinocytes under homeostatic conditions, co-immunoprecipitation revealed that extra-desmosomal Dsg3 and Dsg1 also associate with p38MAPK<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>,<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>. Upon PV antibody binding, pathogenic activation/phosphorylation of p38MAPK has been consistently emphasized and was shown to causally link loss of Dsg3 transadhesion to proteins anchoring Dsg1/3 to the cytoskeletal, such as actin or keratin intermediate filaments, followed by loss of intercellular adhesion<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>,<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>. The four p38MAP kinase isoforms (p38α, p38β, p38γ, p38δ (MAPK14, 11, 12, 13)) as well as multiple p38 splice variants of this ubiquitously expressed MAP kinase superfamily are pleotropic responders to environmental, intracellular and pathological stresses to ensure cell survival and they exhibit distinct but also overlapping and compensatory functions<sup><a href="#CR62" class="usa-link" aria-describedby="CR62">62</a></sup>. Of interest in the context of PV is that p38MAP kinases are typically activated by mechanical insult, to phosphorylate, in case of the most studied family member p38α, over 100 protein targets throughout all cellular compartments, including the nucleus. P38MAPK targets involve transcription factors, DNA/DNA binding proteins as well as kinases and structural proteins including actin and keratins. Hence, p38MAPK regulate a wide range of processes in response to mechanical stress from transcription, chromatin remodeling, mRNA stability, cell cycle regulation and translation to protein degradation and localization, endocytosis, metabolism, and cytoskeleton dynamics including migration<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>,<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a></sup>, of which only a few processes have been assigned to PV so far. In the epidermis and other epithelial tissues, the three mainly expressed p38MAPK isoforms are p38α, p38γ and p38δ. In this context, it is noteworthy that current p38MAPK inhibitors, of interest in therapeutic approaches in PV, only effectively inhibit the p38α and p38β but not or to a lesser extent the p38γ and p38δ isoforms<sup><a href="#CR62" class="usa-link" aria-describedby="CR62">62</a></sup>. Hence, it is currently not known to which extent these isoforms operate and compensate for each other in PV, which might be the reason for some discrepant results described below.</p>
<p id="Par13">PV IgG-induced p38MAPK phosphorylation occurs rapidly, with peaks observed as early as after 15 min<sup><a href="#CR64" class="usa-link" aria-describedby="CR64">64</a></sup> which further propagate in waves up to the final blister formation<sup><a href="#CR65" class="usa-link" aria-describedby="CR65">65</a></sup>. The studies utilizing p38α and p38β or p38α inhibitors SB202190 and EO1428, and the broad range BIRB 796 inhibitor showed significant inhibition of intercellular adhesion loss in different models and with several antibodies<sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>,<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>,<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>–<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>. Interestingly, Mao et al. revealed the involvement of p38MAPK in Dsg3 internalization triggered by an experimental Dsg3/1 monoclonal antibody cloned from a PV patient<sup><a href="#CR79" class="usa-link" aria-describedby="CR79">79</a></sup>. However, conditional deletion of p38α in mouse epidermis was not sufficient to protect against this antibody-induced blistering<sup><a href="#CR80" class="usa-link" aria-describedby="CR80">80</a></sup>. A later study by Mao et al. showed that while some knockout animals developed subcorneal blisters, suprabasal blister formation was significantly decreased in mice lacking epidermal p38α<sup><a href="#CR71" class="usa-link" aria-describedby="CR71">71</a></sup>. This said, it is worth mentioning that the study by Mao et al. is the only one which addressed a specific p38MAPK isoform in PV. The result of this seminal work evokes the possibility that not only p38α but also the p38γ or p38δ isoforms contribute to PV blistering, or, alternatively, that p38γ or p38δ compensate in case of p38α deletion<sup><a href="#CR62" class="usa-link" aria-describedby="CR62">62</a></sup>. Involvement or compensation of other isoforms might also be the reason that p38α and p38β inhibitors like <a href="https://www.ncbi.nlm.nih.gov/nuccore/PD169316" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">PD169316</a> and SB203580 were in some cases less effective or ineffective in preventing intercellular adhesion loss. Some of these studies also concluded on p38MAPK activation down- instead of upstream of PV blistering, which however might pertain to the finding that keratin retraction/p38MAPK activation and Dsg3 endocytosis are complementary processes<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>. Similarly, Saito et al. discovered that SB202190 inhibited PV IgG-induced blistering and fragmentation but not the one of AK23 in vitro and ex vivo<sup><a href="#CR68" class="usa-link" aria-describedby="CR68">68</a></sup>; however, subsequent studies demonstrated its efficacy in inhibiting AK23-induced pathogenic effects<sup><a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>,<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>–<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>.</p>
<p id="Par14">Cell-Matrix adhesion molecules constitute an important mechanosensory apparatus of epithelial cells that cross-talk to cell-cell adhesion molecules as might also be the case in PV<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a></sup>. Recruitment and activation/phosphorylation of Src to cell-cell contacts and receptor tyrosine kinases such as EGFR family members is considered a mechano-switch to tune tissue-specific functions. This includes functional deregulation of E-cadherin and integrin adhesion implicating focal adhesion kinase (FAK) downstream of RhoA activation<sup><a href="#CR83" class="usa-link" aria-describedby="CR83">83</a></sup>. Chernyavsky et al. were the first to demonstrate that Src is activated by PV IgG treatment; however, knockdown of Dsg1 or Dsg3 did not reduce Src activation<sup><a href="#CR84" class="usa-link" aria-describedby="CR84">84</a></sup>. Recently, Egu et al. showed that PV IgG, but not PF IgG, activate several Src family kinases, including Blk, Yes, Fyn, Frk, Lck, and Src<sup><a href="#CR85" class="usa-link" aria-describedby="CR85">85</a></sup>. Although numerous studies across various models have reported the beneficial effects of Src inhibition downstream of EGFR<sup><a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>,<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>,<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>–<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a></sup>, its efficacy was found to be antibody- and time-dependent<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>,<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>,<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a></sup>. However, decoupling Src from actin remodeling via the E-cadherin-based cortactin seemed not critical for epidermal blistering in an ex-vivo model in presence of anti-Dsg3 and Dsg1 antibodies as described by Kugelmann et al.<sup><a href="#CR90" class="usa-link" aria-describedby="CR90">90</a></sup>. This may suggest that the anti-Dsg1 antibodies in PV can activate rescue signaling pathways to prevent blistering. Gil et al. revealed that FAK is significantly phosphorylated at tyrosine 397/925 by PV IgG through epidermal growth factor receptor (EGFR) activation, and FAK inhibition abolished PV IgG induced blister formation in the neonatal passive transfer mouse model<sup><a href="#CR87" class="usa-link" aria-describedby="CR87">87</a></sup>. Later, they further elucidated the signaling pathways involved and showed that activation of EGFR induces phosphorylation of FAK through the neuronal nitric oxide synthase (nNOS) pathway in PV<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>. FAK phosphorylation at tyrosine residue 397 is considered an autophosphorylation site, while tyrosine residue 925 is Src or EGFR dependent. As EGFR and contextual Src activation play an important role in PV pathogenesis, mechanosensing through FAK activation can also be anticipated in PV<sup><a href="#CR93" class="usa-link" aria-describedby="CR93">93</a>,<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a></sup>. Interestingly, addition of fibronectin, a binding partner of integrins and an activator of FAK to an ex vivo model of PV was found to reduce acantholysis and intraepidermal binding of the pemphigus antibodies<sup><a href="#CR95" class="usa-link" aria-describedby="CR95">95</a></sup>.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Cytoskeleton</h3>
<p id="Par15">Keratins, the key components of intermediate filaments in the epidermis, play a pivotal role in the anchoring and stabilization of desmosomes and are essential for maintaining proper desmosomal adhesion and tissue integrity<sup><a href="#CR96" class="usa-link" aria-describedby="CR96">96</a>,<a href="#CR97" class="usa-link" aria-describedby="CR97">97</a></sup>. Furthermore, they are long known to contribute to mechanosensing for example via Keratin8/18-mediated modulation of the small GTPase RhoA<sup><a href="#CR82" class="usa-link" aria-describedby="CR82">82</a></sup> which can be controlled by p38MAPK<sup><a href="#CR63" class="usa-link" aria-describedby="CR63">63</a></sup>. The typical morphological characteristic of keratin filament retraction from cell borders is a common feature observed across all clinical phenotypes of pemphigus and can be detected in in vitro and ex vivo pemphigus models as well as in patients’ non-lesional and lesional epithelia, thus preceding bona fide blister formation. Furthermore, keratins account for the mechanical properties of keratinocytes, underscoring their critical importance in the maintenance of tissue integrity. Vielmuth et al.<sup><a href="#CR76" class="usa-link" aria-describedby="CR76">76</a></sup> found that the knockout of keratin cluster II significantly impaired intercellular adhesion compared to wild-type cells while the subsequent treatment with AK23, PV-IgG or PF-IgG did conceivably not further compromise intercellular adhesion. Although the mechanism by which the desmoplakin/keratin anchorage is compromised in PV is still largely unknown, it can be anticipated to occur through inside-out signaling under control of the many competent effectors downstream of PV antibody-mediated Dsg3/Dsg1 receptor signaling (Figs. <a href="#Fig1" class="usa-link">1</a>–<a href="#Fig3" class="usa-link">3</a>).</p>
<p id="Par16">Studies on PV attest to the critical role of the actin cytoskeleton in regulating the crosstalk between E-cadherin- and Dsg3 to assemble and disassemble desmosomes<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>,<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a></sup>. Patel et al.<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup> were first to address the direct causal contribution of changes in actin and tubulin cytoskeletal in PV. Using mouse keratinocytes, they demonstrated that the preincubation with inhibitors of actin (Cytochalasin D) or tubulin (Colchicine) polymerization, both individually and in combination, failed to diminish the internalization and binding of PV IgG upon stimulation with PV sera. Conversely, Gliem et al.<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup> found that pretreatment with a 10-fold lower dose of Cytochalasin D, enhanced internalization and aggravated PV IgG induced loss of intercellular adhesion in HaCaT keratinocytes. Consistently, the incubation of cells with the actin-stabilizing agent jasplakinolide enhanced junction stability, reduced the pathogenicity in terms of PV IgG-induced sheet fragmentation and rescued Dsg3 localization at cell borders. Jennings et al.<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup> tested another inhibitor of actin polymerization (Lantraculin D) on human keratinocytes with similar results.</p>
<p id="Par17">A change in mechanical forces requires actin cytoskeleton re-organization, more precisely contraction of actin through the actomyosin motor proteins. The actomyosin activity can be modulated by the calcium-binding protein calmodulin, which triggers the phosphorylation of myosin light chains and the subsequent contraction of the actomyosin complex. Sánchez-Carpintero et al.<sup><a href="#CR99" class="usa-link" aria-describedby="CR99">99</a></sup> utilized the calmodulin inhibitor W-7 hydrochloride to prevent PV IgG induced blister formation in neonatal mice. Similarly, Sumigray et al.<sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup> revealed that treating mouse keratinocytes with AK23 leads to increased contractility, and knocking out Myh9 (Myosin IIA) inhibits AK23-induced cell sheet fragmentation, suggesting a role for myosin IIA and actomyosin contraction in PV loss of adhesion. Intriguingly, short-term RhoA-mediated actin contraction and PKCα activation of desmoplakin/keratin interaction was found to result in desmosome assembly.</p>
<p id="Par18">Modulators of actin dynamics are the Rho family of small GTPases as well as cortactin, actomyosin and α-adducin, which also stabilize the junctional cortex<sup><a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>–<a href="#CR102" class="usa-link" aria-describedby="CR102">102</a></sup>. Specifically, the Rho family of GTPases are mechano-transducers which function as highly complex molecular switches between fates by regulating actin polymerization, cell polarity, vesicular trafficking, cell contraction, and mitosis<sup><a href="#CR103" class="usa-link" aria-describedby="CR103">103</a></sup>. Accordingly, transient RhoA/Rac activation is involved in the stabilization of transadhering E-cadherin-based contacts and maintenance of Myosin II association to uphold junctional contractile force regulated, for example, by cortactin and α-adducin phosphorylation to drive the desmoplakin-keratin interaction for desmosome assembly and keratinocyte differentiation<sup><a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>,<a href="#CR98" class="usa-link" aria-describedby="CR98">98</a>,<a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>,<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a></sup>. However, under mechanical tension, as introduced above, sustained RhoA activation can implicate K8/K18 and JUP recruitment to sites of cellular tension to reinforce F-actin stress fibers<sup><a href="#CR82" class="usa-link" aria-describedby="CR82">82</a></sup> while compromising desmosome plaque maturation<sup><a href="#CR98" class="usa-link" aria-describedby="CR98">98</a></sup>, a process likely implicating p38MAPK<sup><a href="#CR63" class="usa-link" aria-describedby="CR63">63</a></sup>. The subsequent loss of tension and RhoA/Rac-1 inhibition would then lead to rapid disruption of junctional integrity<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>,<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>,<a href="#CR106" class="usa-link" aria-describedby="CR106">106</a></sup>.</p>
<p id="Par19">Indicative of inhibition of Rho family members in desmosome disassembly in PV, the non-selective and selective RhoA activators CNF-1 (RhoA, Rac1, and Cdc42 activators) and CNFy (RhoA) significantly reduced weakening of desmosomes in ex vivo and in vitro models in response to PV IgG<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>,<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>,<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a></sup>. Waschke et al.<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup> also showed that CNFy increased stress fiber formation along junctions and abolished cell sheet fragmentation and desmoplakin re-organization. In a follow-up study the group further confirmed that inhibition of actin polymerization (using Lantraculin B), the target of RhoA, abolished the protective effect of this RhoA activator<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. Although the above-mentioned studies used patient-derived PV IgG, Jin et al. and Rötzer et al. reported similar results with PV IgG and the pathogenic monoclonal anti-Dsg3 antibody AK23<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>,<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>,<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a></sup>. Additionally, Rötzer et al. discovered that the protective effect of pharmacological RhoA activation is diminished by silencing α-adducin, increasing fragmentation, compatible with the understanding that the actin-binding protein α-adducin is regulated by RhoA and PKC<sup><a href="#CR108" class="usa-link" aria-describedby="CR108">108</a></sup> to promote E-cadherin/Dsg3 interaction and stabilization at the plasma membrane preceding desmosome formation<sup><a href="#CR109" class="usa-link" aria-describedby="CR109">109</a></sup>. Intriguingly, Rötzer et al. further demonstrated that α-adducin is serine-phosphorylated, hence activated, in response to AK23 or PV IgG, and found this to occur via calcium influx and PKC<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>. The authors thus discussed that α-adducin activation through calcium/PKC-mediated phosphorylation represents a rescue mechanism in PV. Collectively, these studies suggested that Dsg3 antibody-mediated inhibition of Rho GTPases alters the cytoskeletal architecture in keratinocytes preceding acantholysis, potentially paralleled by a rescue mechanism involving RhoA activation and tyrosine phosphorylation of α-adducin on Ser726. Beyond pharmacological modulation of mechanical structures and mechanosensing pathways, Jin et al.<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup> applied cyclic mechanical stretching of cell sheets. They conceivably found this to have the opposite effect than the suggested release of tension/transadhesion on Dsg3 by PV antibodies described above, namely, to reduce p38MAPK phosphorylation and enhance RhoA recruitment to cell boarders which, in line with the findings above, mitigated AK23-induced loss of intercellular adhesion. This is compatible with the concept of protective mechanisms discussed by Rötzer et al.<sup><a href="#CR108" class="usa-link" aria-describedby="CR108">108</a></sup> and potentially with regenerative mechanisms following shrinkage of desmosomes and blister formation reported in hair follicle stem cells of the adult passive transfer mouse model for PV<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. However, as discussed by Jin et al.<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>, it can currently not be distinguished whether pharmacological Rho GTPase activation prior blistering prevents an initial Rho GTPase inhibition in PV (Table <a href="#Tab1" class="usa-link">1</a>) or strengthens the E-cadherin/actin/actomyosin complex to bear increased mechanical force and balance loss of tension at desmosomal complexes. Notwithstanding, both possibilities are indicative of inside-out signaling weakening desmosomes, urging the application of advanced longitudinal techniques to respond to these questions.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Plasma membrane and Endocytosis</h3>
<p id="Par20">Endocytosis is a mechanosensitive process that involves precise orchestration of tightly regulated mechanical cues such as dynamic remodeling of the plasma membrane that occurs at the sub-micrometer level. Mechanistically, a range of conditions influence the membrane remodeling process including plasma membrane tension<sup><a href="#CR110" class="usa-link" aria-describedby="CR110">110</a></sup>. Signaling-wise, actin-based endocytosis can potentially implicate some of the here described key effectors in PV such as p38MAPK, RhoA, cdc42 and PKCα<sup><a href="#CR111" class="usa-link" aria-describedby="CR111">111</a>,<a href="#CR112" class="usa-link" aria-describedby="CR112">112</a></sup>. Delva et al.<sup><a href="#CR113" class="usa-link" aria-describedby="CR113">113</a></sup> evaluated the role of different endocytic pathways in PV IgG-induced-Dsg3 internalization. They found that caveolin-1 or dynamin II knockout did not affect AK23-induced Dsg3 internalization in cells. However, the alteration of lipid rafts via filipin or nystatin treatment drastically prevented the PV-IgG or AK23-induced internalization of Dsg3, suggesting a clathrin- and dynamin-independent but cholesterol-dependent mechanism for Dsg3 endocytosis in PV. Consistent with these findings, two other studies using another lipid raft inhibitor, methyl-β-cyclodextrin, reported similar results<sup><a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>,<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>. Interestingly, the inhibition of Dsg3 endocytosis was found to prevent the antibody-induced loss of intercellular adhesion, but did not affect keratin retraction or p38MAPK phosphorylation, indicating that these pathological phenomena may be independent processes<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>. Most intriguingly, Pigmentosa GTPase regulator interacting protein 1-like (RPGRIP1L) was found to specifically control the endocytosis of desmoglein but not desmocollin cadherins, and the knockout of RPGRIP1L in mice led to shrinkage of desmosomes and spontaneous development of suprabasal blisters reminiscent of PV. Furthermore, in HaCaT keratinocytes, RPGRIP1L knockdown resulted in the internalization of Dsg3 and a loss of intercellular adhesion. Notably, the treatment of RPGRIP1L knockdown cells with PV antibodies further reduced cell-cell adhesion, potentially suggesting complementary pathways<sup><a href="#CR114" class="usa-link" aria-describedby="CR114">114</a></sup>, such as described above with regards to keratin retraction/p38MAPK activation and Dsg3 endocytosis<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>.</p>
<p id="Par21">The plasminogen activator enzyme (Pa) system has been linked to diverse cellular effects. Notably, Pa functions as both proteolytic enzyme (to convert e.g., plasminogen to plasmin) and signal transducer and interacts with a variety of mechanosensitive receptors, including EGFR, cadherins and integrins<sup><a href="#CR115" class="usa-link" aria-describedby="CR115">115</a></sup>. Two seminal studies by Hunziker and Morioka evaluated the role of this system in PV. Hunziker and Vessalli<sup><a href="#CR116" class="usa-link" aria-describedby="CR116">116</a></sup> demonstrated that either addition of plasminogen or plasmin to an ex vivo PV model or high doses of plasmin alone were capable of enhancing or inducing acantholysis, respectively. Furthermore, Morioka et al.<sup><a href="#CR117" class="usa-link" aria-describedby="CR117">117</a></sup> revealed that an anti-urokinase plasminogen activator (uPA) antibody completely blocked PV IgG-induced acantholysis, subsequently confirmed by multiple groups using various uPA inhibitors<sup><a href="#CR118" class="usa-link" aria-describedby="CR118">118</a>–<a href="#CR122" class="usa-link" aria-describedby="CR122">122</a></sup>. The discussion regarding the involvement of the Pa system came to a conclusion by a thorough analysis by Mahoney et al.<sup><a href="#CR123" class="usa-link" aria-describedby="CR123">123</a></sup>, which showed uPA or tissue-type plasminogen activator (tPA) KO alone or combined have no impact on PV IgG-induced blister formation in neonatal mice. It is noteworthy, however, that tPA KO animals had a tendency for milder disease.</p>
<p id="Par22">These collective results support the notion that biomechanical signaling through desmosomal cadherins, which is a relatively recent field of research, plays a key role in desmosome shrinkage in PV. It implicates Rho GTPases and the re-organization of the actin/actomyosin cytoskeleton while highlighting a crosstalk between E-cadherin- and Dsg3/1-based plasma membrane exposed molecules and/or junctions in balancing cellular forces. These results give guidance for further research on identifying and discriminating between signals by these respective stress-bearing cadherins including the crosstalk to integrins in epithelial cells and PV.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Electrical signaling</h3>
<p id="Par23">Only a limited number of studies, in total 22, have addressed causative electric potential/ion signaling in PV pathogenesis with main focus on the role of calcium ions and calcium-responsive molecules summarized in Table <a href="#Tab2" class="usa-link">2</a> and Fig. <a href="#Fig2" class="usa-link">2</a>. Occurring within seconds after anti-Dsg1 or anti-Dsg3 antibody incubation, as first reported by Seishima et al. in the squamous cell carcinoma keratinocyte line DJM-1<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>, an increase in intracellular calcium flux is the fastest signal recorded so far after antibody incubation. It can be mediated through various mechanisms, such as activating calcium channels at the plasma membrane or releasing calcium from intracellular stores like the endoplasmic reticulum<sup><a href="#CR124" class="usa-link" aria-describedby="CR124">124</a></sup>. Upon stimulation, opening of plasma membrane calcium channels allows extracellular calcium to enter the cytosol, while calcium release from intracellular stores can be triggered by IP3R activation caused by Inositol 1,4,5-trisphosphate (IP3) production through Phosphatidylinositol 4-Kinase alpha (PI4Kα) and Phospholipase C (PLC). Seishima et al. showed an increase in IP3 and release of calcium from intracellular stores following anti-Dsg1 or anti-Dsg3 antibody treatment in keratinocyte 2D cultures<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Characteristics of studies included in bioelectrical signaling axis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Author</th>
<th colspan="1" rowspan="1">Year</th>
<th colspan="2" rowspan="1">Target molecule</th>
<th colspan="1" rowspan="1">Intervention</th>
<th colspan="1" rowspan="1">Treatment Modality</th>
<th colspan="1" rowspan="1">Model</th>
<th colspan="1" rowspan="1">Antibody</th>
<th colspan="1" rowspan="1">Preventing Pathology</th>
<th colspan="1" rowspan="1">Measured Outcome</th>
</tr></thead>
<tbody>
<tr><td colspan="10" rowspan="1"><strong>Calcium, calcium channels, and calcium activated proteins</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Arredondo et al.<sup><a href="#CR125" class="usa-link" aria-describedby="CR125">125</a></sup>
</td>
<td colspan="1" rowspan="1">2005</td>
<td colspan="2" rowspan="1">Calpain I and II</td>
<td colspan="1" rowspan="1">MDL-28170 (10 µM), PD-150606 (50 µM), Calpastatin peptide (50 µM), MDL-28170 (10 µM) + PD-150606 (50 µM) + Calpastatin peptide (50 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">Morphometric analysis of acantholysis in vitro and in vivo</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kalantari-Dehaghi et al.<sup><a href="#CR126" class="usa-link" aria-describedby="CR126">126</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="2" rowspan="1">Calcineurin</td>
<td colspan="1" rowspan="1">Cyclosporine A (0.1 μM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Morphometric anaylsis of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rötzer et al.<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="2" rowspan="1">Intracellular Calcium</td>
<td colspan="1" rowspan="1">BAPTA-AM (50 µM)</td>
<td colspan="1" rowspan="1">Cotreatment for 4 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="2" rowspan="1">Intracellular Calcium</td>
<td colspan="1" rowspan="1">BAPTA-AM (200 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 4 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">mPV IgG, mcPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>
</td>
<td colspan="1" rowspan="1">2021</td>
<td colspan="2" rowspan="1">CRAC, PI4KA</td>
<td colspan="1" rowspan="1">BTP-2 (NA), GSK-F1 (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro, Ex vivo</td>
<td colspan="1" rowspan="1">mPV IgG, mcPV IgG, AK23, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA and keratin retraction measured by immunofluorescence microscopy. Ex vivo: Gross and microscopic evaluation of tissue.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="2" rowspan="1">CRAC, PI4K</td>
<td colspan="1" rowspan="1">BTP-2 (10 µM), GSK-F1 (10 nM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">2G4</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Xie et al.<sup><a href="#CR127" class="usa-link" aria-describedby="CR127">127</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="2" rowspan="1">Calcineurin</td>
<td colspan="1" rowspan="1">FK506 (100 nM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA, Immunofluorescence microscopy, and western blotting was performed for Dsg3 depletion</td>
</tr>
<tr><td colspan="10" rowspan="1"><strong>PLC, IP3R and PI3K</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Esaki et al.<sup><a href="#CR128" class="usa-link" aria-describedby="CR128">128</a></sup>
</td>
<td colspan="1" rowspan="1">1995</td>
<td colspan="1" rowspan="1">PLC</td>
<td colspan="2" rowspan="1">U73122 (10 µM)</td>
<td colspan="1" rowspan="1">Pre and cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG or sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sánchez-Carpintero et al.<sup><a href="#CR99" class="usa-link" aria-describedby="CR99">99</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">PLC</td>
<td colspan="2" rowspan="1">U73122 (100 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 3 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Burmester et al.<sup><a href="#CR77" class="usa-link" aria-describedby="CR77">77</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">PI3Kα, PI3Kβ</td>
<td colspan="2" rowspan="1">A66 (0.1, 1, and 10 µM), TGX-221 (0.1, 1, and 10 µM)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 2 h then discarding supernatant. Ex vivo: Cotreatment</td>
<td colspan="1" rowspan="1">A66: In vitro, ex vivo. TGX-221: in vitro</td>
<td colspan="1" rowspan="1">In vitro: Immunophresis material from PV patient. ex vivo: PX43 scFv</td>
<td colspan="1" rowspan="1">A66 ( + ), TGX-221 (-)</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Gross and light microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>
</td>
<td colspan="1" rowspan="1">2021</td>
<td colspan="1" rowspan="1">PLC, IP3R</td>
<td colspan="2" rowspan="1">U73122 (Cell culture: NA, HSOC: 50 µL of 4 µM), Xestospongin C (Cell culture: NA, HSOC: 50 µL of 2 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 hour</td>
<td colspan="1" rowspan="1">In vitro, Ex vivo</td>
<td colspan="1" rowspan="1">mPV IgG, mcPV IgG, AK23, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA and keratin retraction measured by immunofluorescence microscopy. Ex vivo: Gross and microscopic evaluation of tissue.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egu et al.<sup><a href="#CR130" class="usa-link" aria-describedby="CR130">130</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">PLC, IP3R</td>
<td colspan="2" rowspan="1">U73122 (50 µL of 4 µM), Xestospongin C (50 µL of 2 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+/-</td>
<td colspan="1" rowspan="1">length of desmosomes, percentage of split desmosomes, and keratin retraction was measured by electron microscopy.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hiermaier et al.<sup><a href="#CR129" class="usa-link" aria-describedby="CR129">129</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">PLC, IP3R</td>
<td colspan="2" rowspan="1">U73122 (4 µM), Xestospongin C (0.4 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for1 hour</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">PLC, IP3R</td>
<td colspan="2" rowspan="1">U73122 (4 µM), Xestospongin C (2 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">2G4</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr><td colspan="10" rowspan="1"><strong>PKC</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Kowalewski et al.<sup><a href="#CR133" class="usa-link" aria-describedby="CR133">133</a></sup>
</td>
<td colspan="1" rowspan="1">1994</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Isoquinoline sulfonamide (H7)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sánchez-Carpintero et al.<sup><a href="#CR99" class="usa-link" aria-describedby="CR99">99</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Bisindolylmaleinamide (100 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 3 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR134" class="usa-link" aria-describedby="CR134">134</a></sup>
</td>
<td colspan="1" rowspan="1">2010</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Go6976 (5 nM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Number of single cells were counted as the index of detachment</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Spindler et al.<sup><a href="#CR135" class="usa-link" aria-describedby="CR135">135</a></sup>
</td>
<td colspan="1" rowspan="1">2011</td>
<td colspan="1" rowspan="1">PKC, PKCα</td>
<td colspan="2" rowspan="1">Go6976 (PTNM: 500 nM in 50 µL, in vitro: 500 nM, ex vivo: NA), Safingol (PTNM: 40 µM in 50 µL, in vitro: 40 µM, ex vivo: NA), PKCα siRNA</td>
<td colspan="1" rowspan="1">PTNM: pretreatment for 2 h and Cotreatment. Invitro and ex vivo: Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, ex vivo, PTNM. PKC siRNA only in vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Go6976 and Safingol (+), PKC siRNA (-)</td>
<td colspan="1" rowspan="1">PTNM: Gross and microscopic evaluation of blister formation. In vitro and ex vivo: immunofluorescence microscopy and KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Dehner et al.<sup><a href="#CR136" class="usa-link" aria-describedby="CR136">136</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Bisindolylmaleimide X hydrochloride (Bim-X, 1 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA and keratin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Rötzer et al.<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Bim-X (1 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR75" class="usa-link" aria-describedby="CR75">75</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Bim-X (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, mcPV IgG, mPV IgG, atPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egu et al.<sup><a href="#CR205" class="usa-link" aria-describedby="CR205">205</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">PKC</td>
<td colspan="2" rowspan="1">Bim-X (50 µL of 1 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Blister score and cleft length was calculated based on H&amp;E stained sections. Evaluation of desmosomes were performed by electron microscopy</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p31"><p>Treatment modalities: Pretreatment, Intervention added before antibody application. Cotreatment, Intervention added simultaneously with the antibody. Posttreatment, Intervention added after antibody application. Model: Ex vivo, human skin organ culture. In vitro, 2D cultured keratinocyte cell lines or primary cells. PTNM, Passive transfer neonatal mouse model. PTAM, Passive transfer adult mouse model. Antibodies: mPV IgG, mucosal PV IgG. mcPV IgG, mucocutaneous PV IgG. atPV IgG, Atypical PV IgG. PF IgG, pemphigus foliaceus IgG. Preventing Pathology: ( + ) effective in preventing antibody-induced pathology, (-) Ineffective in preventing antibody-induced pathology, (x) worsened antibody-induced pathology. <em>KDA</em> Keratinocyte dissociation assay, <em>NA</em> Not Available.</p></div></div></section><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Diagram of the signaling network of bioelectrical effectors activated by PV antibody binding to Dsg3 or Dsg1/3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373888_41536_2025_426_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a92/12373888/67d43e67fdb2/41536_2025_426_Fig2_HTML.jpg" loading="lazy" id="d33e522" height="493" width="691" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The figure depicts the reported pathways and molecular interactions centering around the increase of intracellular calcium concentration and consequences thereof (boxes at the bottom). Arrows indicate the interactions between specific molecules involved in the signaling cascade. Effector molecules that have been tested across various experimental PV models and antibody types are highlighted in bold to emphasize their roles within the bioelectrical pathways. This scheme outlines bioelectrical signaling events initiated by PV antibody binding to Dsg proteins, illustrating the potential intervention points and molecular interactions. This figure was created in BioRender. Hariton, W. (2025) <a href="https://BioRender.com/3f3hvc2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/3f3hvc2</a>.</p></figcaption></figure></section><section id="Sec9"><h3 class="pmc_sec_title">Calcium, calcium channels, and calcium activated proteins</h3>
<p id="Par24">Rötzer et al. and Walter et al. confirmed that chelation of intra- and extracellular calcium with BAPTA-AM reduces fragmentation in vitro caused by anti-Dsg1, Dsg3/1 and Dsg3 antibodies, while, conversely, only anti-Dsg1 containing PV IgG caused a measurable cytosolic calcium influx<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>,<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup>. Furthermore, Arredondo et al. demonstrated that inhibiting the calcium-activated cysteine proteases Calpain I and II using MDL-28170, PD-150606, Calpastatin peptide, alone or in combination ameliorates PV IgG-induced acantholysis in both in vitro and in vivo PV models. However, the effectiveness was only seen for one of the two tested PV IgG antibodies in the in vivo model, with no information on the anti-Dsg1/3 profile<sup><a href="#CR125" class="usa-link" aria-describedby="CR125">125</a></sup>. Calcineurins, activated by Calcium influx and calmodulins upstream of nuclear translocation of NFAT transcription factors, were also shown to be involved in PV pathogenesis<sup><a href="#CR126" class="usa-link" aria-describedby="CR126">126</a>,<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a></sup>. Schmitt et al., also investigated the role of Calcium release-activated channels (CRAC), and PI4KA in two separate studies<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>. Their research demonstrated that PI4KA and CRAC inhibitors effectively prevented antibody-induced loss of intercellular adhesion restricted to anti-Dsg1 antibodies or PV IgG containing both anti-Dsg1 and 3 antibodies but not anti-Dsg3 antibodies alone or AK23 or 2G4. Although these results contrast with initial findings<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>, it is noteworthy that anti-Dsg3 antibody containing PV IgG used in these two studies were not able to fragment normal epidermal keratinocyte sheets, suggesting experimental conditions with high expression of compensatory Dsg1 levels preventing fragmentation<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. This suggested that complementary pathogenic signaling pathways can be activated by the anti-Dsg1 antibodies in PV IgG. However, recent studies have challenged this notion, revealing that intracellular calcium influx is specific for the anti-Dsg3/Dsg1-targeted epitope<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>. Notably, anti-Dsg3 antibodies targeting the extracellular domain 1 (EC1) such as AK23, a monoclonal anti-Dsg3 antibody, failed to induce calcium influx in normal human keratinocytes, whereas 2G4, another monoclonal antibody against the membrane proximal part of Dsg3, triggered calcium influx. These results need further investigations as they seemingly are not compatible with findings on IP3 inhibition which is later discussed in detail<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>. Furthermore, only inhibition of CRAC, but not PLC, IP3R, or PI4Kα, resulted in the suppression of 2G4-induced intracellular calcium influx, suggesting an alternative pathway for opening intracellular calcium channels besides the PLC pathway. Inhibitors of upstream signaling of calcium have also shown varying results with monoclonal anti-Dsg3 antibodies. While PLC inhibition partially abrogated AK23 induced loss of intercellular adhesion, this effect was not observed with 2G4<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>. Altogether, these results suggest the testable hypothesis that the Dsg1 expression level of keratinocytes is crucial to study the ability of anti-Dsg3 antibody alone on triggering a calcium influx.</p></section><section id="Sec10"><h3 class="pmc_sec_title">PLC, IP3, IP3R, Ca2 + , PKC</h3>
<p id="Par25">The PLC/IP3/calcium release axis from intracellular stores relies on PLC recruitment to cell adhesion receptors at the plasma membrane such as Dsg3 and Dsg1<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>; hence, hindering PLC can diminish calcium release from intracellular stores as well as through extracellular ion channels. Several studies have explored the involvement of PLC in PV pathogenesis through various models. Esaki et al., Hiermaier et al. Schmitt et al. 2021 and 2023 utilized in vitro models. Except for Schmitt et al. 2023 who used 2G4 (a monoclonal pathogenic antibody against the juxtaposed membrane domain EC5 of Dsg3), all studies showed PLC inhibition to be effective in preventing PV IgG-mediated (with and without anti-Dsg1 antibodies) loss of intercellular adhesion<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>,<a href="#CR128" class="usa-link" aria-describedby="CR128">128</a>,<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a></sup>. This was further supported by the findings of Sánchez-Carpintero et al. and Schmitt et al. in 2021, using passive transfer neonatal mouse and ex vivo PV models, respectively<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a></sup>. Through electron microscopy, Egu et al. further illustrated that inhibiting PLC notably reduced PV IgG-induced keratin retraction, though it did not affect desmosome shrinkage, numbers, or splitting<sup><a href="#CR130" class="usa-link" aria-describedby="CR130">130</a></sup>, consistent with p38MAPK-dependent and independent pathways in PV<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup> (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<p id="Par26">Following the activation of PLC and the subsequent production of IP3, the inositol IP3 receptor (IP3R) is activated, leading to the opening of calcium channels on the tricellular organelles such as the endoplasmic reticulum. Schmitt et al. 2021, 2023, Egu et al. and Hiermaier et al. used IP3R inhibitors to validate implication of this receptor in PV pathogenesis<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>,<a href="#CR129" class="usa-link" aria-describedby="CR129">129</a>,<a href="#CR130" class="usa-link" aria-describedby="CR130">130</a></sup>. In line with results of PLC inhibition, all studies showed that IP3R inhibition is effective in preventing antibody induced loss of intercellular adhesion, except for 2G4. Moreover, electron microscopic evaluation revealed that IP3R inhibition significantly decreased PV IgG-induced desmosome splitting and keratin retraction while it had no effect on shrinkage of desmosomes, presumably being modulated by enhanced Dsg3 turn-over, which was unexpected in light of the activities of PLC described above<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>.</p>
<p id="Par27">Protein Kinase C (PKC) which is activated downstream of deacyl glycerol (DAG) or Ca2+ release from intracellular stores (Figs. <a href="#Fig2" class="usa-link">2</a> and <a href="#Fig3" class="usa-link">3</a>), plays a crucial role in signal transduction, regulating the structure, composition, and function of desmosomes<sup><a href="#CR131" class="usa-link" aria-describedby="CR131">131</a></sup>. Osada et al. were the first to demonstrate that antibody stimulation activates Ca2 + - and diacylglycerol (DAG)-dependent PKCα, as well as DAG-dependent PKCs δ and η, and atypical PKC (ζ), with recruitment to the plasma membrane, occurring as early as 30 s post-stimulation<sup><a href="#CR132" class="usa-link" aria-describedby="CR132">132</a></sup>. This activation aligns with increased Ca2+ influx and phospholipase C (PLC) activation described above. Various studies employing in vitro and patient-derived PV models have indicated that PKC inhibition can prevent PV-related pathologies<sup><a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>,<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>,<a href="#CR99" class="usa-link" aria-describedby="CR99">99</a>,<a href="#CR133" class="usa-link" aria-describedby="CR133">133</a>–<a href="#CR136" class="usa-link" aria-describedby="CR136">136</a></sup>. However, findings from ex vivo models remain inconclusive; while Spindler et al. reported that PKCα inhibition prevents Dsg3 depletion, Egu et al. recently found that PKC inhibitors are ineffective in preventing blister formation, desmosome shrinkage, or splitting<sup><a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>,<a href="#CR135" class="usa-link" aria-describedby="CR135">135</a></sup>, results requiring further investigations.</p>
<p id="Par28">In summary, the electrical signaling axis implicated in PV pathogenesis has been primarily associated with intracellular calcium influx and its related signaling effectors. While it was previously believed that calcium influx depends on Dsg1 and not Dsg3, this finding will be revisited by carefully monitoring Dsg1 expression levels. Furthermore, other ion channels will need to be addressed in PV pathogenesis.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Biochemical signaling</h3>
<p id="Par29">Activation or inhibition of biochemical effectors downstream of Dsg3/Dsg1 has been most widely studied in PV and integrates a variety of components belonging to known signaling pathways. These include specific plasma membrane receptors such as growth factor receptors, canonical Wnt or G-protein-coupled receptors as well as receptors of the TNF superfamily. A total of 91 studies addressed the modulation and pathogenicity of these effectors functionally by pharmacological modulators or gene knockout. All 91 studies of the biochemical signaling axis are summarized in Table <a href="#Tab3" class="usa-link">3</a> and effector signals in Fig. <a href="#Fig3" class="usa-link">3</a>.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Characteristics of studies included in biochemical signaling axis</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Author</th>
<th colspan="1" rowspan="1">Year</th>
<th colspan="1" rowspan="1">Target molecule</th>
<th colspan="1" rowspan="1">Intervention</th>
<th colspan="1" rowspan="1">Treatment Modality</th>
<th colspan="1" rowspan="1">Model</th>
<th colspan="1" rowspan="1">Antibody</th>
<th colspan="1" rowspan="1">Preventing Pathology</th>
<th colspan="1" rowspan="1">Measured Outcome</th>
</tr></thead>
<tbody>
<tr><td colspan="9" rowspan="1"><strong>Receptor tyrosine kinase growth factor receptors and signaling</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Hunziker et al.<sup><a href="#CR139" class="usa-link" aria-describedby="CR139">139</a></sup>
</td>
<td colspan="1" rowspan="1">1986</td>
<td colspan="1" rowspan="1">PDGF</td>
<td colspan="1" rowspan="1">Stimulated or sonicated platelets (100 µL/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Frušić-Zlotkin et al.<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>
</td>
<td colspan="1" rowspan="1">2006</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">AG1478 (10 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Qualitative visualization of acanthoylsis by phase contrast microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heupel a et al.<sup><a href="#CR92" class="usa-link" aria-describedby="CR92">92</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">GW2974 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA and keratin or F-actin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pretel et al.<sup><a href="#CR86" class="usa-link" aria-describedby="CR86">86</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">Erlotinib (100 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Clinical activity and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gil et al.<sup><a href="#CR87" class="usa-link" aria-describedby="CR87">87</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">CL-387785 (10 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 hours</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Bektas et al.<sup><a href="#CR69" class="usa-link" aria-describedby="CR69">69</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">CL-387785 (10 µM), PD15330 (10 µM), BPIQ-II (10 µM), Gefitinib (5–10 µM), Erlotinib (5–10 µM), AG1478 (in vitro: 0.1–10 µM, PTNM: 4 µg)</td>
<td colspan="1" rowspan="1">AG1478: Pretreatment for 2 h. Other inhibitors: overnight incubation or 2 h</td>
<td colspan="1" rowspan="1">In vitro, PTNM</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: keratin retraction and Dsg3 internalization was visualized with immunofluorescence microscopy. Dsg3 depletion was measured by western blot. Loss of intercellular adhesion was measured by KDA. PTNM: Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Espana et al.<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">CL-387785 (10 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sayar et al.<sup><a href="#CR137" class="usa-link" aria-describedby="CR137">137</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">Erlotinib (In vitro: 0.4–4 µg/mL, PTNM: 4–100 µg/g), Lapatinib (4–45 µg/g), EGFR KO</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 6 h. PTNM: Pretreatment for 4 h</td>
<td colspan="1" rowspan="1">In vitro, PTNM</td>
<td colspan="1" rowspan="1">AK23 with suboptimal dose of patient derived anti-dsg1 antibody, PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. PTNM: Gross and microscopic histology of skin and palate. Length of blister was quantified relative percentage to total length of section.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">Erlotinib (2.5 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">mPV IgG, mcPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ivars et al.<sup><a href="#CR91" class="usa-link" aria-describedby="CR91">91</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">CL-387785 (10 µg/g), Cetuximab (100 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation with histological scoring</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Burmester et al.<sup><a href="#CR77" class="usa-link" aria-describedby="CR77">77</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">VEGFR2</td>
<td colspan="1" rowspan="1">Vandetanib (0.1, 1, and 10 µM)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 2 h then discarding supernatant. Ex vivo: Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, ex vivo</td>
<td colspan="1" rowspan="1">In vitro: Immunophresis material from PV patient. ex vivo: PX43 scFv</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Gross and light microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hariton et al.<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">EGFR</td>
<td colspan="1" rowspan="1">Lapatinib (9 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 4 h and post-treatment after 4 days</td>
<td colspan="1" rowspan="1">PTAM</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Percentage of hair follicle blistering was evaluated by H&amp;E staining</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egu et al.<sup><a href="#CR85" class="usa-link" aria-describedby="CR85">85</a></sup>
</td>
<td colspan="1" rowspan="1">2024</td>
<td colspan="1" rowspan="1">EGFR (ErbB1 and ErbB1/2), TrkA</td>
<td colspan="1" rowspan="1">Lapatinib (44 nM), Erlotinib (2.5 µM), siTRKA (siRNA)</td>
<td colspan="1" rowspan="1">Lapatinib and Erlotinib: Pretreatment for 1 h. siTRKA: Pretreatment for 24 h</td>
<td colspan="1" rowspan="1">Lapatinib and Erlotinib: ex vivo and in vitro. siTRKA: in vitro</td>
<td colspan="1" rowspan="1">Lapatinib and Erlotinib: PV IgG. siTRKA: AK23, PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">in vitro: KDA and STED microscopy. Ex vivo: Blister scoring based on H&amp;E staining and EM.</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Src</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Chernyavsky et al.<sup><a href="#CR84" class="usa-link" aria-describedby="CR84">84</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Cell volume and keratin aggregation were measured</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heupel a et al.<sup><a href="#CR92" class="usa-link" aria-describedby="CR92">92</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG 1–5</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA and keratin or F-actin retraction measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pretel et al.<sup><a href="#CR86" class="usa-link" aria-describedby="CR86">86</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Clinical activity and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gil et al.<sup><a href="#CR87" class="usa-link" aria-describedby="CR87">87</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Espana et al.<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR89" class="usa-link" aria-describedby="CR89">89</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">Src inhibitor-1 (1 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Morphometric analysis of cell-cell detachment and KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR75" class="usa-link" aria-describedby="CR75">75</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, mcPV IgG, mPV IgG, atPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kugelmann et al.<sup><a href="#CR90" class="usa-link" aria-describedby="CR90">90</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (In vitro: 10 µM, ex vivo and PTNM: 50 µL of 10 µM)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 2 h, ex vivo and PTNM: Cotreatment</td>
<td colspan="1" rowspan="1">PTNM, In vitro, ex vivo</td>
<td colspan="1" rowspan="1">PV1-4 IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo and PTNM: Blister score was counted in H&amp;E stained samples</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ivars et al.<sup><a href="#CR91" class="usa-link" aria-describedby="CR91">91</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP1 (1 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation with histological scoring</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmitt et al.<sup><a href="#CR78" class="usa-link" aria-describedby="CR78">78</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Src</td>
<td colspan="1" rowspan="1">PP2 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, 2G4</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA. Dsg3 internalization, keratin retraction, and desmosome numbers were visualized using STED microscopy.</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Caspases</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Wang et al.<sup><a href="#CR160" class="usa-link" aria-describedby="CR160">160</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">Caspase 1</td>
<td colspan="1" rowspan="1">YVAD-CHO (100 nM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Arredondo et al.<sup><a href="#CR125" class="usa-link" aria-describedby="CR125">125</a></sup>
</td>
<td colspan="1" rowspan="1">2005</td>
<td colspan="1" rowspan="1">Caspases</td>
<td colspan="1" rowspan="1">Z-DCB-MK, DEVD-CHO, Z-DEVD-FMK, Z-DCB-MK + DEVD-CHO + Z-DEVD-FMK (all 10 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG-1a/PV IgG-2b</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Morphometric analysis of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pretel et al.<sup><a href="#CR86" class="usa-link" aria-describedby="CR86">86</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Caspases</td>
<td colspan="1" rowspan="1">cpm-VAD-CHO (1.6 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">clinical activity and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmidt et al.<sup><a href="#CR149" class="usa-link" aria-describedby="CR149">149</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">Caspases</td>
<td colspan="1" rowspan="1">VAD-fmk (20–300 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA and Dsg3 Immunofluorescence staining to detect keratin retraction, and intercellular gaps</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pacheco-Tovar et al.<sup><a href="#CR157" class="usa-link" aria-describedby="CR157">157</a></sup>
</td>
<td colspan="1" rowspan="1">2011</td>
<td colspan="1" rowspan="1">Caspases</td>
<td colspan="1" rowspan="1">Ac-DEVD-CMK (20 mM in 50 µL)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gil et al.<sup><a href="#CR87" class="usa-link" aria-describedby="CR87">87</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">Caspases</td>
<td colspan="1" rowspan="1">cpm-VAD-CHO (1.6 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Espana et al.<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">Caspases</td>
<td colspan="1" rowspan="1">cpm-VAD-CHO (1.6 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Luyet et al.<sup><a href="#CR158" class="usa-link" aria-describedby="CR158">158</a></sup>
</td>
<td colspan="1" rowspan="1">2015</td>
<td colspan="1" rowspan="1">Caspase 2, Caspase 3, Caspase 8, Caspase 9, Caspase 12, Caspases</td>
<td colspan="1" rowspan="1">Z-DEVD-FMK (40 µM), Ac-DEVD-CMK (In vitro: 40 µM, PTNM and PTAM: 6 µg/g), Z-IETD-FMK (100 µM), Z-LEHD-FMK (50 µM), Z-ATAD-FMK (10 µM), Z-VAD-FMK (40 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">All In vitro, Ac-DEVD-CMK: PTNM and PTAM</td>
<td colspan="1" rowspan="1">Ac-DEVD-CMK and Z-DEVD-FMK: PV IgG1/2, AK23, AK23/PF. Z-IETD-FMK, Z-LEHD-FMK, and Z-ATAD-FMK: PV IgG1/2, AK23. Z-VAD-FMK: AK23</td>
<td colspan="1" rowspan="1">Ac-DEVD-CMK, Z-DEVD-FMK, and Z-VAD-FMK ( + ), Z-IETD-FMK, Z-LEHD-FMK, and Z-ATAD-FMK (-)</td>
<td colspan="1" rowspan="1">In vitro: KDA. PTNM and PTAM: Quantified hair follicle blister and length of blister</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hariton et al.<sup><a href="#CR159" class="usa-link" aria-describedby="CR159">159</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">Caspase 3</td>
<td colspan="1" rowspan="1">K14 promoter-driven keratinocyte-specific caspase-3-deficient mice (casp3EKO)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTAM</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Histological quantification of telogen hair follicle blisters</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Eichkorn et al.<sup><a href="#CR161" class="usa-link" aria-describedby="CR161">161</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">Caspases + UVA</td>
<td colspan="1" rowspan="1">Z-VAD-FMK + UVA (NA)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Wnt Pathway</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Williamson et al.<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>
</td>
<td colspan="1" rowspan="1">2006</td>
<td colspan="1" rowspan="1">c-Myc, GSK3β</td>
<td colspan="1" rowspan="1">c-Myc inhibitor 3 (5404711, 6 µM), MI-1 (5521700), SB216763 (2 µg/g), Lithium Chloride (200 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">c-Myc inhibitor 3: PV IgG, AK23. SB216763: AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schlögl et al.<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>
</td>
<td colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">Casein Kinase 1 (CK1)</td>
<td colspan="1" rowspan="1">D4476 (100 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">KDA and immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hariton et al.<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">BIO</td>
<td colspan="1" rowspan="1">GSK-3 (10 µg/g daily for 2 days)</td>
<td colspan="1" rowspan="1">Injection after 4 days of AK23 treatment</td>
<td colspan="1" rowspan="1">PTAM</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Percentage of hair follicle blistering was evaluated by H&amp;E staining</td>
</tr>
<tr>
<td colspan="4" rowspan="1"><strong>Glucocorticoid and G protein-coupled receptors</strong></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schiltz et al.<sup><a href="#CR164" class="usa-link" aria-describedby="CR164">164</a></sup>
</td>
<td colspan="1" rowspan="1">1979</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor</td>
<td colspan="1" rowspan="1">Hydrocortisone, Triamcinolone acetide (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">dIF and H&amp;E staining light microscopy examination of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Anhalt et al.<sup><a href="#CR165" class="usa-link" aria-describedby="CR165">165</a></sup>
</td>
<td colspan="1" rowspan="1">1986</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor</td>
<td colspan="1" rowspan="1">Dexamethansone (10 and 20 mg/kg/day in 48 h period)</td>
<td colspan="1" rowspan="1">24 h pretreatment and simultaneous with PV IgG injection</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Clinical extent scoring, and H&amp;E staining light microscopy evaluation of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Naito et al.<sup><a href="#CR166" class="usa-link" aria-describedby="CR166">166</a></sup>
</td>
<td colspan="1" rowspan="1">1989</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor</td>
<td colspan="1" rowspan="1">Dexamethansone (20 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Visual examination for Nikolsky sign as well as histological examination of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Grando et al.<sup><a href="#CR168" class="usa-link" aria-describedby="CR168">168</a></sup>
</td>
<td colspan="1" rowspan="1">1993</td>
<td colspan="1" rowspan="1">Acetylcholine receptor</td>
<td colspan="1" rowspan="1">Acetylcholine, Bethanechol, Carbachol or Methacholine (All 1 nM to 100 µM)</td>
<td colspan="1" rowspan="1">1 h after addition of PV IgG</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Qualitative visualization of acanthoylsis by phase contrast microscopy. Measuring permeability of [‘H]thymidine by transwell experiment</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Asano et al.<sup><a href="#CR121" class="usa-link" aria-describedby="CR121">121</a></sup>
</td>
<td colspan="1" rowspan="1">2001</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor</td>
<td colspan="1" rowspan="1">Dexamethansone (0.1, 1 mM)</td>
<td colspan="1" rowspan="1">Pretreatment for 24 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Immunofluorescence examination of keratin retraction and desmoplakin distribution</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Nguyen a et al.<sup><a href="#CR154" class="usa-link" aria-describedby="CR154">154</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor</td>
<td colspan="1" rowspan="1">Methylprednisolone (15 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Nguyen b et al.<sup><a href="#CR155" class="usa-link" aria-describedby="CR155">155</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">Acetylcholine receptor, acetylcholine esterase</td>
<td colspan="1" rowspan="1">Carbacol (0.04 µg/g), Pyridostigmine bromide (0.1 µg/g)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Chernyavsky et al.<sup><a href="#CR169" class="usa-link" aria-describedby="CR169">169</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">α7 nicotinic acetylcholine receptor, Muscarinic acetylcholine receptor M1</td>
<td colspan="1" rowspan="1">AR-<a href="https://www.ncbi.nlm.nih.gov/nuccore/R17779" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">R17779</a> (100 µM), Pilocarpine (50 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Measuring permeability monolayer 1 hour after treatment with [3H]thymidine by transwell experiment</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Spindler et al.<sup><a href="#CR170" class="usa-link" aria-describedby="CR170">170</a></sup>
</td>
<td colspan="1" rowspan="1">2010</td>
<td colspan="1" rowspan="1">ß-Adrenergic receptor, Adenylyl cyclase (cAMP)/ Phosphodiesterase-4 (cAMP), Protein Kinase A (PKA)</td>
<td colspan="1" rowspan="1">Isoproterenol (in vitro: 100 µM, PTNM: 10 µM), Propranolol (10 µM), Forskolin/ Rolipram (5 µM/10 µM, H89 (10 µM)</td>
<td colspan="1" rowspan="1">PTNM: Pretreatment for 2 h or simultaneous. in vitro: simultaneous, 24 h after PV IgG treatment with media exchange for 2 h</td>
<td colspan="1" rowspan="1">Isoproterenol and propranolol: In vitro and PTNM. Forskolin/Rolipram, H89: In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Isoproterenol (+), Propranolol (-), Forskolin/ Rolipram (+), H89 (-)</td>
<td colspan="1" rowspan="1">PTNM: Gross and microscopic evaluation of blister formation. In vitro: immunofluorescence microscopy and KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mao et al.<sup><a href="#CR167" class="usa-link" aria-describedby="CR167">167</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor, STAT3</td>
<td colspan="1" rowspan="1">Hydrocortisone (In vitro: 100 µg/mL, PTNM: topical cream with 5% hydrocortisone), STAT3 Inhibitor XVIII (BP-1-102, In vitro: 25 nM, PTNM: topical cream with 12.5 nM rapamycin), constitutively activated Stat3 (Stat3C) overexpression</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment. In vivo: Topical application for 3 days before antibody treatment.</td>
<td colspan="1" rowspan="1">In vitro, PTNM</td>
<td colspan="1" rowspan="1">Hydrocortisone and STAT3C: PV IgG. STAT3 Inhibitor XVIII: PV IgG, PX43</td>
<td colspan="1" rowspan="1">Hydrocortisone and STAT3 Inhibitor XVIII (+), Stat3C (-)</td>
<td colspan="1" rowspan="1">In vitro: KDA. PTNM: Gross and histological evaluation of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sigmund et al.<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Phosphodiesterase 4 (cAMP)</td>
<td colspan="1" rowspan="1">Apremilast (In vitro: 1–100 µM, ex vivo: 50 µL of 1 µM, PTNM: 2 × 30 mg/day)</td>
<td colspan="1" rowspan="1">In vitro and ex vivo: Pretreatment for 1 h, PTNM: Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro, ex vivo, PTNM</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA and immunofluorescence imaging. Ex vivo: Blister length in H&amp;E histology. PTNM: Blister length was quantified in H&amp;E histology.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Xie et al.<sup><a href="#CR127" class="usa-link" aria-describedby="CR127">127</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Glucocorticoid receptor, Glucocorticoid receptor + Calcineurin</td>
<td colspan="1" rowspan="1">Clobetasol propionate (1 µM), Clobetasol + FK506 (1 µM + 100 nM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA, Immunofluorescence microscopy, and western blotting was performed for Dsg3 depletion</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>TNF-α and inflammatory mediator signaling</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Feliciani et al.<sup><a href="#CR140" class="usa-link" aria-describedby="CR140">140</a></sup>
</td>
<td colspan="1" rowspan="1">1999</td>
<td colspan="1" rowspan="1">IL1α, TNF-α</td>
<td colspan="1" rowspan="1">Anti-IL1α antibody (2 µg/mL), Anti-TNF-α antibody (2 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min and cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Acantholysis measured by cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Feliciani et al.<sup><a href="#CR141" class="usa-link" aria-describedby="CR141">141</a></sup>
</td>
<td colspan="1" rowspan="1">2000</td>
<td colspan="1" rowspan="1">IL1α, TNF-α, IL1α + TNF-α, IL1, IL1β, IL2</td>
<td colspan="1" rowspan="1">Anti-IL1α antibody (2 µg/mL), anti-TNF-α antibody (2 µg/mL), anti-IL1α + anti-TNF-α antibody (2 µg/mL), Anti-IL2 antibody (2 µg/mL), ICE knockout, IL1β knockout, TNFR1R2 knockout</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min and cotreatment</td>
<td colspan="1" rowspan="1">In vitro: Anti-IL1α, Anti-TNF-α, Anti-IL1α + Anti-TNF-α, Anti-IL2. PTNM: ICE knockout, IL1β knockout, TNFR1R2 knockout</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">All except anti-IL2 antibody (+), Anti-IL2 antibody (-)</td>
<td colspan="1" rowspan="1">In vitro: Acantholysis measured by cell detachment assay. PTNM: Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Toto et al.<sup><a href="#CR143" class="usa-link" aria-describedby="CR143">143</a></sup>
</td>
<td colspan="1" rowspan="1">2000</td>
<td colspan="1" rowspan="1">CD28, IL10</td>
<td colspan="1" rowspan="1">CD28 knockout, IL10 knockout, IL10 (50 ng)</td>
<td colspan="1" rowspan="1">Pretreatment for 15–60 min</td>
<td colspan="1" rowspan="1">In vitro: CD28 knockout. PTNM: CD28 knockout, IL10 knockout, IL10 injection</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">CD28 knockout (PTNM X, in vitro -), IL10 knockout (X), IL10 injection (+)</td>
<td colspan="1" rowspan="1">In vitro: Acantholysis measured by cell detachment assay. PTNM: Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Feliciani et al.<sup><a href="#CR122" class="usa-link" aria-describedby="CR122">122</a></sup>
</td>
<td colspan="1" rowspan="1">2003</td>
<td colspan="1" rowspan="1">IL1α, TNF-α, IL1α + TNF-α, IL2</td>
<td colspan="1" rowspan="1">Anti-IL1α antibody (2 µg/mL), anti-TNF-α antibody (2 µg/mL), anti-IL1α + anti-TNF-α antibody (2 µg/mL), Anti-IL2 antibody (2 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min and cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">All except anti-IL2 antibody (+), Anti-IL2 antibody (-)</td>
<td colspan="1" rowspan="1">Acantholysis measured by cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Orlov et al.<sup><a href="#CR146" class="usa-link" aria-describedby="CR146">146</a></sup>
</td>
<td colspan="1" rowspan="1">2006</td>
<td colspan="1" rowspan="1">Fas, TNF-α, Fas + TNF-α</td>
<td colspan="1" rowspan="1">Fas-L (25 ng/ml), TNF-α (25 ng/ml), Fas-L + TNF-α</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, EpiDermFT (3D Culture)</td>
<td colspan="1" rowspan="1">PV IgG1/2</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">Quantitative analysis of morphologic changes such as cell volume, cell detachment, and acantholysis in monolayers and EpiDermFT</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Marquina et al.<sup><a href="#CR145" class="usa-link" aria-describedby="CR145">145</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">iNOS, eNOS, nNOS, NOS, NF-κB</td>
<td colspan="1" rowspan="1">1400 W (3 µg/g), L-N5-(1-Iminoethyl) ornitine dihydrochloride (L-NIO, 30 µg/g), S-methyl-L-thiocitruline dihdrochloride (SMTC, 50 ug/g), [N(G)-monomethyl-L-arginine (L-NMMA, 0.5 µg/g), Parthenolide (6 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">1400 W (-), L-NIO (-), SMTC ( + ), L-NMMA (+), Parthenolide (-)</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schmidt et al.<sup><a href="#CR149" class="usa-link" aria-describedby="CR149">149</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">FLIP</td>
<td colspan="1" rowspan="1">FLIP-L (overexpression), FLIP-S (overexpression)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA and Dsg3 Immunofluorescence staining to detect keratin retraction, and intercellular gaps</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schulze et al.<sup><a href="#CR153" class="usa-link" aria-describedby="CR153">153</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">Rag2 knockout</td>
<td colspan="1" rowspan="1">Rag2</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTAM</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Histologcal examination for hair follicle and suprabasal blisters of skin and palate</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Espana et al.<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">nNOS</td>
<td colspan="1" rowspan="1">SMTC (10 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lotti et al.<sup><a href="#CR147" class="usa-link" aria-describedby="CR147">147</a></sup>
</td>
<td colspan="1" rowspan="1">2018</td>
<td colspan="1" rowspan="1">FasL, Soluble FasL, Membrane bound FasL</td>
<td colspan="1" rowspan="1">Anti-FasL Antibody (CD178, in vitro: 1 or 15 µg/mL, PTNM: 40 µg), Soluble FasL knockout, Membrane bound FasL knockout</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 1 h, PTNM: 1, 2, or 3 h after PV IgG</td>
<td colspan="1" rowspan="1">In vitro: Anti-FasL Antibody. PTNM: Anti-FasL antibody, Soluble FasL knockout, Membrane bound FasL knockout</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Anti-FasL Antibody (+), Soluble FasL knockout (+), Membrane bound FasL knockout (-)</td>
<td colspan="1" rowspan="1">In vitro: KDA. PTNM: Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Radeva et al.<sup><a href="#CR150" class="usa-link" aria-describedby="CR150">150</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">ST18</td>
<td colspan="1" rowspan="1">ST18 overexpression</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG1-2, AK23</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Assaf et al.<sup><a href="#CR142" class="usa-link" aria-describedby="CR142">142</a></sup>
</td>
<td colspan="1" rowspan="1">2021</td>
<td colspan="1" rowspan="1">ST18, TNF-α</td>
<td colspan="1" rowspan="1">ST18 overexpression, Anti-TNF-α antibody (20 µg/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">TNF-α (+), ST18 overexpression (-)</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Assaf et al.<sup><a href="#CR151" class="usa-link" aria-describedby="CR151">151</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">ST18</td>
<td colspan="1" rowspan="1">ST18 overexpression</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">Immunofluorescence staining of membrane Dsg3</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lin et al.<sup><a href="#CR156" class="usa-link" aria-describedby="CR156">156</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">CD4 + SOCS3</td>
<td colspan="1" rowspan="1">CD4 + T-Cell SOCS3 knockdown</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lotti et al.<sup><a href="#CR148" class="usa-link" aria-describedby="CR148">148</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Soluble FasL</td>
<td colspan="1" rowspan="1">PC111 (Anti-solube FasL Antibody, in vitro: 0.001-10 µg/mL, ex vivo: 1, 10, 50, and 100 μg)</td>
<td colspan="1" rowspan="1">Treatment was applied 2 h after PV antibody treatment</td>
<td colspan="1" rowspan="1">In vitro, ex vivo</td>
<td colspan="1" rowspan="1">PV IgG, PX43 scFv</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liang et al.<sup><a href="#CR144" class="usa-link" aria-describedby="CR144">144</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">IL-37, IL-37 + STAT3</td>
<td colspan="1" rowspan="1">Recombinent human IL-37 (100 ng/mL), Colivelin + IL-37 (0.5 µM + 100 ng/mL)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro wildtype and Caveolin-1 shRNA cells</td>
<td colspan="1" rowspan="1">Rabbit polyclonal anti-Dsg3 antibody</td>
<td colspan="1" rowspan="1">In vitro (+), in vitro Caveolin-1 shRNA cells (-),Colivelin + IL-37 (-)</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Luan et al.<sup><a href="#CR152" class="usa-link" aria-describedby="CR152">152</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Inflammation</td>
<td colspan="1" rowspan="1">Thalidomide (10–50 mg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Fc Receptors</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Schiltz et al.<sup><a href="#CR171" class="usa-link" aria-describedby="CR171">171</a></sup>
</td>
<td colspan="1" rowspan="1">1980</td>
<td colspan="1" rowspan="1">Serum, Fc portion of antibody</td>
<td colspan="1" rowspan="1">IgG depletion of conditioned medium by affinity chromatography, PV IgG digestion by paparin</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">From PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hunziker et al.<sup><a href="#CR206" class="usa-link" aria-describedby="CR206">206</a></sup>
</td>
<td colspan="1" rowspan="1">1985</td>
<td colspan="1" rowspan="1">Fc receptor</td>
<td colspan="1" rowspan="1">IVIG (Sandoglobin, 0.3–30 mg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 6 and 24 h or 1 h with PV sera</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">dIF and H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kawana et al.<sup><a href="#CR172" class="usa-link" aria-describedby="CR172">172</a></sup>
</td>
<td colspan="1" rowspan="1">1985</td>
<td colspan="1" rowspan="1">Fc receptor</td>
<td colspan="1" rowspan="1">PV F(ab´)<sub>2</sub> fragments</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">From PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro epidermal cell detachment visualization using phase microscopy and coulter counter</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Anhalt et al.<sup><a href="#CR173" class="usa-link" aria-describedby="CR173">173</a></sup>
</td>
<td colspan="1" rowspan="1">1986</td>
<td colspan="1" rowspan="1">Fc receptor</td>
<td colspan="1" rowspan="1">PV F(ab´)<sub>2</sub>, Fab´ fragments</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">From PV IgG</td>
<td colspan="1" rowspan="1">PV F(ab´)<sub>2</sub> (-), Fab´ ( + )</td>
<td colspan="1" rowspan="1">Clinical extent scoring, dIF and H&amp;E staining light microscopy evaluation of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mascaro Jr et al.<sup><a href="#CR174" class="usa-link" aria-describedby="CR174">174</a></sup>
</td>
<td colspan="1" rowspan="1">1998</td>
<td colspan="1" rowspan="1">Fc receptor</td>
<td colspan="1" rowspan="1">PV F(ab´)<sub>2</sub>, Fab´ fragments</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">From PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">dIF and H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Arredondo et al.<sup><a href="#CR125" class="usa-link" aria-describedby="CR125">125</a></sup>
</td>
<td colspan="1" rowspan="1">2005</td>
<td colspan="1" rowspan="1">Fc receptor</td>
<td colspan="1" rowspan="1">IVIG</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG-1a/PV IgG-2b</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Morphometric analysis of acantholysis in</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mimouni et al.<sup><a href="#CR176" class="usa-link" aria-describedby="CR176">176</a></sup>.</td>
<td colspan="1" rowspan="1">2005</td>
<td colspan="1" rowspan="1">Fc Receptor</td>
<td colspan="1" rowspan="1">IVIG (5 mg/mouse), normal F(ab´)<sub>2</sub> (6 mg/mouse), normal Fc portion (7 mg/mouse), recombinant Dsg3 (2 mg, premixed with PV IgG)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR175" class="usa-link" aria-describedby="CR175">175</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">Serum</td>
<td colspan="1" rowspan="1">PV IgG-free serum (0.5 mg)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">From PV sera</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">KDA and immunofluorescence imaging</td>
</tr>
<tr>
<td colspan="1" rowspan="1">de Bruin et al.<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">Fc Receptor</td>
<td colspan="1" rowspan="1">PV Fab</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">From PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Keratin retraction was measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mimouni et al.<sup><a href="#CR177" class="usa-link" aria-describedby="CR177">177</a></sup>
</td>
<td colspan="1" rowspan="1">2010</td>
<td colspan="1" rowspan="1">Fc Receptor</td>
<td colspan="1" rowspan="1">PV specific anti-idiotypic antibody (30 µg/mouse), IVIG (30 and 2000 µg/mouse)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">Anti-Dsg 1 and 3 scFv</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Zakrzewicz et al.<sup><a href="#CR207" class="usa-link" aria-describedby="CR207">207</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">Neonatal Fc receptor (FcRn)</td>
<td colspan="1" rowspan="1">Efgartigimode (25 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min or treatment after 30 min of antibody</td>
<td colspan="1" rowspan="1">In vitro wildtype Fc-IHH knockout cells</td>
<td colspan="1" rowspan="1">hAK23, mAK23, 4B3, PV IgG</td>
<td colspan="1" rowspan="1">Wildtype cells (+), Fc-IHH knockout cells (-), mAK23 (-)</td>
<td colspan="1" rowspan="1">KDA and Dsg3 depletion by western blotting</td>
</tr>
<tr><td colspan="9" rowspan="1"><strong>Others</strong></td></tr>
<tr>
<td colspan="1" rowspan="1">Lanza et al.<sup><a href="#CR208" class="usa-link" aria-describedby="CR208">208</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">Cyclin-dependent kinase 2</td>
<td colspan="1" rowspan="1">Cdk2 siRNA, Roscovitine (100 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">In vitro: Cdk2 siRNA. PTNM: Roscovitine</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Morphometric analysis of cell-cell detachment</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Pretel et al.<sup><a href="#CR86" class="usa-link" aria-describedby="CR86">86</a></sup>
</td>
<td colspan="1" rowspan="1">2009</td>
<td colspan="1" rowspan="1">mTOR</td>
<td colspan="1" rowspan="1">Rapamycin (5 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Clinical activity and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Lanza et al.<sup><a href="#CR209" class="usa-link" aria-describedby="CR209">209</a></sup>
</td>
<td colspan="1" rowspan="1">2011</td>
<td colspan="1" rowspan="1">Perk</td>
<td colspan="1" rowspan="1">Perk siRNA</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera and immunoglobulin-free sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Gil et al.<sup><a href="#CR87" class="usa-link" aria-describedby="CR87">87</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">mTOR</td>
<td colspan="1" rowspan="1">Rapamycin (5 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Espana et al.<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">mTOR</td>
<td colspan="1" rowspan="1">Rapamycin (5 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of tissue</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Mao et al.<sup><a href="#CR71" class="usa-link" aria-describedby="CR71">71</a></sup>
</td>
<td colspan="1" rowspan="1">2014</td>
<td colspan="1" rowspan="1">MK2</td>
<td colspan="1" rowspan="1">MK2 inhibitor III (In vitro: 2.5 µg/mL, PTNM: 6.25 µg), MK2 shRNA, MK2 knockout</td>
<td colspan="1" rowspan="1">Pretreatment for 2 hours</td>
<td colspan="1" rowspan="1">In vitro: MK2 inhibitor III, MK2 shRNA. PTNM: MK2 inhibitor III, MK2 knockout</td>
<td colspan="1" rowspan="1">PX43</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: Dsg3 internalization was measured by immunofluorescence microscopy and western blotting. PTNM: Gross and microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Walter et al.<sup><a href="#CR75" class="usa-link" aria-describedby="CR75">75</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">MEK 1/2</td>
<td colspan="1" rowspan="1">U0126 (NA)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">AK23, mcPV IgG, mPV IgG, atPV IgG, PF IgG</td>
<td colspan="1" rowspan="1">mcPV IgG, PF IgG (+), AK23, mPV IgG, atPV IgG (-)</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Egu et al.<sup><a href="#CR205" class="usa-link" aria-describedby="CR205">205</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">MEK 1/2</td>
<td colspan="1" rowspan="1">U0126 (50 µL of 5 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Blister score and cleft length was calculated based on H&amp;E stained sections. Evaluation of desmosomes were performed by electron microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Radeva et al.<sup><a href="#CR150" class="usa-link" aria-describedby="CR150">150</a></sup>
</td>
<td colspan="1" rowspan="1">2019</td>
<td colspan="1" rowspan="1">MEK 1/2</td>
<td colspan="1" rowspan="1">U0126 (5 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 hour</td>
<td colspan="1" rowspan="1">In vitro ST18 overexpression</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Burmester et al.<sup><a href="#CR77" class="usa-link" aria-describedby="CR77">77</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">PDK1, PLK1, MEK 1</td>
<td colspan="1" rowspan="1">BX-795, Rigosertib, Selumetinib (0.1, 1, and 10 µM)</td>
<td colspan="1" rowspan="1">In vitro: Pretreatment for 2 h then discarding supernatant. Ex vivo: Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, ex vivo</td>
<td colspan="1" rowspan="1">In vitro: Immunophresis material from PV patient. ex vivo: PX43 scFv</td>
<td colspan="1" rowspan="1">BX-795, Selumetinib (+), Rigosertib (in vitro: +, ex vivo: -)</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Gross and light microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Ivars et al.<sup><a href="#CR91" class="usa-link" aria-describedby="CR91">91</a></sup>
</td>
<td colspan="1" rowspan="1">2020</td>
<td colspan="1" rowspan="1">ADAM10</td>
<td colspan="1" rowspan="1">GI254023X (150 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of blister formation with histological scoring</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kugelmann et al.<sup><a href="#CR210" class="usa-link" aria-describedby="CR210">210</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">ADAM10, ADAM17</td>
<td colspan="1" rowspan="1">GI254023X (in vitro: 20 µM, ex vivo: 50 µL of 20 µM), Tapi-1 (10 µM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro, ex vivo</td>
<td colspan="1" rowspan="1">mPV IgG 2/3, mcPV IgG1/4, AK23</td>
<td colspan="1" rowspan="1">In vitro for GI254023X: mcPV IgG1, mPV IgG 2/3, and Ak23 (+), mcPV IgG4 (-). Ex vivo for GI254023X: was tested with mcPV IgG4 only (-). Tapi-1 (-)</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Blister scoring based on H&amp;E staining was evaluated</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hiermaier et al.<sup><a href="#CR129" class="usa-link" aria-describedby="CR129">129</a></sup>
</td>
<td colspan="1" rowspan="1">2022</td>
<td colspan="1" rowspan="1">MEK 1/2</td>
<td colspan="1" rowspan="1">U0126 (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG, PF IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hariton et al.<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">Smoothened receptor</td>
<td colspan="1" rowspan="1">SAG (5 µg/g daily for 2 days)</td>
<td colspan="1" rowspan="1">Injection after 4 days of AK23 treatment</td>
<td colspan="1" rowspan="1">PTAM</td>
<td colspan="1" rowspan="1">AK23</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">Percentage of hair follicle blistering was evaluated by H&amp;E staining</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Valentino et al.<sup><a href="#CR211" class="usa-link" aria-describedby="CR211">211</a></sup>
</td>
<td colspan="1" rowspan="1">2023</td>
<td colspan="1" rowspan="1">miR-148a</td>
<td colspan="1" rowspan="1">miR-148a mimic</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">mPV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p39"><p>Treatment modalities: Pretreatment, Intervention added before antibody application. Cotreatment, Intervention added simultaneously with the antibody. Posttreatment, Intervention added after antibody application. Model: Ex vivo, human skin organ culture. In vitro, 2D cultured keratinocyte cell lines or primary cells. PTNM, Passive transfer neonatal mouse model. PTAM, Passive transfer adult mouse model. Antibodies: mPV IgG, mucosal PV IgG. mcPV IgG, mucocutaneous PV IgG. atPV IgG, Atypical PV IgG. PF IgG, pemphigus foliaceus IgG. Preventing Pathology: ( + ) effective in preventing antibody-induced pathology, (-) Ineffective in preventing antibody-induced pathology, (x) worsened antibody-induced pathology. <em>KDA</em> Keratinocyte dissociation assay, <em>NA</em> Not Available.</p></div></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Tyrosine kinase growth factor receptors and signaling</h3>
<p id="Par30">The EGFR growth factor receptor family stands out as one of the most extensively researched biochemical signaling pathways in all models of PV, compatible with a crosstalk between these receptors and Dsg3 and Dsg1. Frušić-Zlotkin et al., were the first to demonstrate in HaCat cells that PV IgG induces EGFR phosphorylation within 30 min after PV IgG exposure and inhibiting it can halt PV IgG-induced acantholysis<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>. With the exception of the study by Heupel et al., various research works involving different antibodies and in vitro and in vivo PV disease models have consistently shown the protective impact of EGFR inhibition in PV pathogenesis<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>,<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>,<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>–<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>,<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>,<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>,<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a></sup>. Notably, Walter et al. found that only PV IgGs containing anti-Dsg3 antibodies and not Dsg3/Dsg1 could induce EGFR phosphorylation, and EGFR inhibitors were ineffective in preventing PF IgG-induced fragmentation<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. Furthermore, Ivars et al. reported that EGFR inhibition failed to prevent epidermal blistering in a neonatal mouse model with PV IgG containing anti-desmocollin (Dsc) 3 antibodies, while, conversely, Hudemann et al. have shown that anti-Dsc3 IgG induces the activation of EGFR and p38MAPK, but not Src, in HaCaT cells<sup><a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>,<a href="#CR138" class="usa-link" aria-describedby="CR138">138</a></sup>. Significantly, Sayar et al. underscored the importance of maintaining basal EGFR activity when inhibiting PV blistering in mouse epidermis<sup><a href="#CR137" class="usa-link" aria-describedby="CR137">137</a></sup>. They highlighted that the EGFR inhibition needs to be within a specific range to preserve its basal epidermal activity, to prevent blister formation. Furthermore, complete EGFR inhibition through pharmaceutical agents or gene knockout could be harmful to keratinocyte survival and exacerbate blister formation triggered by autoantibodies in skin but not mucosa, aligning with the dermatological adverse events of EGFR inhibitors. The most recent study by Hariton et al. unveiled a dualistic nature of EGFR activity. EGFR inhibition before antibody injection and blistering in adult mice was found to reduce induction of new hair follicle blisters, whereas EGFR inhibitor treatment in presence of blisters aggravated lesions by hindering regeneration and healing<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. The latter study discriminated for the first time between a blister-inducing and blister-healing response phase marked by initial activation followed by inhibition of EGFR, and conversely, blister-inducing Wnt inhibition followed by blister-healing Wnt activation. While the two phases may explain the discrepant findings concerning p38MAK and actin cytoskeleton/RhoA inhibition and activation, they need to be taken into consideration for therapeutic applications.</p>
<p id="Par31">Inhibition of other growth factor receptors, such as VEGFR2 and TrkA, have also been demonstrated to prevent the loss of intercellular adhesion induced by PV IgG, PX43 or AK23 in both in vitro and ex vivo models<sup><a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>,<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a></sup>. Egu et al. further revealed that TrkA operates downstream of EGFR, where PV IgG led to increased expression and phosphorylation of TrkA at Y490<sup><a href="#CR85" class="usa-link" aria-describedby="CR85">85</a></sup>. On the other hand, Hunziker et al. found that simultaneous injection of PV serum with stimulated or sonicated platelets, which are enriched with PDGF, into an ex vivo model, enhanced blister formation<sup><a href="#CR139" class="usa-link" aria-describedby="CR139">139</a></sup>.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Other downstream signaling effectors</h3>
<p id="Par32">Important effectors downstream of EGFR and receptors such as of the TNF superfamily are PI3K/ERK/Akt. They have only been investigated to a limited extent. Burmester et al. revealed that PI3Kα but not PI3Kβ prevents PV pathologies in both in vitro and ex vivo models<sup><a href="#CR77" class="usa-link" aria-describedby="CR77">77</a></sup>. Additional signaling mediators related to receptor tyrosine kinase growth factors are listed in Table <a href="#Tab3" class="usa-link">3</a>.</p></section><section id="Sec14"><h3 class="pmc_sec_title">The TNF superfamily and inflammatory mediator signaling</h3>
<p id="Par33">Several studies have evaluated the role of inflammatory cytokines in PV pathogenesis, including protective or disease-promoting effects. Neutralizing or knocking out TNF-α, IL-1α, IL-1β and IL6 but not IL2, has been demonstrated to alleviate the loss of intercellular adhesion, suggesting the implication of inflammatory mediators in blister formation<sup><a href="#CR122" class="usa-link" aria-describedby="CR122">122</a>,<a href="#CR140" class="usa-link" aria-describedby="CR140">140</a>–<a href="#CR142" class="usa-link" aria-describedby="CR142">142</a></sup>. Conversely, a protective effect counteracting blistering was attributed to IL10 and IL37<sup><a href="#CR143" class="usa-link" aria-describedby="CR143">143</a>,<a href="#CR144" class="usa-link" aria-describedby="CR144">144</a></sup>. Inhibiting neuronal nitric oxide synthase (nNOS) upregulation and NF-κB nuclear translocation, which can be triggered downstream of TNF/FasR signaling, also prevented skin blistering in mice<sup><a href="#CR145" class="usa-link" aria-describedby="CR145">145</a></sup>. In line with these findings, soluble Fas ligand was shown to be causative in various models and interventions in PV pathogenesis, and its action could be successfully blocked with the human monoclonal antibody PC111 in an ex-vivo model<sup><a href="#CR146" class="usa-link" aria-describedby="CR146">146</a>–<a href="#CR148" class="usa-link" aria-describedby="CR148">148</a></sup>. Notwithstanding, the administration of FLIP<sub>L</sub> and FLIP<sub>S,</sub> which inhibit NF-κB downstream of FasR, did not ameliorate antibody-induced acantholysis, keratin retraction, and fragmentation<sup><a href="#CR149" class="usa-link" aria-describedby="CR149">149</a></sup>. Other mediators of inflammation were also shown to be involved in PV pathogenesis, notably p38MAPK, discussed in the section on biomechanical signaling<sup><a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>,<a href="#CR145" class="usa-link" aria-describedby="CR145">145</a></sup>. TNF-α signaling via pro-inflammatory cytokines and p38MAPK was further highlighted by a constitutive mutation (“PV risk variant” rs17315309) in the transcription factor Suppression of tumorigenicity 18 (ST18) gene or its overexpression in human keratinocytes in vitro, which trigger a self-amplifying cycle for Dsg3 downregulation in presence of PV IgG<sup><a href="#CR142" class="usa-link" aria-describedby="CR142">142</a>,<a href="#CR150" class="usa-link" aria-describedby="CR150">150</a>,<a href="#CR151" class="usa-link" aria-describedby="CR151">151</a></sup>. Finally, Luan et al. revealed that PV IgG increased the intracellular proinflammatory adapter protein MyD88 along with other PV phenotypic changes such as NF-κB and blistering, which were ameliorated in HaCaT cells and mice by thalidomide, an immunomodulatory and anti-inflammatory glutamic acid derivative<sup><a href="#CR152" class="usa-link" aria-describedby="CR152">152</a></sup>. While inflammatory responses by keratinocytes have been demonstrated to be pathogenic in PV, as outlined above, a role of innate or adaptive immune cells in blister formation sensu stricto could be excluded by passive transfer of PV IgG into mice. Several studies utilizing immunocompromised mice exhibited a similar blistering phenotype than immunocompetent mice<sup><a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>–<a href="#CR155" class="usa-link" aria-describedby="CR155">155</a></sup>. However, Toto et al. demonstrated a higher incidence of PV blisters with low dose PV IgG in CD28 KO mice compared to wild-type mice although in vitro evaluation showed similar acantholysis between KO and wild-type cells<sup><a href="#CR143" class="usa-link" aria-describedby="CR143">143</a></sup>. Similarly, co-incubation of keratinocytes with SOCS3 knocked-down CD4 + T cells, exhibiting a shift towards the Th1/Th17 phenotype, also aggravated PV IgG induced fragmentation<sup><a href="#CR156" class="usa-link" aria-describedby="CR156">156</a></sup>.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Caspases</h3>
<p id="Par34">Involvement of caspases in PV acantholysis has been reported in 10 independent studies<sup><a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>–<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>,<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>,<a href="#CR149" class="usa-link" aria-describedby="CR149">149</a>,<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>–<a href="#CR161" class="usa-link" aria-describedby="CR161">161</a></sup>. Except for Schmidt et al. all studies found caspase 1/2/3 inhibition but not inhibition of caspase 8/9/12 to prevent PV pathology<sup><a href="#CR149" class="usa-link" aria-describedby="CR149">149</a></sup>. The role of caspase activation in PV pathogenesis remains a critical and unresolved issue, particularly regarding its contribution to apoptosis-dependent versus newly recognized, non-apoptotic processes<sup><a href="#CR162" class="usa-link" aria-describedby="CR162">162</a></sup>. Some evidence indicates that caspases are activated leading to apoptosis in PV<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>,<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>,<a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>,<a href="#CR157" class="usa-link" aria-describedby="CR157">157</a>,<a href="#CR160" class="usa-link" aria-describedby="CR160">160</a></sup>. However, recent studies suggest that while apoptosis may occur as a fail-safe mechanism, also in PV, the initial pathogenic event leading to acantholysis is the activation of caspases, rather than apoptosis itself<sup><a href="#CR158" class="usa-link" aria-describedby="CR158">158</a>,<a href="#CR159" class="usa-link" aria-describedby="CR159">159</a></sup>. This is supported by the current understanding that both proteolytic and non-proteolytic activities of caspases are involved in cytoskeletal rearrangements, cell cycle regulation, cytoplasmic reduction, cell migration, and fate determination, thereby providing a rational for their roles beyond apoptosis<sup><a href="#CR162" class="usa-link" aria-describedby="CR162">162</a></sup>.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Canonical and non-canonical Wnt signaling</h3>
<p id="Par35">The Wnt pathway was implicated in PV pathogenesis in various models from three different groups. JUP, a crucial mediator of cell-cell adhesion and Wnt signaling, is implicated in both cell adhesion and fate determination and was already addressed in the biomechanical signaling section. Studies have shown that Wnt activation utilizing various GSK3 inhibitors prevents blister formation in neonatal and adult mouse models<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Williamson et al. further confirmed the involvement of Myc in the pathogenesis of PV<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>, a pro-proliferative transcription factor in the Wnt pathway. Additionally, Hariton et al. recently revealed that Wnt activation using BIO not only attenuated hair follicle blister formation but also facilitated blister regeneration and healing in mice. This finding may have significant implications for clinical applications. In line with these findings, Casein kinase-1, an enzyme that serves dual roles in the Wnt pathway, has also been shown to associate with keratin intermediate filaments via FAM83H<sup><a href="#CR163" class="usa-link" aria-describedby="CR163">163</a></sup>. Schögel et al. demonstrated that inhibiting this molecule exacerbates AK23-induced fragmentation in vitro<sup><a href="#CR81" class="usa-link" aria-describedby="CR81">81</a></sup>. Together, these studies highlight that canonical Wnt and possibly also non-canonical Wnt (upstream of PLC/PKC) inhibition play a critical role in regulating cell adhesion as well as in influencing fate conversion and regeneration.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Glucocorticoid and other G protein-coupled receptors</h3>
<p id="Par36">Corticosteroids, which primarily exert their effects through Corticosteroid G-protein-coupled receptors, are the cornerstone of therapeutic treatment of PV patients and have also been explored in preclinical studies. Among six research studies, at keratinocyte level, only half were able to demonstrate the efficacy of corticosteroids on preventing loss of adhesion in the context of PV pathogenesis<sup><a href="#CR127" class="usa-link" aria-describedby="CR127">127</a>,<a href="#CR154" class="usa-link" aria-describedby="CR154">154</a>,<a href="#CR164" class="usa-link" aria-describedby="CR164">164</a>–<a href="#CR167" class="usa-link" aria-describedby="CR167">167</a></sup>. Nguyen et al. found that pretreatment, and not co-treatment, with methylprednisolone reduced blistering in both neonatal Balb/c and athymic nude mice<sup><a href="#CR154" class="usa-link" aria-describedby="CR154">154</a></sup>, suggesting a therapeutic effect reducing initiation of new blisters. Similarly, Mao et al. reported comparable results in an in vitro model, as well as with the topical application of hydrocortisone in a neonatal C57BL/6 J mouse model which likely acts through the prevention of STAT3 activation<sup><a href="#CR167" class="usa-link" aria-describedby="CR167">167</a></sup>.</p>
<p id="Par37">Adrenergic and acetylcholine receptors are another family of G protein-coupled receptors that have been studied in PV pathogenesis and might, in rare cases, even be directly targeted by antibodies in PV IgG other than anti-Dsg3/Dsg1. Initially, Grando et al. demonstrated that acetylcholine agonists can prevent PV IgG-induced acantholysis, provided that exposure to PV IgG is limited to less than 8 hours<sup><a href="#CR168" class="usa-link" aria-describedby="CR168">168</a></sup>. These experiments were further validated using a mouse model and with additional acetylcholine receptor agonists<sup><a href="#CR155" class="usa-link" aria-describedby="CR155">155</a></sup>. In a recent study, Chernyavsky et al. found that the effects of PV IgG on keratinocytes involve the phosphorylation of both p120- and β-catenin, with PKC mediating the serine phosphorylation of β-catenin and Src mediating the tyrosine phosphorylation of p120-catenin<sup><a href="#CR169" class="usa-link" aria-describedby="CR169">169</a></sup>. Furthermore, downstream signaling of keratinocyte M1 muscarinic receptors interfered with the PV IgG-dependent catenin phosphorylation through the activation of both protein phosphatase 2 A (PP2A) and protein-tyrosine phosphatase (PTP). In contrast, the mechanism of action of α7 nicotinic receptors involved both the activation of PTP and the inhibition of Src. Each inhibitor only partially reversed the effect of PV IgG. Apart from cholinergic receptors, Spindler et al. investigated the role of adrenergic receptors and confirmed previous studies, that the activation of β-Adrenergic receptors prevents loss of intercellular adhesion in vitro and blister formation in an vivo model in response to PV antibodies<sup><a href="#CR170" class="usa-link" aria-describedby="CR170">170</a></sup>. Also, β-adrenergic receptor agonists facilitated the recovery of cell-cell adhesion following the removal of autoantibodies<sup><a href="#CR170" class="usa-link" aria-describedby="CR170">170</a></sup>. Increasing cAMP levels using phosphodiesterase inhibitors protected from the loss of intercellular adhesion through blockage of p38MAPK, while, conversely, the inhibition of protein kinase A (PKA) exacerbated the effects of the antibody<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>,<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a></sup>. The status of phosphodiesterase activity in PV is currently unknown, however the increase in cAMP monitored after PV IgG stimulation was suggested to pertain to the repair/regenerative phase<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>,<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a></sup>, revealed and amply described by Hariton et al.<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>.</p></section><section id="Sec18"><h3 class="pmc_sec_title">Fc Receptors</h3>
<p id="Par38">In 1979, a seminal study by Schiltz et al. demonstrated that Fab fragments of PV IgG, obtained by enzymatic digestion using papain (Fab), were as effective than entire IgG, suggesting that antibody-mediated crosslinking of target receptors is not required for PV pathogenicity. Moreover, IgG depleted fraction of patient serum failed to cause acantholysis<sup><a href="#CR171" class="usa-link" aria-describedby="CR171">171</a></sup>. Later studies yielded inconsistent results regarding the efficacy of Fab or F(ab´)<sub>2</sub> in acantholysis. While Kawana et al. reported that PV F(ab´)<sub>2</sub> was ineffective in an in vitro model, Anhalt and Till found that all mice receiving PV F(ab´)<sub>2</sub> developed cutaneous blisters and erosions, whereas none of the mice receiving PV Fab fragments developed lesions<sup><a href="#CR172" class="usa-link" aria-describedby="CR172">172</a>,<a href="#CR173" class="usa-link" aria-describedby="CR173">173</a></sup>. Conversely, Mascaro Jr et al. revealed that both F(ab´)<sub>2</sub> and Fab fragments induced acantholysis in mice<sup><a href="#CR174" class="usa-link" aria-describedby="CR174">174</a></sup>. Consistently, de Bruin et al. found that the Fab portion was as effective as PV IgG in causing loss of intercellular adhesion in cultured keratinocytes<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>. The role of serum-born factors in inducing acantholysis was further evaluated by Cirilo et al. who showed, on interest for intravenous IgG, that PV serum lacking IgG can partially reduce the intercellular adhesion, but this effect was not statistically significant<sup><a href="#CR175" class="usa-link" aria-describedby="CR175">175</a></sup>. Mimouni et al. conducted two studies revealing that the beneficial effects of normal IgG are not solely dependent on the Fc portion but also involve the F(ab´)<sub>2</sub> fragments<sup><a href="#CR176" class="usa-link" aria-describedby="CR176">176</a>,<a href="#CR177" class="usa-link" aria-describedby="CR177">177</a></sup>.</p>
<p id="Par39">Fc receptor activation can also induce Src activation, which may be mistakenly interpreted as Dsg signaling. However, studies have demonstrated that Src inhibition using mouse monoclonal antibodies with low affinity for human Fc receptors is effective<sup><a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>,<a href="#CR178" class="usa-link" aria-describedby="CR178">178</a></sup>. Therefore, Src activation cannot be attributed to Fc receptor signaling.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Other factors</h3>
<p id="Par40">Other factors such as protease inhibitors, complement system, mitochondrial potential, among others are briefly outlined in Table <a href="#Tab4" class="usa-link">4</a>.</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Characteristics of other studies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Author</th>
<th colspan="1" rowspan="1">Year</th>
<th colspan="1" rowspan="1">Target molecule</th>
<th colspan="1" rowspan="1">Intervention</th>
<th colspan="1" rowspan="1">Treatment Modality</th>
<th colspan="1" rowspan="1">Model</th>
<th colspan="1" rowspan="1">Antibody</th>
<th colspan="1" rowspan="1">Preventing Pathology</th>
<th colspan="1" rowspan="1">Measured Outcome</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Michel et al.<sup><a href="#CR212" class="usa-link" aria-describedby="CR212">212</a></sup>
</td>
<td colspan="1" rowspan="1">1977</td>
<td colspan="1" rowspan="1">Complement (C3)</td>
<td colspan="1" rowspan="1">Complement inactivation by heating the serum at 56 °C for 30 min or dialysis</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">dIF and H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Farb et al.<sup><a href="#CR213" class="usa-link" aria-describedby="CR213">213</a></sup>
</td>
<td colspan="1" rowspan="1">1978</td>
<td colspan="1" rowspan="1">Serine proteases, Broad spectrum proteinase</td>
<td colspan="1" rowspan="1">Soybean trypsin inhibitor (100 µg/mL), α2-macroglobulin (0.5 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 24 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera (Heat inactivated)</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Cell detachment assay. Binding of antibodies was measured by dIF. Cellular viability was measured by incorporation of radioactive amino acid into TCA precipitable protein</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schiltz et al.<sup><a href="#CR164" class="usa-link" aria-describedby="CR164">164</a></sup>
</td>
<td colspan="1" rowspan="1">1979</td>
<td colspan="1" rowspan="1">Serine proteases, unknown</td>
<td colspan="1" rowspan="1">Soybean trypsin inhibitor (100 µg/mL), Thioglucose salt of gold (10 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">dIF and H&amp;E staining light microscopy examination of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Schiltz et al.<sup><a href="#CR171" class="usa-link" aria-describedby="CR171">171</a></sup>
</td>
<td colspan="1" rowspan="1">1980</td>
<td colspan="1" rowspan="1">C3, Protein synthesis</td>
<td colspan="1" rowspan="1">Complement inactivation by heating the serum at 56 °C for 1 h, Puromycin (0.1–100 µM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">C3 (-), Puromycin (+)</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Singer et al.<sup><a href="#CR214" class="usa-link" aria-describedby="CR214">214</a></sup>
</td>
<td colspan="1" rowspan="1">1980</td>
<td colspan="1" rowspan="1">Serine proteases, Broad spectrum proteinase</td>
<td colspan="1" rowspan="1">Soybean trypsin inhibitor (100 µg/mL), α2-macroglobulin (0.5 mg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">In vitro: Soybean trypsin inhibitor, alpha2-macroglobulin. PTNM: Soybean trypsin inhibitor</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Morioka et al.<sup><a href="#CR215" class="usa-link" aria-describedby="CR215">215</a></sup>
</td>
<td colspan="1" rowspan="1">1981</td>
<td colspan="1" rowspan="1">Serine proteases, Aspartyl proteases, Cysteine peptidase</td>
<td colspan="1" rowspan="1">Soybean trypsin inhibitor (75–5000 µg/mL), Pepstatin A (2–40 µg/mL), N-ethylmaleimide (NEM, 0.1–1 mM)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">dIF and H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Hashimoto et al.<sup><a href="#CR216" class="usa-link" aria-describedby="CR216">216</a></sup>
</td>
<td colspan="1" rowspan="1">1983</td>
<td colspan="1" rowspan="1">Plasmin, Trypsin, Serine proteases</td>
<td colspan="1" rowspan="1">Plasminogen (200 µg/mL), Lima bean trypsin inhibitor (NA), Aprotinin (60 TIU)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV IgG, PV IgG + Plasminogen</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Woo et al.<sup><a href="#CR217" class="usa-link" aria-describedby="CR217">217</a></sup>
</td>
<td colspan="1" rowspan="1">1983</td>
<td colspan="1" rowspan="1">
<p>Serine proteases,</p>
<p>Aspartyl proteases,</p>
<p>Trypsin,</p>
<p>Protease</p>
</td>
<td colspan="1" rowspan="1">Soybean trypsin inhibitor (100 µg/mL), Aprotinin (800 units/mL), Pepstatin (50 µg/mL), Lima bean trypsin inhibitor (400 µg/mL), α2-macroglobulin (540 µg/mL), Chymostatin (600 µg/mL), Leupeptin (500 µg/mL), Antipain (100 µg/mL)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Soybean trypsin inhibitor, Aprotinin, α2-macroglobulin, Pepstatin, Lima bean trypsin inhibitor (+), Chymostatin, Leupeptin, Antipain (-)</td>
<td colspan="1" rowspan="1">Cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kawana et al.<sup><a href="#CR172" class="usa-link" aria-describedby="CR172">172</a></sup>
</td>
<td colspan="1" rowspan="1">1985</td>
<td colspan="1" rowspan="1">Complement, C1q, Plasmin</td>
<td colspan="1" rowspan="1">Complement addition (10% normal human serum), Complement depletion, C1q depleted fraction, complement inactivation by heating the serum at 56 °C for 30 min, Plasminogen depleted serum</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Complement addition, Plasminogen depleted serum (-), Complement depletion, C1q depleted fraction, complement inactivation by heating the serum at 56 °C for 30 min (+)</td>
<td colspan="1" rowspan="1">Cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Anhalt et al.<sup><a href="#CR173" class="usa-link" aria-describedby="CR173">173</a></sup>
</td>
<td colspan="1" rowspan="1">1986</td>
<td colspan="1" rowspan="1">C5, C3</td>
<td colspan="1" rowspan="1">C5 knockout, Cobra Venom Factor (CoVF) (NA)</td>
<td colspan="1" rowspan="1">Pretreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">C5 knockout (-), CoVF (+)</td>
<td colspan="1" rowspan="1">The clinical extent scoring and H&amp;E staining light microscopy evaluation of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Naito et al.<sup><a href="#CR166" class="usa-link" aria-describedby="CR166">166</a></sup>
</td>
<td colspan="1" rowspan="1">1989</td>
<td colspan="1" rowspan="1">Proteases, Serine Proteases</td>
<td colspan="1" rowspan="1">FOY (Gabexate mesylate, ex vivo: 1–10 mg/mL, PTNM: 133 µg/g), FOY-305 (Camostat mesylate, Ex vivo: 0.5–5 mg/mL, PTNM: 100 µg/g), FUT-175 (Nafamostat Mesilate, ex vivo: 0.1–5 mg/mL, PTNM: 13 µg/g), α1-proteinase inhibitor (Ex vivo: 2.5, 25 mg/mL, PTNM: 1.67 µg/g)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo, PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Ex vivo: all (+). PTNM: FOY-305 and α1-proteinase inhibitor (+), FUT-175 and FOY (-)</td>
<td colspan="1" rowspan="1">Ex vivo: H&amp;E staining and microscopic evaluation for acantholysis. PTNM: Visual examination for Nikolsky sign as well as histological examination of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kawana et al.<sup><a href="#CR218" class="usa-link" aria-describedby="CR218">218</a></sup>
</td>
<td colspan="1" rowspan="1">1990</td>
<td colspan="1" rowspan="1">Ultraviolet light</td>
<td colspan="1" rowspan="1">UVB (0.06 to 0.18 J/cm<sup>2</sup>)</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">In vivo PV patient skin</td>
<td colspan="1" rowspan="1">In vivo PV patient skin</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy and immunofluorescence examination</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Dobrev et al.<sup><a href="#CR219" class="usa-link" aria-describedby="CR219">219</a></sup>
</td>
<td colspan="1" rowspan="1">1996</td>
<td colspan="1" rowspan="1">Proteases</td>
<td colspan="1" rowspan="1">p-aminomethylbenzoic acid (PAMBA, 1 mg/mL), Aprotinin (10 ATrE/ml)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">Ex vivo</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">H&amp;E staining light microscopy examination of blister formation and acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Feliciani et al.<sup><a href="#CR140" class="usa-link" aria-describedby="CR140">140</a></sup>
</td>
<td colspan="1" rowspan="1">1999</td>
<td colspan="1" rowspan="1">C3</td>
<td colspan="1" rowspan="1">Anti-C3 antibody (10 µg/mL)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min and Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Acantholysis was measured at cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Asano et al.<sup><a href="#CR121" class="usa-link" aria-describedby="CR121">121</a></sup>
</td>
<td colspan="1" rowspan="1">2001</td>
<td colspan="1" rowspan="1">Proteases</td>
<td colspan="1" rowspan="1">PAMBA (10, 50 µg/mL), Aprotinin (0.1, 1 TIU)</td>
<td colspan="1" rowspan="1">Pretreatment for 30 min</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">Immunofluorescence examination of keratin retraction and desmoplakin</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Sánchez-Carpintero et al.<sup><a href="#CR99" class="usa-link" aria-describedby="CR99">99</a></sup>
</td>
<td colspan="1" rowspan="1">2004</td>
<td colspan="1" rowspan="1">Tyrosine kinases</td>
<td colspan="1" rowspan="1">Genistein (500 µg/g), Herbimycin (15 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 3 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Feliciani et al.<sup><a href="#CR220" class="usa-link" aria-describedby="CR220">220</a></sup>
</td>
<td colspan="1" rowspan="1">2007</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">Tannic acid (0.1 nM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">x</td>
<td colspan="1" rowspan="1">Acantholysis was measured by cell detachment assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Cirillo et al.<sup><a href="#CR221" class="usa-link" aria-describedby="CR221">221</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">Kinases</td>
<td colspan="1" rowspan="1">Staurosporine (100 nM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Acantholysis measured by immunofluorescence microscopy</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Delva et al.<sup><a href="#CR113" class="usa-link" aria-describedby="CR113">113</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">Tyrosine kinases</td>
<td colspan="1" rowspan="1">Genistein (40 µM)</td>
<td colspan="1" rowspan="1">Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA, immunofluorescence imaging, and Dsg3 internalization assay</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Marquina et al.<sup><a href="#CR145" class="usa-link" aria-describedby="CR145">145</a></sup>
</td>
<td colspan="1" rowspan="1">2008</td>
<td colspan="1" rowspan="1">Tyrosine kinases</td>
<td colspan="1" rowspan="1">Genistein (500 µg/g)</td>
<td colspan="1" rowspan="1">Pretreatment for 2 h</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Clinical activitiy and microscopic evaluation of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Saito et al.<sup><a href="#CR68" class="usa-link" aria-describedby="CR68">68</a></sup>
</td>
<td colspan="1" rowspan="1">2012</td>
<td colspan="1" rowspan="1">Tyrosine kinases</td>
<td colspan="1" rowspan="1">Genistein (Ex vivo: 6.25 µg, in vitro: 50 µM)</td>
<td colspan="1" rowspan="1">Ex vivo: Pretreatment for 2 h. In vitro: Pretreatment for 1 h</td>
<td colspan="1" rowspan="1">Ex vivo, in vitro</td>
<td colspan="1" rowspan="1">PV IgG, AK23</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">In vitro: KDA. Ex vivo: Gross and microscopic evaluation of blister formation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Kalantari-Dehaghi et al.<sup><a href="#CR126" class="usa-link" aria-describedby="CR126">126</a></sup>
</td>
<td colspan="1" rowspan="1">2013</td>
<td colspan="1" rowspan="1">Mitochondria, NAD</td>
<td colspan="1" rowspan="1">Minocycline (0.05 mM), Nicotinamide (10 mM)</td>
<td colspan="1" rowspan="1">Cotreatment</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV IgG</td>
<td colspan="1" rowspan="1">Minocycline (+), Nicotinamide (-)</td>
<td colspan="1" rowspan="1">Morphometric analysis of acantholysis</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Liang et al.<sup><a href="#CR222" class="usa-link" aria-describedby="CR222">222</a></sup>
</td>
<td colspan="1" rowspan="1">2017</td>
<td colspan="1" rowspan="1">Unknown</td>
<td colspan="1" rowspan="1">Naringenin (50, 100, 200 µM)</td>
<td colspan="1" rowspan="1">24 h after PV sera treatment</td>
<td colspan="1" rowspan="1">In vitro</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">KDA</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Wei et al.<sup><a href="#CR223" class="usa-link" aria-describedby="CR223">223</a></sup>
</td>
<td colspan="1" rowspan="1">2021</td>
<td colspan="1" rowspan="1">Thioredoxin-2 (Trx2)</td>
<td colspan="1" rowspan="1">Trx2 Overexpression</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">PTNM</td>
<td colspan="1" rowspan="1">PV sera</td>
<td colspan="1" rowspan="1">+</td>
<td colspan="1" rowspan="1">Gross and microscopic evaluation of acantholysis and blister formation</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p56"><p>Treatment modalities: Pretreatment, Intervention added before antibody application. Cotreatment, Intervention added simultaneously with the antibody. Model: Ex vivo, human skin organ culture. In vitro, 2D cultured keratinocyte cell lines or primary cells. PTNM, Passive transfer neonatal mouse model. Antibodies: PV IgG or sera, pemphigus vulgaris IgG/sera. PF IgG, pemphigus foliaceus IgG. Preventing Pathology: ( + ) effective in preventing antibody-induced pathology, (-) Ineffective in preventing antibody-induced pathology, (x) worsened antibody-induced pathology. <em>KDA</em> Keratinocyte dissociation assay, <em>NA</em> Not Available.</p></div></div></section></section></section><section id="Sec20"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par41">This systematic review allows for the first time to present a comprehensive network of 128 functionally validated effector signals in PV published since inception in 1977 up to mid-2024. These effectors can be categorized according to three general signaling axis typifying adhesion receptor signaling<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>: biomechanical (Fig. <a href="#Fig1" class="usa-link">1</a>), bioelectrical (Fig. <a href="#Fig2" class="usa-link">2</a>), and biochemical (Fig. <a href="#Fig3" class="usa-link">3</a>). While the understanding of biomechanical signaling is only starting to emerge and bioelectrical effectors, in particular ion channels, have drawn little attention so far, the best studied effectors in loss of intercellular adhesion relate to biochemical signal transduction upon loss of Dsg transadhesion.</p>
<p id="Par42">It is noteworthy that modulation of the great majority of the 128 effector molecules in PV have been revealed through cell biological approaches followed by functional validation through pharmacological activation, deactivation or gene deletion prior to antibody application, thus mainly addressing effectors responsible for blister initiation. Among these, we defined as key effectors in PV (indicated in bold in Figs. <a href="#Fig1" class="usa-link">1</a>–<a href="#Fig3" class="usa-link">3</a>), those molecules which have been consistently identified and validated by multiple sources using various models, antibodies and manipulations. In all signaling axis combined (Fig. <a href="#Fig4" class="usa-link">4</a>), these are, remarkably, the molecules which were found to be associated with extra-desmosomal Dsg3 or Dsg1; JUP, p38MAPK, PLCγ/PKC, EGFR/ErB2 and GSK-3β/JUP (Wnt signaling). The implications of these effectors are consistent with stress-induced cytoskeleton reorganization, junctional release, increased migration and proliferation. Activation of growth factor and tyrosine kinase receptors, including EGFR/ErbB2, govern three major processes: mitotic activation, cytoskeletal rearrangement and migration, encompassing endocytosis of junctional components and release of adhesive strength. The pro-migratory and pro-mitotic phenotype in PV is consistently seen throughout the biomechanical signaling axis and is supported by Wnt inhibition, closing the gateway towards keratinocyte differentiation through nuclear signaling and stabilization of junctions at the plasma membrane<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR179" class="usa-link" aria-describedby="CR179">179</a></sup>. Several other studies have demonstrated the influx of intracellular calcium and activation of tyrosine kinase receptor-dependent signaling pathways further supporting enhanced migration. Moreover, the suggested inhibition of small GTPases, such as RhoA, Rac-1 and Cdc42 in PV<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup> or the early redistribution of activated RhoA away from the plasma membrane<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>, and the reported actin depolymerization<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>, would also support migration. However, to define the rebalance of forces through the Rho GTPase family of highly dynamic, complex and compartmentalized molecular switches, more sophisticated technologies like live cell imaging or experimental manipulations such as FRET<sup><a href="#CR180" class="usa-link" aria-describedby="CR180">180</a></sup>, as initiated by Jin et al.<sup><a href="#CR181" class="usa-link" aria-describedby="CR181">181</a></sup>, will be required. Consistent with calcium influx and a migration/mitosis phenotype, calcium release-activated channels (CRAC), and calmodulins were identified as effectors in the bioelectrical axis, which were however mainly identified to be activated in presence of low Dsg1 protein expression<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup> or complementary anti-Dsg1 antibodies. The increase in intracellular calcium concentration<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>,<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>,<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a></sup> also favors migration in addition to the release of inflammatory cytokines<sup><a href="#CR125" class="usa-link" aria-describedby="CR125">125</a>–<a href="#CR127" class="usa-link" aria-describedby="CR127">127</a></sup>. Additional key effectors defining the biochemical axis are soluble FasL and Caspases (TNF superfamily). Furthermore, the TNF-α superfamily regulates survival and apoptotic genes under stress conditions. Taken together, this signaling network is highly consistent and supports actin rearrangement<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>, and contractility<sup><a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup> as well as increased proliferation<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>,<a href="#CR153" class="usa-link" aria-describedby="CR153">153</a>,<a href="#CR182" class="usa-link" aria-describedby="CR182">182</a>,<a href="#CR183" class="usa-link" aria-describedby="CR183">183</a></sup> and migration while reducing differentiation<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Other studies outside the scope of PV have also confirmed the role of Dsg3, and in some cases also Dsg1, in cell migration<sup><a href="#CR184" class="usa-link" aria-describedby="CR184">184</a>–<a href="#CR187" class="usa-link" aria-describedby="CR187">187</a></sup>, proliferation<sup><a href="#CR188" class="usa-link" aria-describedby="CR188">188</a>–<a href="#CR190" class="usa-link" aria-describedby="CR190">190</a></sup>, and the regulation of the actin cytoskeleton. Consistently, extra-desmosomal Dsg3 has been shown to be associated with actin fibers and ezrin, functioning as an upstream regulator of Rho GTPases and Src<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>,<a href="#CR186" class="usa-link" aria-describedby="CR186">186</a></sup>. Finally, morphological regeneration and restoration of desmosomal junctions were reported to occur via downregulation of EGFR, activation of Wnt signaling, the upregulation of RhoA/Rac-1 and the increase of adherens junction proteins E-cadherin, β-catenin and JUP. The latter presumably increases the tension load to offset desmosomal instability, consistent with α-adducin phosphorylation and p38MAPK inhibition<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>,<a href="#CR181" class="usa-link" aria-describedby="CR181">181</a></sup>.</p>
<p id="Par43">Collectively, the binding of autoantibodies to desmosomal antigens supports an astonishingly coherent model whereby outside-in signaling mediated by the major PV target receptors Dsg3/Dsg1 leads within seconds to minutes through a rapid influx of calcium to activation of PLC and PKC, p38MAPK, and EGFR as well as Wnt inhibition (Fig. <a href="#Fig4" class="usa-link">4</a>). These cascades are known to lead to actin remodeling, enhanced Dsg3/JUP endocytosis and desmosomal shrinkage as well as keratin retraction, contributing to the destabilization of desmosomes and weakening of cell-cell adhesion presumably along a process of inside-out signaling such as p38MAPK and PKC activation. Also, Rho GTPases, particularly RhoA, and their inactivation in PV pathogenesis may further facilitate weakening of desmosomal adhesion, while reactive oxygen species (ROS) and apoptotic pathways survey the signaling events associated with acantholysis.</p>
<p id="Par44">While a coherent picture is provided for blister initiating effectors reported in PV, the longitudinal analyses, and in particular the study of effectors of protective or regenerative processes during and after blister formation will be essential to be considered when designing therapeutic approaches to avoid adverse effects of effector modulation on already existing blisters, as reported by Hariton et al.<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Furthermore, studying only one time point can introduce a bias, as signaling molecules are subject to dynamic changes, which has been shown in case of EGFR, Wnt and RhoA<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a>,<a href="#CR181" class="usa-link" aria-describedby="CR181">181</a>,<a href="#CR191" class="usa-link" aria-describedby="CR191">191</a>–<a href="#CR193" class="usa-link" aria-describedby="CR193">193</a></sup>. This is also compatible with the biological understanding that the cell populations in the basal layer of stratified epithelia reflected in keratinocyte 2D cultures are heterogeneous (stem cells, transit amplifying, differentiating progenitor cells)<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. Therefore, and once more, measuring a change in signaling molecules at a single time point may lead to conclusions that cannot be validated in clinical translation. Lastly, in order to understand Dsg3 and Dsg1 receptor signaling in PV and particularly in epithelial homeostasis in detail, it is imperative to investigate the extra-desmosomal (without desmoplakin) and desmosomal (with desmoplakin) fraction separately through biochemical fractionation or imaging.</p>
<p id="Par45">Concerning inhibitor/activator screening studies, it must be mentioned that validation of the molecular target in the biological setting with and without the pharmacological drug is mandatory, as some molecules may not be directly involved or causative in PV pathogenesis but may instead strengthen the cytoskeleton network, desmosomes or other adhesion molecules as a compensatory mechanism, thereby seemingly preventing or attenuating blister formation<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>,<a href="#CR170" class="usa-link" aria-describedby="CR170">170</a></sup>. Moreover, when probing Dsg3 signaling, the status of Dsg1 expression needs to be monitored, as high Dsg1 levels may compromise signaling results, or compensate for loss of Dsg3 cell-cell contacts. Further discriminating between Dsg3 and Dsg1 receptor signaling will help to better address this gap. As another caveat, some signaling molecules respond within seconds to minutes after antibody binding, inferring that the application of inhibitors or activators occurs too late and may not effectively interrupt the signaling cascade, yielding misleading results<sup><a href="#CR194" class="usa-link" aria-describedby="CR194">194</a></sup>. Another issue identified is that in many studies chemical concentrations were not titrated and only one single dose was used. This might not be effective or come with secondary, PV-unrelated effects, and was for example shown to be particularly important for fundamental biological pathways like EGFR. It was shown in one study that EGFR inhibition is ineffective in preventing the loss of intercellular adhesion, while Sayer et al. demonstrated a biphasic dose-response relationship where only doses within a hermetic zone effectively prevent blister formation<sup><a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>,<a href="#CR137" class="usa-link" aria-describedby="CR137">137</a></sup>. Additionally, none of the studies measured confounding contaminants, such as endotoxins, which can activate inflammatory pathways and potentially confound PV signaling<sup><a href="#CR195" class="usa-link" aria-describedby="CR195">195</a>,<a href="#CR196" class="usa-link" aria-describedby="CR196">196</a></sup>.</p>
<p id="Par46">In summary, in this systematic literature review, we identified targets that have been tested in various models using different PV antibodies (Fig. <a href="#Fig4" class="usa-link">4</a>). The therapeutic use of these targets necessitates careful consideration of their feasibility and efficacy on both phases of blistering and regeneration. For example, while EGFR is implicated in PV pathogenesis, Hariton et al. demonstrated that lapatinib administration can hinder the healing process of blisters, and thus is not eligible for therapeutic application<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Similarly, p38MAPK plays a crucial role in numerous physiological processes, which will continue to be identified while making it a challenging drug target<sup><a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>,<a href="#CR197" class="usa-link" aria-describedby="CR197">197</a></sup>; several clinical trials have failed due to unacceptable toxicities<sup><a href="#CR198" class="usa-link" aria-describedby="CR198">198</a>,<a href="#CR199" class="usa-link" aria-describedby="CR199">199</a></sup>. More recently developed p38MAPK inhibitors, which have shown greater tolerability in patients, were found to act primarily as EGFR inhibitors rather than direct p38MAPK inhibitors<sup><a href="#CR200" class="usa-link" aria-describedby="CR200">200</a></sup>. Hence, targeting downstream pathways may offer a more feasible approach with fewer side effects, although efficacy remains a concern, as some inhibitors, such as MK2, have only been shown to prevent spontaneous blistering, not Nikolsky-induced blisters<sup><a href="#CR71" class="usa-link" aria-describedby="CR71">71</a>,<a href="#CR201" class="usa-link" aria-describedby="CR201">201</a></sup>. Thus, a more advanced understanding of the intertwined signaling network downstream of PV IgG binding potentially presents the possibility to design combined targets for efficient treatment.</p>
<p id="Par47">In conclusion, the signaling network downstream of transadhesion loss by extra-desmosomal Dsg3/Dsg1 receptors and desmosomal structures, unveiled through half a century of signaling studies on PV, increases the complexity of our understanding of epithelial homeostasis and regeneration. Suggested to be strong enough to reprogram epidermal cell states<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>, the cross-talk triggered from desmosomal cadherins to major cellular circuits and evolutionary older structures such as classical cadherins and integrins<sup><a href="#CR202" class="usa-link" aria-describedby="CR202">202</a></sup> revealed here is astonishing and will require further attention. The great challenge ahead will be to follow through from desmosomal cadherin signaling to global transcriptional reprogramming expected to represent a fine balance between a plethora of intersecting signaling cascades.</p></section><section id="Sec21"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec22"><h3 class="pmc_sec_title">Search strategy</h3>
<p id="Par48">The present systematic review was performed according to the methodology outlined by the 2020 version of the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Four databases—PUBMED, EMBASE, Web of Science, and SCOPUS—were searched for eligible articles using the search terms “pemphigus” AND (“activator” OR “inhibitor” OR “Dsg3 signaling”) from inception until June 12, 2023. The syntax of search terms in each database is mentioned in Supplementary Table <a href="#MOESM1" class="usa-link">S1</a>, Supplementary Information. The reference lists of all relevant articles previously identified through electronic database searches were also checked. After the completion of data extraction, another search was performed to screen for newly published investigations in this interval until April 25, 2024.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Data selection and collection</h3>
<p id="Par49">Search results were combined, and duplicates were excluded using EndNote (version 20.6, Thomson Reuters, 2020). Two reviewers independently reviewed all citations and selected eligible studies. Eligibility was determined after the inclusion criteria were met as follows: (i) studies that used PV sera, PV IgG, or monoclonal antibodies against Dsg3 or Dsg1/3; (ii) Studies that utilized one or more of the following models: human skin explants, 3D keratinocyte cultures, 2D cultured primary or cell line keratinocytes, passive antibody transfer models in neonatal or adult mice; (iii) studies that evaluated a signaling molecule through chemical or genetic manipulation (intervention) to inhibit or aggravate the PV phenotype; (iv) studies that measured at least one of the following pathological outcomes: desmosomal shrinkage, keratin retraction, cell-cell and cell-matrix dissociation, Dsg3 internalization, acantholysis, or blister formation in suprabasal layers or hair follicles.</p>
<p id="Par50">Exclusion criteria included: (i) non-English published studies; (ii) non-original researches (e.g., editorials, reviews, book chapters, commentaries); (iii) studies in humans or in non-human animals other than mice (iv) studies conducted on active transfer PV mouse models; (v) outcome measures other than PV pathological phenotypes mentioned in inclusion criteria; (vi) studies that used non-Dsg antibodies or IgG from atypical PV cases; (vii) unavailability of the full text of articles.</p></section><section id="Sec24"><h3 class="pmc_sec_title">Data extraction</h3>
<p id="Par51">The authors extracted data using a pilot-tested form. The study characteristics extracted from the full-text articles eligible for qualitative analysis included the following categories: (i) bibliographic details (title, authors, publication year, journal); (ii) model characteristics (type of preclinical model); (iii) intervention characteristics (type of experimental manipulation, dose, incubation duration, antibodies used); (iv) details of the examined signaling molecule (signaling molecule, signaling pathway); and (v) outcome measures (type of outcome, primary and secondary outcomes, effectiveness).</p></section><section id="Sec25"><h3 class="pmc_sec_title">Quality assessment</h3>
<p id="Par52">All studies were included in the review; therefore, a formal quality assessment was not considered necessary.</p></section></section><section id="Sec26"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12373888/bin/41536_2025_426_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (495.3KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12373888/bin/41536_2025_426_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 1</a><sup> (31.2KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>This research was funded by the Swiss National Science Foundation (Sinergia CRSII5_202301/1). Authors would like to express their gratitude towards the Sinergia pemphigus consortium members Ralf J. Ludwig, Hauke Busch, Jennifer E. Hundt, and the expert committee Carien M. Niessen, and Ralf Paus for fruitful discussions and constructive criticisms with regard to pemphigus signaling.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>All authors met the following criteria: substantial contributions to the conception and design of the study, acquisition of data, or analysis and interpretation of data; drafting the article or critically revising it for important intellectual content; final approval of the version to be submitted; and accountability for all aspects of the work, ensuring that questions related to the accuracy or integrity of any part of the work were appropriately investigated and resolved. The specific contributions of the authors are detailed as follows: Conception and design of the study: E.J.M. and S.R. Literature search and review of bibliography: S.R., F.K., and W.V.J.H. Analysis and interpretation of data: E.J.M. and S.R. Drafting the article: E.J.M. and S.R. Preparation of figures: W.V.J.H. and E.J.M. Critical revision of the article for important intellectual content: E.J.M., S.R., W.V.J.H., R.L., and L.B. Funding acquisition: E.J.M.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data utilized in this study are fully detailed and available within the article and its supplementary information files, ensuring transparency and facilitating further open research.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par53">Ralf J. Ludwig has received honoraria for speaking or consulting or has obtained research grants from Monasterium Laboratories, Novartis, Lilly, Bayer, Dompe, Synthon, Argen-X, TriNetX, and Incyte during the last 3 years. All other authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="sec27"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s41536-025-00426-x.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Nelson, W. J. The glue that binds us: the hunt for the molecular basis for multicellularity. <em>Cell</em><strong>181</strong>, 495–497 (2020).
</cite> [<a href="https://doi.org/10.1016/j.cell.2020.03.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32234519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nelson,%20W.%20J.%20The%20glue%20that%20binds%20us:%20the%20hunt%20for%20the%20molecular%20basis%20for%20multicellularity.%20Cell181,%20495%E2%80%93497%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Perl, A. L., Pokorny, J. L. &amp; Green, K. J. Desmosomes at a glance. <em>J. Cell Sci.</em><strong>137</strong>, jcs261899 (2024).
</cite> [<a href="https://doi.org/10.1242/jcs.261899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11234380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38940346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perl,%20A.%20L.,%20Pokorny,%20J.%20L.%20&amp;%20Green,%20K.%20J.%20Desmosomes%20at%20a%20glance.%20J.%20Cell%20Sci.137,%20jcs261899%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Dupont, S. &amp; Wickstrom, S. A. Mechanical regulation of chromatin and transcription. <em>Nat. Rev. Genet.</em><strong>23</strong>, 624–643 (2022).
</cite> [<a href="https://doi.org/10.1038/s41576-022-00493-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35606569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dupont,%20S.%20&amp;%20Wickstrom,%20S.%20A.%20Mechanical%20regulation%20of%20chromatin%20and%20transcription.%20Nat.%20Rev.%20Genet.23,%20624%E2%80%93643%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Papusheva, E. &amp; Heisenberg, C. P. Spatial organization of adhesion: force-dependent regulation and function in tissue morphogenesis. <em>EMBO J.</em><strong>29</strong>, 2753–2768 (2010).
</cite> [<a href="https://doi.org/10.1038/emboj.2010.182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2924654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20717145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Papusheva,%20E.%20&amp;%20Heisenberg,%20C.%20P.%20Spatial%20organization%20of%20adhesion:%20force-dependent%20regulation%20and%20function%20in%20tissue%20morphogenesis.%20EMBO%20J.29,%202753%E2%80%932768%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Di, X. et al. Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. <em>Signal Transduct. Target Ther.</em><strong>8</strong>, 282 (2023).
</cite> [<a href="https://doi.org/10.1038/s41392-023-01501-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10387486/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37518181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Di,%20X.%20et%20al.%20Cellular%20mechanotransduction%20in%20health%20and%20diseases:%20from%20molecular%20mechanism%20to%20therapeutic%20targets.%20Signal%20Transduct.%20Target%20Ther.8,%20282%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Maitre, J. L. &amp; Heisenberg, C. P. Three functions of cadherins in cell adhesion. <em>Curr. Biol.</em><strong>23</strong>, R626–R633 (2013).
</cite> [<a href="https://doi.org/10.1016/j.cub.2013.06.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3722483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23885883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maitre,%20J.%20L.%20&amp;%20Heisenberg,%20C.%20P.%20Three%20functions%20of%20cadherins%20in%20cell%20adhesion.%20Curr.%20Biol.23,%20R626%E2%80%93R633%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Gadre, P. et al. Emergence and properties of adult mammalian epidermal stem cells. <em>Dev. Biol.</em><strong>515</strong>, 129–138 (2024).
</cite> [<a href="https://doi.org/10.1016/j.ydbio.2024.07.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39059680/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gadre,%20P.%20et%20al.%20Emergence%20and%20properties%20of%20adult%20mammalian%20epidermal%20stem%20cells.%20Dev.%20Biol.515,%20129%E2%80%93138%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Schmitt, T. et al. Dsg1 and Dsg3 composition of desmosomes across human epidermis and alterations in pemphigus vulgaris patient skin. <em>Front. Immunol.</em><strong>13</strong>, 884241 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.884241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9196036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35711465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt,%20T.%20et%20al.%20Dsg1%20and%20Dsg3%20composition%20of%20desmosomes%20across%20human%20epidermis%20and%20alterations%20in%20pemphigus%20vulgaris%20patient%20skin.%20Front.%20Immunol.13,%20884241%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Di Zenzo, G., Amber, K. T., Sayar, B. S., Muller, E. J. &amp; Borradori, L. Immune response in pemphigus and beyond: progresses and emerging concepts. <em>Semin Immunopathol.</em><strong>38</strong>, 57–74 (2016).
</cite> [<a href="https://doi.org/10.1007/s00281-015-0541-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26597100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Di%20Zenzo,%20G.,%20Amber,%20K.%20T.,%20Sayar,%20B.%20S.,%20Muller,%20E.%20J.%20&amp;%20Borradori,%20L.%20Immune%20response%20in%20pemphigus%20and%20beyond:%20progresses%20and%20emerging%20concepts.%20Semin%20Immunopathol.38,%2057%E2%80%9374%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Sokol, E. et al. Large-scale electron microscopy maps of patient skin and mucosa provide insight into pathogenesis of blistering diseases. <em>J. Investig. Dermatol.</em><strong>135</strong>, 1763–1770 (2015).
</cite> [<a href="https://doi.org/10.1038/jid.2015.109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25789704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sokol,%20E.%20et%20al.%20Large-scale%20electron%20microscopy%20maps%20of%20patient%20skin%20and%20mucosa%20provide%20insight%20into%20pathogenesis%20of%20blistering%20diseases.%20J.%20Investig.%20Dermatol.135,%201763%E2%80%931770%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Mahoney, M. G. et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. <em>J. Clin. Investig.</em><strong>103</strong>, 461–468 (1999).
</cite> [<a href="https://doi.org/10.1172/JCI5252" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC408100/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10021453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahoney,%20M.%20G.%20et%20al.%20Explanations%20for%20the%20clinical%20and%20microscopic%20localization%20of%20lesions%20in%20pemphigus%20foliaceus%20and%20vulgaris.%20J.%20Clin.%20Investig.103,%20461%E2%80%93468%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Hegazy, M. et al. Epidermal stratification requires retromer-mediated desmoglein-1 recycling. <em>Dev. Cell</em><strong>57</strong>, 2683–2698.e2688 (2022).
</cite> [<a href="https://doi.org/10.1016/j.devcel.2022.11.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9973369/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36495876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hegazy,%20M.%20et%20al.%20Epidermal%20stratification%20requires%20retromer-mediated%20desmoglein-1%20recycling.%20Dev.%20Cell57,%202683%E2%80%932698.e2688%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Schmitt, T. &amp; Waschke, J. Autoantibody-specific signalling in pemphigus. <em>Front. Med.</em><strong>8</strong>, 701809 (2021).</cite> [<a href="https://doi.org/10.3389/fmed.2021.701809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8381052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34434944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt,%20T.%20&amp;%20Waschke,%20J.%20Autoantibody-specific%20signalling%20in%20pemphigus.%20Front.%20Med.8,%20701809%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Arnette, C. R. et al. Keratinocyte cadherin desmoglein 1 controls melanocyte behavior through paracrine signaling. <em>Pigment Cell Melanoma Res.</em><strong>33</strong>, 305–317 (2020).
</cite> [<a href="https://doi.org/10.1111/pcmr.12826" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7028503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31563153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arnette,%20C.%20R.%20et%20al.%20Keratinocyte%20cadherin%20desmoglein%201%20controls%20melanocyte%20behavior%20through%20paracrine%20signaling.%20Pigment%20Cell%20Melanoma%20Res.33,%20305%E2%80%93317%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Heupel, W. M., Zillikens, D., Drenckhahn, D. &amp; Waschke, J. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. <em>J. Immunol.</em><strong>181</strong>, 1825–1834 (2008).
</cite> [<a href="https://doi.org/10.4049/jimmunol.181.3.1825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18641320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heupel,%20W.%20M.,%20Zillikens,%20D.,%20Drenckhahn,%20D.%20&amp;%20Waschke,%20J.%20Pemphigus%20vulgaris%20IgG%20directly%20inhibit%20desmoglein%203-mediated%20transinteraction.%20J.%20Immunol.181,%201825%E2%80%931834%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Hariton, W. V. J. et al. A desmosomal cadherin controls multipotent hair follicle stem cell quiescence and orchestrates regeneration through adhesion signaling. <em>iScience</em><strong>26</strong>, 108568 (2023).
</cite> [<a href="https://doi.org/10.1016/j.isci.2023.108568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10755723/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38162019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hariton,%20W.%20V.%20J.%20et%20al.%20A%20desmosomal%20cadherin%20controls%20multipotent%20hair%20follicle%20stem%20cell%20quiescence%20and%20orchestrates%20regeneration%20through%20adhesion%20signaling.%20iScience26,%20108568%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Müller, E. J., Williamson, L., Kolly, C. &amp; Suter, M. M. Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation?. <em>J. Investig. Dermatol.</em><strong>128</strong>, 501–516 (2008).
</cite> [<a href="https://doi.org/10.1038/sj.jid.5701248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18268536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?M%C3%BCller,%20E.%20J.,%20Williamson,%20L.,%20Kolly,%20C.%20&amp;%20Suter,%20M.%20M.%20Outside-in%20signaling%20through%20integrins%20and%20cadherins:%20a%20central%20mechanism%20to%20control%20epidermal%20growth%20and%20differentiation?.%20J.%20Investig.%20Dermatol.128,%20501%E2%80%93516%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Sato, M., Aoyama, Y. &amp; Kitajima, Y. Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. <em>Lab Investig.</em><strong>80</strong>, 1583–1592 (2000).
</cite> [<a href="https://doi.org/10.1038/labinvest.3780168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11045575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sato,%20M.,%20Aoyama,%20Y.%20&amp;%20Kitajima,%20Y.%20Assembly%20pathway%20of%20desmoglein%203%20to%20desmosomes%20and%20its%20perturbation%20by%20pemphigus%20vulgaris-IgG%20in%20cultured%20keratinocytes,%20as%20revealed%20by%20time-lapsed%20labeling%20immunoelectron%20microscopy.%20Lab%20Investig.80,%201583%E2%80%931592%20(2000)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Pasdar, M. &amp; Nelson, W. J. Regulation of desmosome assembly in epithelial cells: kinetics of synthesis, transport, and stabilization of desmoglein I, a major protein of the membrane core domain. <em>J. Cell Biol.</em><strong>109</strong>, 163–177 (1989).
</cite> [<a href="https://doi.org/10.1083/jcb.109.1.163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2115471/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2501314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pasdar,%20M.%20&amp;%20Nelson,%20W.%20J.%20Regulation%20of%20desmosome%20assembly%20in%20epithelial%20cells:%20kinetics%20of%20synthesis,%20transport,%20and%20stabilization%20of%20desmoglein%20I,%20a%20major%20protein%20of%20the%20membrane%20core%20domain.%20J.%20Cell%20Biol.109,%20163%E2%80%93177%20(1989)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Posthaus, H., Dubois, C. M. &amp; Muller, E. Novel insights into cadherin processing by subtilisin-like convertases. <em>FEBS Lett.</em><strong>536</strong>, 203–208 (2003).
</cite> [<a href="https://doi.org/10.1016/s0014-5793(02)03897-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12586364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Posthaus,%20H.,%20Dubois,%20C.%20M.%20&amp;%20Muller,%20E.%20Novel%20insights%20into%20cadherin%20processing%20by%20subtilisin-like%20convertases.%20FEBS%20Lett.536,%20203%E2%80%93208%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Rotzer, V. et al. E-cadherin and Src associate with extradesmosomal Dsg3 and modulate desmosome assembly and adhesion. <em>Cell Mol. Life Sci.</em><strong>72</strong>, 4885–4897 (2015).
</cite> [<a href="https://doi.org/10.1007/s00018-015-1977-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11113844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26115704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rotzer,%20V.%20et%20al.%20E-cadherin%20and%20Src%20associate%20with%20extradesmosomal%20Dsg3%20and%20modulate%20desmosome%20assembly%20and%20adhesion.%20Cell%20Mol.%20Life%20Sci.72,%204885%E2%80%934897%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Tsang, S. M. et al. Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. <em>Exp. Cell Res.</em><strong>318</strong>, 2269–2283 (2012).
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2012.07.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4022105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22796473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsang,%20S.%20M.%20et%20al.%20Desmoglein%203%20acting%20as%20an%20upstream%20regulator%20of%20Rho%20GTPases,%20Rac-1/Cdc42%20in%20the%20regulation%20of%20actin%20organisation%20and%20dynamics.%20Exp.%20Cell%20Res.318,%202269%E2%80%932283%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Tsang, S. M. et al. Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. <em>J. Pathol.</em><strong>227</strong>, 81–93 (2012).
</cite> [<a href="https://doi.org/10.1002/path.3982" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22294297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsang,%20S.%20M.%20et%20al.%20Non-junctional%20human%20desmoglein%203%20acts%20as%20an%20upstream%20regulator%20of%20Src%20in%20E-cadherin%20adhesion,%20a%20pathway%20possibly%20involved%20in%20the%20pathogenesis%20of%20pemphigus%20vulgaris.%20J.%20Pathol.227,%2081%E2%80%9393%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Caldelari, R. et al. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. <em>J. Cell Biol.</em><strong>153</strong>, 823–834 (2001).
</cite> [<a href="https://doi.org/10.1083/jcb.153.4.823" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2192383/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11352942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Caldelari,%20R.%20et%20al.%20A%20central%20role%20for%20the%20armadillo%20protein%20plakoglobin%20in%20the%20autoimmune%20disease%20pemphigus%20vulgaris.%20J.%20Cell%20Biol.153,%20823%E2%80%93834%20(2001)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Williamson, L. et al. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. <em>Embo J.</em><strong>25</strong>, 3298–3309 (2006).
</cite> [<a href="https://doi.org/10.1038/sj.emboj.7601224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1523185/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16871158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Williamson,%20L.%20et%20al.%20Pemphigus%20vulgaris%20identifies%20plakoglobin%20as%20key%20suppressor%20of%20c-Myc%20in%20the%20skin.%20Embo%20J.25,%203298%E2%80%933309%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Aoyama, Y. &amp; Kitajima, Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. <em>J. Investig. Dermatol.</em><strong>112</strong>, 67–71 (1999).
</cite> [<a href="https://doi.org/10.1046/j.1523-1747.1999.00463.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9886266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aoyama,%20Y.%20&amp;%20Kitajima,%20Y.%20Pemphigus%20vulgaris-IgG%20causes%20a%20rapid%20depletion%20of%20desmoglein%203%20(Dsg3)%20from%20the%20Triton%20X-100%20soluble%20pools,%20leading%20to%20the%20formation%20of%20Dsg3-depleted%20desmosomes%20in%20a%20human%20squamous%20carcinoma%20cell%20line,%20DJM-1%20cells.%20J.%20Investig.%20Dermatol.112,%2067%E2%80%9371%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Patel, H. P., Diaz, L. A., Anhalt, G. J., Labib, R. S. &amp; Takahashi, Y. Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. <em>J. Investig. Dermatol.</em><strong>83</strong>, 409–415 (1984).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12273480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6389716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel,%20H.%20P.,%20Diaz,%20L.%20A.,%20Anhalt,%20G.%20J.,%20Labib,%20R.%20S.%20&amp;%20Takahashi,%20Y.%20Demonstration%20of%20pemphigus%20antibodies%20on%20the%20cell%20surface%20of%20murine%20epidermal%20cell%20monolayers%20and%20their%20internalization.%20J.%20Investig.%20Dermatol.83,%20409%E2%80%93415%20(1984)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Suter, M. M., Wilkinson, J. E., Dougherty, E. P. &amp; Lewis, R. M. Ultrastructural localization of pemphigus vulgaris antigen on canine keratinocytes in vivo and in vitro. <em>Am. J. Vet. Res.</em><strong>51</strong>, 507–511 (1990).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2327609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suter,%20M.%20M.,%20Wilkinson,%20J.%20E.,%20Dougherty,%20E.%20P.%20&amp;%20Lewis,%20R.%20M.%20Ultrastructural%20localization%20of%20pemphigus%20vulgaris%20antigen%20on%20canine%20keratinocytes%20in%20vivo%20and%20in%20vitro.%20Am.%20J.%20Vet.%20Res.51,%20507%E2%80%93511%20(1990)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Tsunoda, K. et al. Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris. <em>Am. J. Pathol.</em><strong>179</strong>, 795–806 (2011).
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2011.04.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3157249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21718682/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsunoda,%20K.%20et%20al.%20Pathogenic%20relevance%20of%20IgG%20and%20IgM%20antibodies%20against%20desmoglein%203%20in%20blister%20formation%20in%20pemphigus%20vulgaris.%20Am.%20J.%20Pathol.179,%20795%E2%80%93806%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Shimizu, A. et al. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. <em>J. Investig. Dermatol.</em><strong>122</strong>, 1145–1153 (2004).
</cite> [<a href="https://doi.org/10.1111/j.0022-202X.2004.22426.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15140217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shimizu,%20A.%20et%20al.%20IgG%20binds%20to%20desmoglein%203%20in%20desmosomes%20and%20causes%20a%20desmosomal%20split%20without%20keratin%20retraction%20in%20a%20pemphigus%20mouse%20model.%20J.%20Investig.%20Dermatol.122,%201145%E2%80%931153%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Seishima, M. et al. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. <em>J. Investig. Dermatol.</em><strong>104</strong>, 33–37 (1995).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12613469" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7798638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Seishima,%20M.%20et%20al.%20Pemphigus%20IgG,%20but%20not%20bullous%20pemphigoid%20IgG,%20causes%20a%20transient%20increase%20in%20intracellular%20calcium%20and%20inositol%201,4,5-triphosphate%20in%20DJM-1%20cells,%20a%20squamous%20cell%20carcinoma%20line.%20J.%20Investig.%20Dermatol.104,%2033%E2%80%9337%20(1995)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Zhurinsky, J., Shtutman, M. &amp; Ben-Ze’ev, A. Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. <em>J. Cell Sci.</em><strong>113</strong>, 3127–3139 (2000).
</cite> [<a href="https://doi.org/10.1242/jcs.113.18.3127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10954412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhurinsky,%20J.,%20Shtutman,%20M.%20&amp;%20Ben-Ze%E2%80%99ev,%20A.%20Plakoglobin%20and%20beta-catenin:%20protein%20interactions,%20regulation%20and%20biological%20roles.%20J.%20Cell%20Sci.113,%203127%E2%80%933139%20(2000)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Acehan, D. et al. Plakoglobin is required for effective intermediate filament anchorage to desmosomes. <em>J. Investig. Dermatol.</em><strong>128</strong>, 2665–2675 (2008).
</cite> [<a href="https://doi.org/10.1038/jid.2008.141" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18496566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Acehan,%20D.%20et%20al.%20Plakoglobin%20is%20required%20for%20effective%20intermediate%20filament%20anchorage%20to%20desmosomes.%20J.%20Investig.%20Dermatol.128,%202665%E2%80%932675%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Nanavati, B. N. et al. The desmosome-intermediate filament system facilitates mechanotransduction at adherens junctions for epithelial homeostasis. <em>Curr. Biol.</em><strong>34</strong>, 4081–4090.e4085 (2024).
</cite> [<a href="https://doi.org/10.1016/j.cub.2024.07.074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11387132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39153481/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nanavati,%20B.%20N.%20et%20al.%20The%20desmosome-intermediate%20filament%20system%20facilitates%20mechanotransduction%20at%20adherens%20junctions%20for%20epithelial%20homeostasis.%20Curr.%20Biol.34,%204081%E2%80%934090.e4085%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Waschke, J. et al. Inhibition of Rho A activity causes pemphigus skin blistering. <em>J. Cell Biol.</em><strong>175</strong>, 721–727 (2006).
</cite> [<a href="https://doi.org/10.1083/jcb.200605125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2064672/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17130286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Waschke,%20J.%20et%20al.%20Inhibition%20of%20Rho%20A%20activity%20causes%20pemphigus%20skin%20blistering.%20J.%20Cell%20Biol.175,%20721%E2%80%93727%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Jin, X. et al. Modulation of mechanical stress mitigates anti-Dsg3 antibody-induced dissociation of cell-cell adhesion. <em>Adv. Biol.</em><strong>5</strong>, e2000159 (2021).</cite> [<a href="https://doi.org/10.1002/adbi.202000159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7993752/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33724731/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin,%20X.%20et%20al.%20Modulation%20of%20mechanical%20stress%20mitigates%20anti-Dsg3%20antibody-induced%20dissociation%20of%20cell-cell%20adhesion.%20Adv.%20Biol.5,%20e2000159%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Heupel, W. M. et al. Peptides targeting the desmoglein 3 adhesive interface prevent autoantibody-induced acantholysis in pemphigus. <em>J. Biol. Chem.</em><strong>284</strong>, 8589–8595 (2009).
</cite> [<a href="https://doi.org/10.1074/jbc.M808813200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2659217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19164289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heupel,%20W.%20M.%20et%20al.%20Peptides%20targeting%20the%20desmoglein%203%20adhesive%20interface%20prevent%20autoantibody-induced%20acantholysis%20in%20pemphigus.%20J.%20Biol.%20Chem.284,%208589%E2%80%938595%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Hartmann, V. et al. The human skin organ culture model as an optimal complementary tool for murine pemphigus models. <em>Lab Anim.</em><strong>57</strong>, 381–395 (2023).
</cite> [<a href="https://doi.org/10.1177/00236772221145647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36647613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hartmann,%20V.%20et%20al.%20The%20human%20skin%20organ%20culture%20model%20as%20an%20optimal%20complementary%20tool%20for%20murine%20pemphigus%20models.%20Lab%20Anim.57,%20381%E2%80%93395%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Hudemann, C. et al. IgG against the membrane-proximal portion of the desmoglein 3 ectodomain induces loss of keratinocyte adhesion, a hallmark in pemphigus vulgaris. <em>J. Investig. Dermatol.</em><strong>143</strong>, 254–263.e253 (2023).
</cite> [<a href="https://doi.org/10.1016/j.jid.2022.07.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36089007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hudemann,%20C.%20et%20al.%20IgG%20against%20the%20membrane-proximal%20portion%20of%20the%20desmoglein%203%20ectodomain%20induces%20loss%20of%20keratinocyte%20adhesion,%20a%20hallmark%20in%20pemphigus%20vulgaris.%20J.%20Investig.%20Dermatol.143,%20254%E2%80%93263.e253%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Gliem, M., Heupel, W. M., Spindler, V., Harms, G. S. &amp; Waschke, J. Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. <em>Am. J. Physiol. Cell Physiol.</em><strong>299</strong>, C606–C613 (2010).
</cite> [<a href="https://doi.org/10.1152/ajpcell.00075.2010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20554911/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gliem,%20M.,%20Heupel,%20W.%20M.,%20Spindler,%20V.,%20Harms,%20G.%20S.%20&amp;%20Waschke,%20J.%20Actin%20reorganization%20contributes%20to%20loss%20of%20cell%20adhesion%20in%20pemphigus%20vulgaris.%20Am.%20J.%20Physiol.%20Cell%20Physiol.299,%20C606%E2%80%93C613%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Tucker, D. K., Stahley, S. N. &amp; Kowalczyk, A. P. Plakophilin-1 protects keratinocytes from pemphigus vulgaris IgG by forming calcium-independent desmosomes. <em>J. Investig. Dermatol.</em><strong>134</strong>, 1033–1043 (2014).
</cite> [<a href="https://doi.org/10.1038/jid.2013.401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3961504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24056861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tucker,%20D.%20K.,%20Stahley,%20S.%20N.%20&amp;%20Kowalczyk,%20A.%20P.%20Plakophilin-1%20protects%20keratinocytes%20from%20pemphigus%20vulgaris%20IgG%20by%20forming%20calcium-independent%20desmosomes.%20J.%20Investig.%20Dermatol.134,%201033%E2%80%931043%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Cirillo, N. &amp; Prime, S. S. Desmosomal interactome in keratinocytes: a systems biology approach leading to an understanding of the pathogenesis of skin disease. <em>Cell Mol. Life Sci.</em><strong>66</strong>, 3517–3533 (2009).
</cite> [<a href="https://doi.org/10.1007/s00018-009-0139-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11115514/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19756386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cirillo,%20N.%20&amp;%20Prime,%20S.%20S.%20Desmosomal%20interactome%20in%20keratinocytes:%20a%20systems%20biology%20approach%20leading%20to%20an%20understanding%20of%20the%20pathogenesis%20of%20skin%20disease.%20Cell%20Mol.%20Life%20Sci.66,%203517%E2%80%933533%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Frusic-Zlotkin, M. et al. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis-possible involvement of the EGF receptor. <em>Autoimmunity</em><strong>39</strong>, 563–575 (2006).
</cite> [<a href="https://doi.org/10.1080/08916930600971836" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17101500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Frusic-Zlotkin,%20M.%20et%20al.%20Apoptotic%20mechanism%20in%20pemphigus%20autoimmunoglobulins-induced%20acantholysis-possible%20involvement%20of%20the%20EGF%20receptor.%20Autoimmunity39,%20563%E2%80%93575%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Berkowitz, P. et al. Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. <em>J. Biol. Chem.</em><strong>280</strong>, 23778–23784 (2005).
</cite> [<a href="https://doi.org/10.1074/jbc.M501365200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15840580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berkowitz,%20P.%20et%20al.%20Desmosome%20signaling.%20Inhibition%20of%20p38MAPK%20prevents%20pemphigus%20vulgaris%20IgG-induced%20cytoskeleton%20reorganization.%20J.%20Biol.%20Chem.280,%2023778%E2%80%9323784%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Amagai, M. Autoantibodies against cell adhesion molecules in pemphigus. <em>J. Dermatol.</em><strong>21</strong>, 833–837 (1994).
</cite> [<a href="https://doi.org/10.1111/j.1346-8138.1994.tb03298.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7852644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Amagai,%20M.%20Autoantibodies%20against%20cell%20adhesion%20molecules%20in%20pemphigus.%20J.%20Dermatol.21,%20833%E2%80%93837%20(1994)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Walter, E. et al. Role of Dsg1- and Dsg3-mediated signaling in pemphigus autoantibody-induced loss of keratinocyte cohesion. <em>Front. Immunol.</em><strong>10</strong>, 1128 (2019).
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.01128" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6543754/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31178865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walter,%20E.%20et%20al.%20Role%20of%20Dsg1-%20and%20Dsg3-mediated%20signaling%20in%20pemphigus%20autoantibody-induced%20loss%20of%20keratinocyte%20cohesion.%20Front.%20Immunol.10,%201128%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Jennings, J. M. et al. Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. <em>J. Investig. Dermatol.</em><strong>131</strong>, 706–718 (2011).
</cite> [<a href="https://doi.org/10.1038/jid.2010.389" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3235416/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21160493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jennings,%20J.%20M.%20et%20al.%20Desmosome%20disassembly%20in%20response%20to%20pemphigus%20vulgaris%20IgG%20occurs%20in%20distinct%20phases%20and%20can%20be%20reversed%20by%20expression%20of%20exogenous%20Dsg3.%20J.%20Investig.%20Dermatol.131,%20706%E2%80%93718%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Spindler, V. et al. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. <em>J. Clin. Investig.</em><strong>123</strong>, 800–811 (2013).
</cite> [<a href="https://doi.org/10.1172/JCI60139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3561799/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23298835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spindler,%20V.%20et%20al.%20Peptide-mediated%20desmoglein%203%20crosslinking%20prevents%20pemphigus%20vulgaris%20autoantibody-induced%20skin%20blistering.%20J.%20Clin.%20Investig.123,%20800%E2%80%93811%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Nguyen, B., Dusek, R. L., Beaudry, V. G., Marinkovich, M. P. &amp; Attardi, L. D. Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies. <em>J. Investig. Dermatol.</em><strong>129</strong>, 1710–1718 (2009).
</cite> [<a href="https://doi.org/10.1038/jid.2008.419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2904546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19158843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen,%20B.,%20Dusek,%20R.%20L.,%20Beaudry,%20V.%20G.,%20Marinkovich,%20M.%20P.%20&amp;%20Attardi,%20L.%20D.%20Loss%20of%20the%20desmosomal%20protein%20perp%20enhances%20the%20phenotypic%20effects%20of%20pemphigus%20vulgaris%20autoantibodies.%20J.%20Investig.%20Dermatol.129,%201710%E2%80%931718%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Sumigray, K., Zhou, K. &amp; Lechler, T. Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption. <em>PLoS One</em><strong>9</strong>, e101824 (2014).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0101824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4090201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25006807/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sumigray,%20K.,%20Zhou,%20K.%20&amp;%20Lechler,%20T.%20Cell-cell%20adhesions%20and%20cell%20contractility%20are%20upregulated%20upon%20desmosome%20disruption.%20PLoS%20One9,%20e101824%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Michels, C., Buchta, T., Bloch, W., Krieg, T. &amp; Niessen, C. M. Classical cadherins regulate desmosome formation. <em>J. Investig. Dermatol.</em><strong>129</strong>, 2072–2075 (2009).
</cite> [<a href="https://doi.org/10.1038/jid.2009.17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19262605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michels,%20C.,%20Buchta,%20T.,%20Bloch,%20W.,%20Krieg,%20T.%20&amp;%20Niessen,%20C.%20M.%20Classical%20cadherins%20regulate%20desmosome%20formation.%20J.%20Investig.%20Dermatol.129,%202072%E2%80%932075%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Tunggal, J. A. et al. E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. <em>EMBO J.</em><strong>24</strong>, 1146–1156 (2005).
</cite> [<a href="https://doi.org/10.1038/sj.emboj.7600605" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC556407/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15775979/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tunggal,%20J.%20A.%20et%20al.%20E-cadherin%20is%20essential%20for%20in%20vivo%20epidermal%20barrier%20function%20by%20regulating%20tight%20junctions.%20EMBO%20J.24,%201146%E2%80%931156%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Shafraz, O. et al. E-cadherin binds to desmoglein to facilitate desmosome assembly. <em>eLife</em><strong>7</strong>, e37629 (2018).
</cite> [<a href="https://doi.org/10.7554/eLife.37629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6066328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29999492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shafraz,%20O.%20et%20al.%20E-cadherin%20binds%20to%20desmoglein%20to%20facilitate%20desmosome%20assembly.%20eLife7,%20e37629%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Fuchs, M. et al. Cytoskeletal anchorage of different Dsg3 pools revealed by combination of hybrid STED/SMFS-AFM. <em>Cell Mol. Life Sci.</em><strong>80</strong>, 25 (2023).
</cite> [<a href="https://doi.org/10.1007/s00018-022-04681-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9816259/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36602635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fuchs,%20M.%20et%20al.%20Cytoskeletal%20anchorage%20of%20different%20Dsg3%20pools%20revealed%20by%20combination%20of%20hybrid%20STED/SMFS-AFM.%20Cell%20Mol.%20Life%20Sci.80,%2025%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Getsios, S., Waschke, J., Borradori, L., Hertl, M. &amp; Muller, E. J. From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy. <em>J. Investig. Dermatol.</em><strong>130</strong>, 1764–1768 (2010).
</cite> [<a href="https://doi.org/10.1038/jid.2010.111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20548314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Getsios,%20S.,%20Waschke,%20J.,%20Borradori,%20L.,%20Hertl,%20M.%20&amp;%20Muller,%20E.%20J.%20From%20cell%20signaling%20to%20novel%20therapeutic%20concepts:%20international%20pemphigus%20meeting%20on%20advances%20in%20pemphigus%20research%20and%20therapy.%20J.%20Investig.%20Dermatol.130,%201764%E2%80%931768%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Kohler, T. N. et al. Plakoglobin is a mechanoresponsive regulator of naive pluripotency. <em>Nat. Commun.</em><strong>14</strong>, 4022 (2023).
</cite> [<a href="https://doi.org/10.1038/s41467-023-39515-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10329048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37419903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kohler,%20T.%20N.%20et%20al.%20Plakoglobin%20is%20a%20mechanoresponsive%20regulator%20of%20naive%20pluripotency.%20Nat.%20Commun.14,%204022%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Muller, L., Hatzfeld, M. &amp; Keil, R. Desmosomes as Signaling Hubs in the Regulation of Cell Behavior. <em>Front. Cell Dev. Biol.</em><strong>9</strong>, 745670 (2021).
</cite> [<a href="https://doi.org/10.3389/fcell.2021.745670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8495202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34631720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Muller,%20L.,%20Hatzfeld,%20M.%20&amp;%20Keil,%20R.%20Desmosomes%20as%20Signaling%20Hubs%20in%20the%20Regulation%20of%20Cell%20Behavior.%20Front.%20Cell%20Dev.%20Biol.9,%20745670%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>de Bruin, A. et al. Plakoglobin-dependent disruption of the desmosomal plaque in pemphigus vulgaris. <em>Exp. Dermatol.</em><strong>16</strong>, 468–475 (2007).
</cite> [<a href="https://doi.org/10.1111/j.1600-0625.2007.00557.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17518986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Bruin,%20A.%20et%20al.%20Plakoglobin-dependent%20disruption%20of%20the%20desmosomal%20plaque%20in%20pemphigus%20vulgaris.%20Exp.%20Dermatol.16,%20468%E2%80%93475%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Spindler, V., Dehner, C., Hubner, S. &amp; Waschke, J. Plakoglobin but not desmoplakin regulates keratinocyte cohesion via modulation of p38MAPK signaling. <em>J. Investig. Dermatol.</em><strong>134</strong>, 1655–1664 (2014).
</cite> [<a href="https://doi.org/10.1038/jid.2014.21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24441103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spindler,%20V.,%20Dehner,%20C.,%20Hubner,%20S.%20&amp;%20Waschke,%20J.%20Plakoglobin%20but%20not%20desmoplakin%20regulates%20keratinocyte%20cohesion%20via%20modulation%20of%20p38MAPK%20signaling.%20J.%20Investig.%20Dermatol.134,%201655%E2%80%931664%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Sigmund, A. M. et al. Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus. <em>Nat. Commun.</em><strong>14</strong>, 116 (2023).
</cite> [<a href="https://doi.org/10.1038/s41467-022-35741-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9829900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36624106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sigmund,%20A.%20M.%20et%20al.%20Apremilast%20prevents%20blistering%20in%20human%20epidermis%20and%20stabilizes%20keratinocyte%20adhesion%20in%20pemphigus.%20Nat.%20Commun.14,%20116%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Schmitt, T. et al. Ca(2+) signalling is critical for autoantibody-induced blistering of human epidermis in pemphigus. <em>Br. J. Dermatol.</em><strong>185</strong>, 595–604 (2021).
</cite> [<a href="https://doi.org/10.1111/bjd.20091" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33792909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt,%20T.%20et%20al.%20Ca(2+)%20signalling%20is%20critical%20for%20autoantibody-induced%20blistering%20of%20human%20epidermis%20in%20pemphigus.%20Br.%20J.%20Dermatol.185,%20595%E2%80%93604%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Canovas, B. &amp; Nebreda, A. R. Diversity and versatility of p38 kinase signalling in health and disease. <em>Nat. Rev. Mol. Cell Biol.</em><strong>22</strong>, 346–366 (2021).
</cite> [<a href="https://doi.org/10.1038/s41580-020-00322-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7838852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33504982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Canovas,%20B.%20&amp;%20Nebreda,%20A.%20R.%20Diversity%20and%20versatility%20of%20p38%20kinase%20signalling%20in%20health%20and%20disease.%20Nat.%20Rev.%20Mol.%20Cell%20Biol.22,%20346%E2%80%93366%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Wöll, S., Windoffer, R. &amp; Leube, R. E. p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells. <em>J. Cell Biol.</em><strong>177</strong>, 795–807 (2007).
</cite> [<a href="https://doi.org/10.1083/jcb.200703174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2064280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17535969/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?W%C3%B6ll,%20S.,%20Windoffer,%20R.%20&amp;%20Leube,%20R.%20E.%20p38%20MAPK-dependent%20shaping%20of%20the%20keratin%20cytoskeleton%20in%20cultured%20cells.%20J.%20Cell%20Biol.177,%20795%E2%80%93807%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Marchenko, S., Chernyavsky, A. I., Arredondo, J., Gindi, V. &amp; Grando, S. A. Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. <em>J. Biol. Chem.</em><strong>285</strong>, 3695–3704 (2010).
</cite> [<a href="https://doi.org/10.1074/jbc.M109.081570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2823510/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20007702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marchenko,%20S.,%20Chernyavsky,%20A.%20I.,%20Arredondo,%20J.,%20Gindi,%20V.%20&amp;%20Grando,%20S.%20A.%20Antimitochondrial%20autoantibodies%20in%20pemphigus%20vulgaris:%20a%20missing%20link%20in%20disease%20pathophysiology.%20J.%20Biol.%20Chem.285,%203695%E2%80%933704%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Berkowitz, P. et al. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. <em>Proc. Natl Acad. Sci. U.S.A.</em><strong>103</strong>, 12855–12860 (2006).
</cite> [<a href="https://doi.org/10.1073/pnas.0602973103" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1568937/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16908851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berkowitz,%20P.%20et%20al.%20p38MAPK%20inhibition%20prevents%20disease%20in%20pemphigus%20vulgaris%20mice.%20Proc.%20Natl%20Acad.%20Sci.%20U.S.A.103,%2012855%E2%80%9312860%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Lee, H. E. et al. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. <em>J. Biol. Chem.</em><strong>284</strong>, 12524–12532 (2009).
</cite> [<a href="https://doi.org/10.1074/jbc.M808204200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2673318/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19270308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee,%20H.%20E.%20et%20al.%20Biphasic%20activation%20of%20p38MAPK%20suggests%20that%20apoptosis%20is%20a%20downstream%20event%20in%20pemphigus%20acantholysis.%20J.%20Biol.%20Chem.284,%2012524%E2%80%9312532%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Jolly, P. S. et al. p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. <em>J. Biol. Chem.</em><strong>285</strong>, 8936–8941 (2010).
</cite> [<a href="https://doi.org/10.1074/jbc.M109.087999" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2838315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20093368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jolly,%20P.%20S.%20et%20al.%20p38MAPK%20signaling%20and%20desmoglein-3%20internalization%20are%20linked%20events%20in%20pemphigus%20acantholysis.%20J.%20Biol.%20Chem.285,%208936%E2%80%938941%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Saito, M. et al. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. <em>PLoS One</em><strong>7</strong>, e50696 (2012).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0050696" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3513318/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23226536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saito,%20M.%20et%20al.%20Signaling%20dependent%20and%20independent%20mechanisms%20in%20pemphigus%20vulgaris%20blister%20formation.%20PLoS%20One7,%20e50696%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Bektas, M., Jolly, P. S., Berkowitz, P., Amagai, M. &amp; Rubenstein, D. S. A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. <em>J. Biol. Chem.</em><strong>288</strong>, 9447–9456 (2013).
</cite> [<a href="https://doi.org/10.1074/jbc.M112.438010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3611014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23404504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bektas,%20M.,%20Jolly,%20P.%20S.,%20Berkowitz,%20P.,%20Amagai,%20M.%20&amp;%20Rubenstein,%20D.%20S.%20A%20pathophysiologic%20role%20for%20epidermal%20growth%20factor%20receptor%20in%20pemphigus%20acantholysis.%20J.%20Biol.%20Chem.288,%209447%E2%80%939456%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Hartlieb, E., Rotzer, V., Radeva, M., Spindler, V. &amp; Waschke, J. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes. <em>J. Biol. Chem.</em><strong>289</strong>, 17043–17053 (2014).
</cite> [<a href="https://doi.org/10.1074/jbc.M113.489336" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4059146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24782306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hartlieb,%20E.,%20Rotzer,%20V.,%20Radeva,%20M.,%20Spindler,%20V.%20&amp;%20Waschke,%20J.%20Desmoglein%202%20compensates%20for%20desmoglein%203%20but%20does%20not%20control%20cell%20adhesion%20via%20regulation%20of%20p38%20mitogen-activated%20protein%20kinase%20in%20keratinocytes.%20J.%20Biol.%20Chem.289,%2017043%E2%80%9317053%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Mao, X. et al. MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. <em>J. Investog. Dermatol.</em><strong>134</strong>, 68–76 (2014).</cite> [<a href="https://doi.org/10.1038/jid.2013.224" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3786199/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23657501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao,%20X.%20et%20al.%20MAPKAP%20kinase%202%20(MK2)-dependent%20and%20-independent%20models%20of%20blister%20formation%20in%20pemphigus%20vulgaris.%20J.%20Investog.%20Dermatol.134,%2068%E2%80%9376%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Rotzer, V., Breit, A., Waschke, J. &amp; Spindler, V. Adducin is required for desmosomal cohesion in keratinocytes. <em>J. Biol. Chem.</em><strong>289</strong>, 14925–14940 (2014).
</cite> [<a href="https://doi.org/10.1074/jbc.M113.527127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4031542/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24711455/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rotzer,%20V.,%20Breit,%20A.,%20Waschke,%20J.%20&amp;%20Spindler,%20V.%20Adducin%20is%20required%20for%20desmosomal%20cohesion%20in%20keratinocytes.%20J.%20Biol.%20Chem.289,%2014925%E2%80%9314940%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Vielmuth, F., Waschke, J. &amp; Spindler, V. Loss of desmoglein binding is not sufficient for keratinocyte dissociation in pemphigus. <em>J. Investig. Dermatol.</em><strong>135</strong>, 3068–3077 (2015).
</cite> [<a href="https://doi.org/10.1038/jid.2015.324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26288352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vielmuth,%20F.,%20Waschke,%20J.%20&amp;%20Spindler,%20V.%20Loss%20of%20desmoglein%20binding%20is%20not%20sufficient%20for%20keratinocyte%20dissociation%20in%20pemphigus.%20J.%20Investig.%20Dermatol.135,%203068%E2%80%933077%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Egu, D. T., Walter, E., Spindler, V. &amp; Waschke, J. Inhibition of p38MAPK signalling prevents epidermal blistering and alterations of desmosome structure induced by pemphigus autoantibodies in human epidermis. <em>Br. J. Dermatol.</em><strong>177</strong>, 1612–1618 (2017).
</cite> [<a href="https://doi.org/10.1111/bjd.15721" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28600798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egu,%20D.%20T.,%20Walter,%20E.,%20Spindler,%20V.%20&amp;%20Waschke,%20J.%20Inhibition%20of%20p38MAPK%20signalling%20prevents%20epidermal%20blistering%20and%20alterations%20of%20desmosome%20structure%20induced%20by%20pemphigus%20autoantibodies%20in%20human%20epidermis.%20Br.%20J.%20Dermatol.177,%201612%E2%80%931618%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Walter, E. et al. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. <em>Sci. Rep.</em><strong>7</strong>, 3579 (2017).
</cite> [<a href="https://doi.org/10.1038/s41598-017-03697-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5472593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28620161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Walter,%20E.%20et%20al.%20Different%20signaling%20patterns%20contribute%20to%20loss%20of%20keratinocyte%20cohesion%20dependent%20on%20autoantibody%20profile%20in%20pemphigus.%20Sci.%20Rep.7,%203579%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Vielmuth, F. et al. Keratins regulate p38MAPK-dependent desmoglein binding properties in pemphigus. <em>Front. Immunol.</em><strong>9</strong>, 528 (2018).
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.00528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5868517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29616033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vielmuth,%20F.%20et%20al.%20Keratins%20regulate%20p38MAPK-dependent%20desmoglein%20binding%20properties%20in%20pemphigus.%20Front.%20Immunol.9,%20528%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Burmester, I. A. K. et al. Identification of novel therapeutic targets for blocking acantholysis in pemphigus. <em>Br. J. Pharm.</em><strong>177</strong>, 5114–5130 (2020).</cite> [<a href="https://doi.org/10.1111/bph.15233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7588822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32815159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burmester,%20I.%20A.%20K.%20et%20al.%20Identification%20of%20novel%20therapeutic%20targets%20for%20blocking%20acantholysis%20in%20pemphigus.%20Br.%20J.%20Pharm.177,%205114%E2%80%935130%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Schmitt, T. et al. Dsg3 epitope-specific signalling in pemphigus. <em>Front. Immunol.</em><strong>14</strong>, 1163066 (2023).
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1163066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10151755/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37143675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt,%20T.%20et%20al.%20Dsg3%20epitope-specific%20signalling%20in%20pemphigus.%20Front.%20Immunol.14,%201163066%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Payne, A. S. et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. <em>J. Clin. Investig.</em><strong>115</strong>, 888–899 (2005).
</cite> [<a href="https://doi.org/10.1172/JCI24185" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1070425/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15841178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Payne,%20A.%20S.%20et%20al.%20Genetic%20and%20functional%20characterization%20of%20human%20pemphigus%20vulgaris%20monoclonal%20autoantibodies%20isolated%20by%20phage%20display.%20J.%20Clin.%20Investig.115,%20888%E2%80%93899%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Mao, X., Sano, Y., Park, J. M. &amp; Payne, A. S. p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris. <em>J. Biol. Chem.</em><strong>286</strong>, 1283–1291 (2011).
</cite> [<a href="https://doi.org/10.1074/jbc.M110.172874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3020736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21078676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao,%20X.,%20Sano,%20Y.,%20Park,%20J.%20M.%20&amp;%20Payne,%20A.%20S.%20p38%20MAPK%20activation%20is%20downstream%20of%20the%20loss%20of%20intercellular%20adhesion%20in%20pemphigus%20vulgaris.%20J.%20Biol.%20Chem.286,%201283%E2%80%931291%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Schlogl, E. et al. Keratin retraction and Desmoglein3 internalization independently contribute to autoantibody-induced cell dissociation in pemphigus vulgaris. <em>Front. Immunol.</em><strong>9</strong>, 858 (2018).
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.00858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5996934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29922278/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schlogl,%20E.%20et%20al.%20Keratin%20retraction%20and%20Desmoglein3%20internalization%20independently%20contribute%20to%20autoantibody-induced%20cell%20dissociation%20in%20pemphigus%20vulgaris.%20Front.%20Immunol.9,%20858%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Ohashi, K., Fujiwara, S. &amp; Mizuno, K. Roles of the cytoskeleton, cell adhesion and rho signalling in mechanosensing and mechanotransduction. <em>J. Biochem.</em><strong>161</strong>, 245–254 (2017).
</cite> [<a href="https://doi.org/10.1093/jb/mvw082" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28082721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ohashi,%20K.,%20Fujiwara,%20S.%20&amp;%20Mizuno,%20K.%20Roles%20of%20the%20cytoskeleton,%20cell%20adhesion%20and%20rho%20signalling%20in%20mechanosensing%20and%20mechanotransduction.%20J.%20Biochem.161,%20245%E2%80%93254%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Leckband, D. Cadherins and growth factor receptors: signaling mechano-switches at intercellular junctions. <em>Curr. Opin. Biomed. Eng.</em><strong>28</strong>, 100503 (2023).</cite> [<a href="https://scholar.google.com/scholar_lookup?Leckband,%20D.%20Cadherins%20and%20growth%20factor%20receptors:%20signaling%20mechano-switches%20at%20intercellular%20junctions.%20Curr.%20Opin.%20Biomed.%20Eng.28,%20100503%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Chernyavsky, A. I., Arredondo, J., Kitajima, Y., Sato-Nagai, M. &amp; Grando, S. A. Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. <em>J. Biol. Chem.</em><strong>282</strong>, 13804–13812 (2007).
</cite> [<a href="https://doi.org/10.1074/jbc.M611365200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17344213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chernyavsky,%20A.%20I.,%20Arredondo,%20J.,%20Kitajima,%20Y.,%20Sato-Nagai,%20M.%20&amp;%20Grando,%20S.%20A.%20Desmoglein%20versus%20non-desmoglein%20signaling%20in%20pemphigus%20acantholysis:%20characterization%20of%20novel%20signaling%20pathways%20downstream%20of%20pemphigus%20vulgaris%20antigens.%20J.%20Biol.%20Chem.282,%2013804%E2%80%9313812%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Egu, D. T. et al. EGFR inhibition by Erlotinib rescues desmosome ultrastructure and keratin anchorage and protects against pemphigus vulgaris IgG-induced acantholysis in human epidermis. <em>J. Investig. Dermatol.</em><strong>144</strong>, 2440–2452 (2024).
</cite> [<a href="https://doi.org/10.1016/j.jid.2024.03.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38642796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egu,%20D.%20T.%20et%20al.%20EGFR%20inhibition%20by%20Erlotinib%20rescues%20desmosome%20ultrastructure%20and%20keratin%20anchorage%20and%20protects%20against%20pemphigus%20vulgaris%20IgG-induced%20acantholysis%20in%20human%20epidermis.%20J.%20Investig.%20Dermatol.144,%202440%E2%80%932452%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Pretel, M. et al. An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. <em>Exp. Dermatol.</em><strong>18</strong>, 771–780 (2009).
</cite> [<a href="https://doi.org/10.1111/j.1600-0625.2009.00893.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19552768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pretel,%20M.%20et%20al.%20An%20imbalance%20in%20Akt/mTOR%20is%20involved%20in%20the%20apoptotic%20and%20acantholytic%20processes%20in%20a%20mouse%20model%20of%20pemphigus%20vulgaris.%20Exp.%20Dermatol.18,%20771%E2%80%93780%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Gil, M. P., Modol, T., Espana, A. &amp; Lopez-Zabalza, M. J. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris. <em>Exp. Dermatol.</em><strong>21</strong>, 254–259 (2012).
</cite> [<a href="https://doi.org/10.1111/j.1600-0625.2012.01441.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22320676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gil,%20M.%20P.,%20Modol,%20T.,%20Espana,%20A.%20&amp;%20Lopez-Zabalza,%20M.%20J.%20Inhibition%20of%20FAK%20prevents%20blister%20formation%20in%20the%20neonatal%20mouse%20model%20of%20pemphigus%20vulgaris.%20Exp.%20Dermatol.21,%20254%E2%80%93259%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Espana, A., Modol, T., Gil, M. P. &amp; Lopez-Zabalza, M. J. Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase. <em>Exp. Dermatol.</em><strong>22</strong>, 125–130 (2013).
</cite> [<a href="https://doi.org/10.1111/exd.12088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23362871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Espana,%20A.,%20Modol,%20T.,%20Gil,%20M.%20P.%20&amp;%20Lopez-Zabalza,%20M.%20J.%20Neural%20nitric%20oxide%20synthase%20participates%20in%20pemphigus%20vulgaris%20acantholysis%20through%20upregulation%20of%20Rous%20sarcoma,%20mammalian%20target%20of%20rapamycin%20and%20focal%20adhesion%20kinase.%20Exp.%20Dermatol.22,%20125%E2%80%93130%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Cirillo, N., AlShwaimi, E., McCullough, M. &amp; Prime, S. S. Pemphigus vulgaris autoimmune globulin induces Src-dependent tyrosine-phosphorylation of plakophilin 3 and its detachment from desmoglein 3. <em>Autoimmunity</em><strong>47</strong>, 134–140 (2014).
</cite> [<a href="https://doi.org/10.3109/08916934.2013.866100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24328683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cirillo,%20N.,%20AlShwaimi,%20E.,%20McCullough,%20M.%20&amp;%20Prime,%20S.%20S.%20Pemphigus%20vulgaris%20autoimmune%20globulin%20induces%20Src-dependent%20tyrosine-phosphorylation%20of%20plakophilin%203%20and%20its%20detachment%20from%20desmoglein%203.%20Autoimmunity47,%20134%E2%80%93140%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Kugelmann, D. et al. Role of Src and Cortactin in pemphigus skin blistering. <em>Front. Immunol.</em><strong>10</strong>, 626 (2019).
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.00626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6461052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31024527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kugelmann,%20D.%20et%20al.%20Role%20of%20Src%20and%20Cortactin%20in%20pemphigus%20skin%20blistering.%20Front.%20Immunol.10,%20626%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Ivars, M. et al. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient. <em>Br. J. Dermatol.</em><strong>182</strong>, 1194–1204 (2020).
</cite> [<a href="https://doi.org/10.1111/bjd.18382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31370093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ivars,%20M.%20et%20al.%20The%20involvement%20of%20ADAM10%20in%20acantholysis%20in%20mucocutaneous%20pemphigus%20vulgaris%20depends%20on%20the%20autoantibody%20profile%20of%20each%20patient.%20Br.%20J.%20Dermatol.182,%201194%E2%80%931204%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Heupel, W. M., Engerer, P., Schmidt, E. &amp; Waschke, J. Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. <em>Am. J. Pathol.</em><strong>174</strong>, 475–485 (2009).
</cite> [<a href="https://doi.org/10.2353/ajpath.2009.080392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2630556/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19147829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heupel,%20W.%20M.,%20Engerer,%20P.,%20Schmidt,%20E.%20&amp;%20Waschke,%20J.%20Pemphigus%20vulgaris%20IgG%20cause%20loss%20of%20desmoglein-mediated%20adhesion%20and%20keratinocyte%20dissociation%20independent%20of%20epidermal%20growth%20factor%20receptor.%20Am.%20J.%20Pathol.174,%20475%E2%80%93485%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Kim, S. H. &amp; Kim, S. H. Antagonistic effect of EGF on FAK phosphorylation/dephosphorylation in a cell. <em>Cell Biochem. Funct.</em><strong>26</strong>, 539–547 (2008).
</cite> [<a href="https://doi.org/10.1002/cbf.1457" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18543351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim,%20S.%20H.%20&amp;%20Kim,%20S.%20H.%20Antagonistic%20effect%20of%20EGF%20on%20FAK%20phosphorylation/dephosphorylation%20in%20a%20cell.%20Cell%20Biochem.%20Funct.26,%20539%E2%80%93547%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Choma, D. P., Milano, V., Pumiglia, K. M. &amp; DiPersio, C. M. Integrin alpha3beta1-dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5. <em>J. Investig. Dermatol.</em><strong>127</strong>, 31–40 (2007).
</cite> [<a href="https://doi.org/10.1038/sj.jid.5700505" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16917494/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Choma,%20D.%20P.,%20Milano,%20V.,%20Pumiglia,%20K.%20M.%20&amp;%20DiPersio,%20C.%20M.%20Integrin%20alpha3beta1-dependent%20activation%20of%20FAK/Src%20regulates%20Rac1-mediated%20keratinocyte%20polarization%20on%20laminin-5.%20J.%20Investig.%20Dermatol.127,%2031%E2%80%9340%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Hunziker, T., Morgenthaler, J. J. &amp; Gerber, H. A. Fibronectin in pemphigus. <em>Dermatologica</em><strong>174</strong>, 57–67 (1987).
</cite> [<a href="https://doi.org/10.1159/000248986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3549381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hunziker,%20T.,%20Morgenthaler,%20J.%20J.%20&amp;%20Gerber,%20H.%20A.%20Fibronectin%20in%20pemphigus.%20Dermatologica174,%2057%E2%80%9367%20(1987)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Getsios, S., Huen, A. C. &amp; Green, K. J. Working out the strength and flexibility of desmosomes. <em>Nat. Rev. Mol. Cell Biol.</em><strong>5</strong>, 271–281 (2004).
</cite> [<a href="https://doi.org/10.1038/nrm1356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15071552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Getsios,%20S.,%20Huen,%20A.%20C.%20&amp;%20Green,%20K.%20J.%20Working%20out%20the%20strength%20and%20flexibility%20of%20desmosomes.%20Nat.%20Rev.%20Mol.%20Cell%20Biol.5,%20271%E2%80%93281%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>Fuchs, E. Keratins and the skin. <em>Annu Rev. Cell Dev. Biol.</em><strong>11</strong>, 123–153 (1995).
</cite> [<a href="https://doi.org/10.1146/annurev.cb.11.110195.001011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8689554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fuchs,%20E.%20Keratins%20and%20the%20skin.%20Annu%20Rev.%20Cell%20Dev.%20Biol.11,%20123%E2%80%93153%20(1995)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Godsel, L. M. et al. Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA. <em>Mol. Biol. Cell</em><strong>21</strong>, 2844–2859 (2010).
</cite> [<a href="https://doi.org/10.1091/mbc.E10-02-0131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2921118/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20554761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Godsel,%20L.%20M.%20et%20al.%20Plakophilin%202%20couples%20actomyosin%20remodeling%20to%20desmosomal%20plaque%20assembly%20via%20RhoA.%20Mol.%20Biol.%20Cell21,%202844%E2%80%932859%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Sanchez-Carpintero, I. et al. In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. <em>Br. J. Dermatol.</em><strong>151</strong>, 565–570 (2004).
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.2004.06147.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15377341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sanchez-Carpintero,%20I.%20et%20al.%20In%20vivo%20blockade%20of%20pemphigus%20vulgaris%20acantholysis%20by%20inhibition%20of%20intracellular%20signal%20transduction%20cascades.%20Br.%20J.%20Dermatol.151,%20565%E2%80%93570%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Villalonga, P. &amp; Ridley, A. J. <em>Encyclopedia of Biological Chemistry</em> (eds William J. L. &amp; M. D. Lane) 111–115 (Academic Press, 2013).</cite>
</li>
<li id="CR101">
<span class="label">101.</span><cite>Shvetsov, A., Berkane, E., Chereau, D., Dominguez, R. &amp; Reisler, E. The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin. <em>Cell Motil. Cytoskeleton</em><strong>66</strong>, 90–98 (2009).
</cite> [<a href="https://doi.org/10.1002/cm.20328" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3070610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19089942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shvetsov,%20A.,%20Berkane,%20E.,%20Chereau,%20D.,%20Dominguez,%20R.%20&amp;%20Reisler,%20E.%20The%20actin-binding%20domain%20of%20cortactin%20is%20dynamic%20and%20unstructured%20and%20affects%20lateral%20and%20longitudinal%20contacts%20in%20F-actin.%20Cell%20Motil.%20Cytoskeleton66,%2090%E2%80%9398%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Leite, S. C. et al. The actin-binding protein alpha-adducin is required for maintaining axon diameter. <em>Cell Rep.</em><strong>15</strong>, 490–498 (2016).
</cite> [<a href="https://doi.org/10.1016/j.celrep.2016.03.047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4838511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27068466/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Leite,%20S.%20C.%20et%20al.%20The%20actin-binding%20protein%20alpha-adducin%20is%20required%20for%20maintaining%20axon%20diameter.%20Cell%20Rep.15,%20490%E2%80%93498%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>El Masri, R. &amp; Delon, J. RHO GTPases: from new partners to complex immune syndromes. <em>Nat. Rev. Immunol.</em><strong>21</strong>, 499–513 (2021).
</cite> [<a href="https://doi.org/10.1038/s41577-021-00500-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33547421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El%20Masri,%20R.%20&amp;%20Delon,%20J.%20RHO%20GTPases:%20from%20new%20partners%20to%20complex%20immune%20syndromes.%20Nat.%20Rev.%20Immunol.21,%20499%E2%80%93513%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Mosaddeghzadeh, N. &amp; Ahmadian, M. R. The RHO Family GTPases: mechanisms of regulation and signaling. <em>Cells</em><strong>10</strong>, 1831 (2021).
</cite> [<a href="https://doi.org/10.3390/cells10071831" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8305018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34359999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mosaddeghzadeh,%20N.%20&amp;%20Ahmadian,%20M.%20R.%20The%20RHO%20Family%20GTPases:%20mechanisms%20of%20regulation%20and%20signaling.%20Cells10,%201831%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Priya, R., Yap, A. S. &amp; Gomez, G. A. E-cadherin supports steady-state Rho signaling at the epithelial zonula adherens. <em>Differentiation</em><strong>86</strong>, 133–140 (2013).
</cite> [<a href="https://doi.org/10.1016/j.diff.2013.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23643492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Priya,%20R.,%20Yap,%20A.%20S.%20&amp;%20Gomez,%20G.%20A.%20E-cadherin%20supports%20steady-state%20Rho%20signaling%20at%20the%20epithelial%20zonula%20adherens.%20Differentiation86,%20133%E2%80%93140%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>Grossi, M. et al. Negative control of keratinocyte differentiation by Rho/CRIK signaling coupled with up-regulation of KyoT1/2 (FHL1) expressionNegative control of keratinocyte differentiation by Rho/CRIK signaling coupled with up-regulation of KyoT1/2 (FHL1) expression. <em>Proc. Natl Acad. Sci. U.S.A.</em><strong>102</strong>, 11313–11318 (2005).
</cite> [<a href="https://doi.org/10.1073/pnas.0505011102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1183590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16061799/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Grossi,%20M.%20et%20al.%20Negative%20control%20of%20keratinocyte%20differentiation%20by%20Rho/CRIK%20signaling%20coupled%20with%20up-regulation%20of%20KyoT1/2%20(FHL1)%20expressionNegative%20control%20of%20keratinocyte%20differentiation%20by%20Rho/CRIK%20signaling%20coupled%20with%20up-regulation%20of%20KyoT1/2%20(FHL1)%20expression.%20Proc.%20Natl%20Acad.%20Sci.%20U.S.A.102,%2011313%E2%80%9311318%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR107">
<span class="label">107.</span><cite>Tsunoda, K. et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. <em>J. Immunol.</em><strong>170</strong>, 2170–2178 (2003).
</cite> [<a href="https://doi.org/10.4049/jimmunol.170.4.2170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12574390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsunoda,%20K.%20et%20al.%20Induction%20of%20pemphigus%20phenotype%20by%20a%20mouse%20monoclonal%20antibody%20against%20the%20amino-terminal%20adhesive%20interface%20of%20desmoglein%203.%20J.%20Immunol.170,%202170%E2%80%932178%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Fukata, Y. et al. Phosphorylation of adducin by Rho-kinase plays a crucial role in cell motility. <em>J. Cell Biol.</em><strong>145</strong>, 347–361 (1999).
</cite> [<a href="https://doi.org/10.1083/jcb.145.2.347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2133101/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10209029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fukata,%20Y.%20et%20al.%20Phosphorylation%20of%20adducin%20by%20Rho-kinase%20plays%20a%20crucial%20role%20in%20cell%20motility.%20J.%20Cell%20Biol.145,%20347%E2%80%93361%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Hiermaier, M. et al. The actin-binding protein α-adducin modulates desmosomal turnover and plasticity. <em>J. Investig. Dermatol.</em><strong>141</strong>, 1219–1229.e1211 (2021).
</cite> [<a href="https://doi.org/10.1016/j.jid.2020.09.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33098828/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hiermaier,%20M.%20et%20al.%20The%20actin-binding%20protein%20%CE%B1-adducin%20modulates%20desmosomal%20turnover%20and%20plasticity.%20J.%20Investig.%20Dermatol.141,%201219%E2%80%931229.e1211%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR110">
<span class="label">110.</span><cite>Joseph, J. G. &amp; Liu, A. P. Mechanical regulation of endocytosis: new insights and recent advances. <em>Adv. Biosyst.</em><strong>4</strong>, e1900278 (2020).
</cite> [<a href="https://doi.org/10.1002/adbi.202000155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33179871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Joseph,%20J.%20G.%20&amp;%20Liu,%20A.%20P.%20Mechanical%20regulation%20of%20endocytosis:%20new%20insights%20and%20recent%20advances.%20Adv.%20Biosyst.4,%20e1900278%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR111">
<span class="label">111.</span><cite>Chi, X., Wang, S., Huang, Y., Stamnes, M. &amp; Chen, J. L. Roles of rho GTPases in intracellular transport and cellular transformation. <em>Int. J. Mol. Sci.</em><strong>14</strong>, 7089–7108 (2013).
</cite> [<a href="https://doi.org/10.3390/ijms14047089" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3645678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23538840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chi,%20X.,%20Wang,%20S.,%20Huang,%20Y.,%20Stamnes,%20M.%20&amp;%20Chen,%20J.%20L.%20Roles%20of%20rho%20GTPases%20in%20intracellular%20transport%20and%20cellular%20transformation.%20Int.%20J.%20Mol.%20Sci.14,%207089%E2%80%937108%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR112">
<span class="label">112.</span><cite>Phuyal, S. &amp; Farhan, H. Multifaceted Rho GTPase signaling at the endomembranes. <em>Front. Cell Dev. Biol.</em><strong>7</strong>, 127 (2019).
</cite> [<a href="https://doi.org/10.3389/fcell.2019.00127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6646525/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31380367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Phuyal,%20S.%20&amp;%20Farhan,%20H.%20Multifaceted%20Rho%20GTPase%20signaling%20at%20the%20endomembranes.%20Front.%20Cell%20Dev.%20Biol.7,%20127%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR113">
<span class="label">113.</span><cite>Delva, E. et al. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. <em>J. Biol. Chem.</em><strong>283</strong>, 18303–18313 (2008).
</cite> [<a href="https://doi.org/10.1074/jbc.M710046200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2440613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18434319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Delva,%20E.%20et%20al.%20Pemphigus%20vulgaris%20IgG-induced%20desmoglein-3%20endocytosis%20and%20desmosomal%20disassembly%20are%20mediated%20by%20a%20clathrin-%20and%20dynamin-independent%20mechanism.%20J.%20Biol.%20Chem.283,%2018303%E2%80%9318313%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR114">
<span class="label">114.</span><cite>Choi, Y. J. et al. RPGRIP1L is required for stabilizing epidermal keratinocyte adhesion through regulating desmoglein endocytosis. <em>PLoS Genet.</em><strong>15</strong>, e1007914 (2019).
</cite> [<a href="https://doi.org/10.1371/journal.pgen.1007914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6366717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30689641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Choi,%20Y.%20J.%20et%20al.%20RPGRIP1L%20is%20required%20for%20stabilizing%20epidermal%20keratinocyte%20adhesion%20through%20regulating%20desmoglein%20endocytosis.%20PLoS%20Genet.15,%20e1007914%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR115">
<span class="label">115.</span><cite>Alfano, D., Franco, P. &amp; Stoppelli, M. P. Modulation of cellular function by the urokinase receptor signalling: a mechanistic view. <em>Front. Cell Dev. Biol.</em><strong>10</strong>, 818616 (2022).
</cite> [<a href="https://doi.org/10.3389/fcell.2022.818616" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9045800/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35493073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alfano,%20D.,%20Franco,%20P.%20&amp;%20Stoppelli,%20M.%20P.%20Modulation%20of%20cellular%20function%20by%20the%20urokinase%20receptor%20signalling:%20a%20mechanistic%20view.%20Front.%20Cell%20Dev.%20Biol.10,%20818616%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR116">
<span class="label">116.</span><cite>Hunziker, T. &amp; Vassalli, J. D. Plasmin induces acantholysis in skin organ cultures. <em>Arch. Dermatol. Res.</em><strong>279</strong>, 341–346 (1987).
</cite> [<a href="https://doi.org/10.1007/BF00431228" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2957965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hunziker,%20T.%20&amp;%20Vassalli,%20J.%20D.%20Plasmin%20induces%20acantholysis%20in%20skin%20organ%20cultures.%20Arch.%20Dermatol.%20Res.279,%20341%E2%80%93346%20(1987)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR117">
<span class="label">117.</span><cite>Morioka, S., Lazarus, G. S. &amp; Jensen, P. J. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. <em>J. Investig. Dermatol.</em><strong>89</strong>, 474–477 (1987).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12460937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3117905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morioka,%20S.,%20Lazarus,%20G.%20S.%20&amp;%20Jensen,%20P.%20J.%20Involvement%20of%20urokinase-type%20plasminogen%20activator%20in%20acantholysis%20induced%20by%20pemphigus%20IgG.%20J.%20Investig.%20Dermatol.89,%20474%E2%80%93477%20(1987)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR118">
<span class="label">118.</span><cite>Hashimoto, K., Wun, T. C., Baird, J., Lazarus, G. S. &amp; Jensen, P. J. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. <em>J. Investig. Dermatol.</em><strong>92</strong>, 310–314 (1989).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12277087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2465356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hashimoto,%20K.,%20Wun,%20T.%20C.,%20Baird,%20J.,%20Lazarus,%20G.%20S.%20&amp;%20Jensen,%20P.%20J.%20Characterization%20of%20keratinocyte%20plasminogen%20activator%20inhibitors%20and%20demonstration%20of%20the%20prevention%20of%20pemphigus%20IgG-induced%20acantholysis%20by%20a%20purified%20plasminogen%20activator%20inhibitor.%20J.%20Investig.%20Dermatol.92,%20310%E2%80%93314%20(1989)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR119">
<span class="label">119.</span><cite>Wilkinson, J. E., Smith, C. A., Suter, M. M., Falchek, W. &amp; Lewis, R. M. Role of plasminogen activator in pemphigus vulgaris. <em>Am. J. Pathol.</em><strong>134</strong>, 561–569 (1989).
</cite> [<a href="/articles/PMC1879522/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2466403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilkinson,%20J.%20E.,%20Smith,%20C.%20A.,%20Suter,%20M.%20M.,%20Falchek,%20W.%20&amp;%20Lewis,%20R.%20M.%20Role%20of%20plasminogen%20activator%20in%20pemphigus%20vulgaris.%20Am.%20J.%20Pathol.134,%20561%E2%80%93569%20(1989)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR120">
<span class="label">120.</span><cite>Xue, W., Hashimoto, K. &amp; Toi, Y. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis. <em>J. Cutan. Pathol.</em><strong>25</strong>, 469–474 (1998).
</cite> [<a href="https://doi.org/10.1111/j.1600-0560.1998.tb01777.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9821076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xue,%20W.,%20Hashimoto,%20K.%20&amp;%20Toi,%20Y.%20Functional%20involvement%20of%20urokinase-type%20plasminogen%20activator%20receptor%20in%20pemphigus%20acantholysis.%20J.%20Cutan.%20Pathol.25,%20469%E2%80%93474%20(1998)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR121">
<span class="label">121.</span><cite>Asano, S., Seishima, M. &amp; Kitajima, Y. Phosphatidylinositol-specific-phospholipase C cleaves urokinase plasminogen activator receptor from the cell surface and leads to inhibition of pemphigus-IgG-induced acantholysis in DJM-1 cells, a squamous cell carcinoma line. <em>Clin. Exp. Dermatol.</em><strong>26</strong>, 289–295 (2001).
</cite> [<a href="https://doi.org/10.1046/j.1365-2230.2001.00818.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11422178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Asano,%20S.,%20Seishima,%20M.%20&amp;%20Kitajima,%20Y.%20Phosphatidylinositol-specific-phospholipase%20C%20cleaves%20urokinase%20plasminogen%20activator%20receptor%20from%20the%20cell%20surface%20and%20leads%20to%20inhibition%20of%20pemphigus-IgG-induced%20acantholysis%20in%20DJM-1%20cells,%20a%20squamous%20cell%20carcinoma%20line.%20Clin.%20Exp.%20Dermatol.26,%20289%E2%80%93295%20(2001)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR122">
<span class="label">122.</span><cite>Feliciani, C. et al. Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis. <em>Exp. Dermatol.</em><strong>12</strong>, 466–471 (2003).
</cite> [<a href="https://doi.org/10.1034/j.1600-0625.2002.120415.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12930304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feliciani,%20C.%20et%20al.%20Urokinase%20plasminogen%20activator%20mRNA%20is%20induced%20by%20IL-1alpha%20and%20TNF-alpha%20in%20in%20vitro%20acantholysis.%20Exp.%20Dermatol.12,%20466%E2%80%93471%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR123">
<span class="label">123.</span><cite>Mahoney, M. G., Wang, Z. H. &amp; Stanley, J. R. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. <em>J. Investig. Dermatol.</em><strong>113</strong>, 22–25 (1999).
</cite> [<a href="https://doi.org/10.1046/j.1523-1747.1999.00632.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10417613/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mahoney,%20M.%20G.,%20Wang,%20Z.%20H.%20&amp;%20Stanley,%20J.%20R.%20Pemphigus%20vulgaris%20and%20pemphigus%20foliaceus%20antibodies%20are%20pathogenic%20in%20plasminogen%20activator%20knockout%20mice.%20J.%20Investig.%20Dermatol.113,%2022%E2%80%9325%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR124">
<span class="label">124.</span><cite>Manning, D., Dart, C. &amp; Evans, R. L. Store-operated calcium channels in skin. <em>Front. Physiol.</em><strong>13</strong>, 1033528 (2022).
</cite> [<a href="https://doi.org/10.3389/fphys.2022.1033528" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9581152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36277201/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Manning,%20D.,%20Dart,%20C.%20&amp;%20Evans,%20R.%20L.%20Store-operated%20calcium%20channels%20in%20skin.%20Front.%20Physiol.13,%201033528%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR125">
<span class="label">125.</span><cite>Arredondo, J., Chernyavsky, A. I., Karaouni, A. &amp; Grando, S. A. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. <em>Am. J. Pathol.</em><strong>167</strong>, 1531–1544 (2005).
</cite> [<a href="https://doi.org/10.1016/S0002-9440(10)61239-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1613205/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16314468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arredondo,%20J.,%20Chernyavsky,%20A.%20I.,%20Karaouni,%20A.%20&amp;%20Grando,%20S.%20A.%20Novel%20mechanisms%20of%20target%20cell%20death%20and%20survival%20and%20of%20therapeutic%20action%20of%20IVIg%20in%20Pemphigus.%20Am.%20J.%20Pathol.167,%201531%E2%80%931544%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR126">
<span class="label">126.</span><cite>Kalantari-Dehaghi, M. et al. Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies. <em>J. Biol. Chem.</em><strong>288</strong>, 16916–16925 (2013).
</cite> [<a href="https://doi.org/10.1074/jbc.M113.472100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3675624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23599429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kalantari-Dehaghi,%20M.%20et%20al.%20Mechanisms%20of%20mitochondrial%20damage%20in%20keratinocytes%20by%20pemphigus%20vulgaris%20antibodies.%20J.%20Biol.%20Chem.288,%2016916%E2%80%9316925%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR127">
<span class="label">127.</span><cite>Xie, Z., Dai, X., Li, Q., Lin, S. &amp; Ye, X. Tacrolimus reverses pemphigus vulgaris serum-induced depletion of desmoglein in HaCaT cells via inhibition of heat shock protein 27 phosphorylation. <em>BMC Immunol.</em><strong>24</strong>, 43 (2023).
</cite> [<a href="https://doi.org/10.1186/s12865-023-00582-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10634089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37940861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie,%20Z.,%20Dai,%20X.,%20Li,%20Q.,%20Lin,%20S.%20&amp;%20Ye,%20X.%20Tacrolimus%20reverses%20pemphigus%20vulgaris%20serum-induced%20depletion%20of%20desmoglein%20in%20HaCaT%20cells%20via%20inhibition%20of%20heat%20shock%20protein%2027%20phosphorylation.%20BMC%20Immunol.24,%2043%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR128">
<span class="label">128.</span><cite>Esaki, C., Seishima, M., Yamada, T., Osada, K. &amp; Kitajima, Y. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. <em>J. Investig. Dermatol.</em><strong>105</strong>, 329–333 (1995).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12319948" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7665907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Esaki,%20C.,%20Seishima,%20M.,%20Yamada,%20T.,%20Osada,%20K.%20&amp;%20Kitajima,%20Y.%20Pharmacologic%20evidence%20for%20involvement%20of%20phospholipase%20C%20in%20pemphigus%20IgG-induced%20inositol%201,4,5-trisphosphate%20generation,%20intracellular%20calcium%20increase,%20and%20plasminogen%20activator%20secretion%20in%20DJM-1%20cells,%20a%20squamous%20cell%20carcinoma%20line.%20J.%20Investig.%20Dermatol.105,%20329%E2%80%93333%20(1995)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR129">
<span class="label">129.</span><cite>Hiermaier, M. et al. Pemphigus foliaceus autoantibodies induce redistribution primarily of extradesmosomal desmoglein 1 in the Cell Membrane. <em>Front. Immunol.</em><strong>13</strong>, 882116 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.882116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9134081/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35634274/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hiermaier,%20M.%20et%20al.%20Pemphigus%20foliaceus%20autoantibodies%20induce%20redistribution%20primarily%20of%20extradesmosomal%20desmoglein%201%20in%20the%20Cell%20Membrane.%20Front.%20Immunol.13,%20882116%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR130">
<span class="label">130.</span><cite>Egu, D. T., Schmitt, T., Sigmund, A. M. &amp; Waschke, J. Electron microscopy reveals that phospholipase C and Ca(2+) signaling regulate keratin filament uncoupling from desmosomes in Pemphigus. <em>Ann. Anat.</em><strong>241</strong>, 151904 (2022).
</cite> [<a href="https://doi.org/10.1016/j.aanat.2022.151904" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35131450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egu,%20D.%20T.,%20Schmitt,%20T.,%20Sigmund,%20A.%20M.%20&amp;%20Waschke,%20J.%20Electron%20microscopy%20reveals%20that%20phospholipase%20C%20and%20Ca(2+)%20signaling%20regulate%20keratin%20filament%20uncoupling%20from%20desmosomes%20in%20Pemphigus.%20Ann.%20Anat.241,%20151904%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR131">
<span class="label">131.</span><cite>Garrod, D. &amp; Chidgey, M. Desmosome structure, composition and function. <em>Biochim. Biophys. Acta</em><strong>1778</strong>, 572–587 (2008).
</cite> [<a href="https://doi.org/10.1016/j.bbamem.2007.07.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17854763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garrod,%20D.%20&amp;%20Chidgey,%20M.%20Desmosome%20structure,%20composition%20and%20function.%20Biochim.%20Biophys.%20Acta1778,%20572%E2%80%93587%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR132">
<span class="label">132.</span><cite>Osada, K., Seishima, M. &amp; Kitajima, Y. Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. <em>J. Investig Dermatol.</em><strong>108</strong>, 482–487 (1997).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12289726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9077478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Osada,%20K.,%20Seishima,%20M.%20&amp;%20Kitajima,%20Y.%20Pemphigus%20IgG%20activates%20and%20translocates%20protein%20kinase%20C%20from%20the%20cytosol%20to%20the%20particulate/cytoskeleton%20fractions%20in%20human%20keratinocytes.%20J.%20Investig%20Dermatol.108,%20482%E2%80%93487%20(1997)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR133">
<span class="label">133.</span><cite>Kowalewski, C. et al. Protein-Kinase inhibitor H7 prevents the acantholysis induced by pemphigus antibodies. <em>Eur. J. Dermatol.</em><strong>4</strong>, 238–242 (1994).</cite> [<a href="https://scholar.google.com/scholar_lookup?Kowalewski,%20C.%20et%20al.%20Protein-Kinase%20inhibitor%20H7%20prevents%20the%20acantholysis%20induced%20by%20pemphigus%20antibodies.%20Eur.%20J.%20Dermatol.4,%20238%E2%80%93242%20(1994)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR134">
<span class="label">134.</span><cite>Cirillo, N., Lanza, A. &amp; Prime, S. S. Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. <em>Exp. Cell Res.</em><strong>316</strong>, 580–592 (2010).
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2009.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19818770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cirillo,%20N.,%20Lanza,%20A.%20&amp;%20Prime,%20S.%20S.%20Induction%20of%20hyper-adhesion%20attenuates%20autoimmune-induced%20keratinocyte%20cell-cell%20detachment%20and%20processing%20of%20adhesion%20molecules%20via%20mechanisms%20that%20involve%20PKC.%20Exp.%20Cell%20Res.316,%20580%E2%80%93592%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR135">
<span class="label">135.</span><cite>Spindler, V. et al. The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?. <em>Am. J. Pathol.</em><strong>179</strong>, 1905–1916 (2011).
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2011.06.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3181381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21864491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spindler,%20V.%20et%20al.%20The%20extent%20of%20desmoglein%203%20depletion%20in%20pemphigus%20vulgaris%20is%20dependent%20on%20Ca(2+)-induced%20differentiation:%20a%20role%20in%20suprabasal%20epidermal%20skin%20splitting?.%20Am.%20J.%20Pathol.179,%201905%E2%80%931916%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR136">
<span class="label">136.</span><cite>Dehner, C., Rotzer, V., Waschke, J. &amp; Spindler, V. A desmoplakin point mutation with enhanced keratin association ameliorates pemphigus vulgaris autoantibody-mediated loss of cell cohesion. <em>Am. J. Pathol.</em><strong>184</strong>, 2528–2536 (2014).
</cite> [<a href="https://doi.org/10.1016/j.ajpath.2014.05.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25010392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dehner,%20C.,%20Rotzer,%20V.,%20Waschke,%20J.%20&amp;%20Spindler,%20V.%20A%20desmoplakin%20point%20mutation%20with%20enhanced%20keratin%20association%20ameliorates%20pemphigus%20vulgaris%20autoantibody-mediated%20loss%20of%20cell%20cohesion.%20Am.%20J.%20Pathol.184,%202528%E2%80%932536%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR137">
<span class="label">137.</span><cite>Sayar, B. S. et al. EGFR inhibitors erlotinib and lapatinib ameliorate epidermal blistering in pemphigus vulgaris in a non-linear, V-shaped relationship. <em>Exp. Dermatol.</em><strong>23</strong>, 33–38 (2014).
</cite> [<a href="https://doi.org/10.1111/exd.12290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24279293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sayar,%20B.%20S.%20et%20al.%20EGFR%20inhibitors%20erlotinib%20and%20lapatinib%20ameliorate%20epidermal%20blistering%20in%20pemphigus%20vulgaris%20in%20a%20non-linear,%20V-shaped%20relationship.%20Exp.%20Dermatol.23,%2033%E2%80%9338%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR138">
<span class="label">138.</span><cite>Hudemann, C. et al. Human Desmocollin 3‒Specific IgG antibodies are pathogenic in a humanized HLA Class II transgenic mouse model of pemphigus. <em>J. Investig. Dermatol.</em><strong>142</strong>, 915–923.e913 (2022).
</cite> [<a href="https://doi.org/10.1016/j.jid.2021.06.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34265330/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hudemann,%20C.%20et%20al.%20Human%20Desmocollin%203%E2%80%92Specific%20IgG%20antibodies%20are%20pathogenic%20in%20a%20humanized%20HLA%20Class%20II%20transgenic%20mouse%20model%20of%20pemphigus.%20J.%20Investig.%20Dermatol.142,%20915%E2%80%93923.e913%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR139">
<span class="label">139.</span><cite>Hunziker, T., Nydegger, U. E., Lerch, P. G. &amp; Vassalli, J. D. Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures. <em>Clin. Exp. Immunol.</em><strong>64</strong>, 442–449 (1986).
</cite> [<a href="/articles/PMC1542357/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3742881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hunziker,%20T.,%20Nydegger,%20U.%20E.,%20Lerch,%20P.%20G.%20&amp;%20Vassalli,%20J.%20D.%20Platelet-derived%20factors%20enhance%20pemphigus%20acantholysis%20in%20skin%20organ%20cultures.%20Clin.%20Exp.%20Immunol.64,%20442%E2%80%93449%20(1986)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR140">
<span class="label">140.</span><cite>Feliciani, C., Toto, P. &amp; Amerio, P. In vitro C3 mRNA expression in Pemphigus vulgaris: complement activation is increased by IL-1alpha and TNF-alpha. <em>J. Cutan. Med. Surg.</em><strong>3</strong>, 140–144 (1999).
</cite> [<a href="https://doi.org/10.1177/120347549900300306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10082594/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feliciani,%20C.,%20Toto,%20P.%20&amp;%20Amerio,%20P.%20In%20vitro%20C3%20mRNA%20expression%20in%20Pemphigus%20vulgaris:%20complement%20activation%20is%20increased%20by%20IL-1alpha%20and%20TNF-alpha.%20J.%20Cutan.%20Med.%20Surg.3,%20140%E2%80%93144%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR141">
<span class="label">141.</span><cite>Feliciani, C. et al. In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. <em>J. Investig. Dermatol.</em><strong>114</strong>, 71–77 (2000).
</cite> [<a href="https://doi.org/10.1046/j.1523-1747.2000.00835.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10620118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feliciani,%20C.%20et%20al.%20In%20vitro%20and%20in%20vivo%20expression%20of%20interleukin-1alpha%20and%20tumor%20necrosis%20factor-alpha%20mRNA%20in%20pemphigus%20vulgaris:%20interleukin-1alpha%20and%20tumor%20necrosis%20factor-alpha%20are%20involved%20in%20acantholysis.%20J.%20Investig.%20Dermatol.114,%2071%E2%80%9377%20(2000)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR142">
<span class="label">142.</span><cite>Assaf, S. et al. ST18 affects cell-cell adhesion in pemphigus vulgaris in a tumour necrosis factor-alpha-dependent fashion. <em>Br. J. Dermatol.</em><strong>184</strong>, 1153–1160 (2021).
</cite> [<a href="https://doi.org/10.1111/bjd.19679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33205400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Assaf,%20S.%20et%20al.%20ST18%20affects%20cell-cell%20adhesion%20in%20pemphigus%20vulgaris%20in%20a%20tumour%20necrosis%20factor-alpha-dependent%20fashion.%20Br.%20J.%20Dermatol.184,%201153%E2%80%931160%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR143">
<span class="label">143.</span><cite>Toto, P. et al. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. <em>J. Immunol.</em><strong>164</strong>, 522–529 (2000).
</cite> [<a href="https://doi.org/10.4049/jimmunol.164.1.522" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10605050/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Toto,%20P.%20et%20al.%20Immune%20modulation%20in%20pemphigus%20vulgaris:%20role%20of%20CD28%20and%20IL-10.%20J.%20Immunol.164,%20522%E2%80%93529%20(2000)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR144">
<span class="label">144.</span><cite>Liang, J. et al. Interleukin-37 inhibits desmoglein-3 endocytosis and keratinocyte dissociation via upregulation of Caveolin-1 and inhibition of the STAT3 pathway. <em>J. Eur. Acad. Dermatol. Venereol.</em><strong>37</strong>, 1920–1927 (2023).
</cite> [<a href="https://doi.org/10.1111/jdv.19239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37262304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang,%20J.%20et%20al.%20Interleukin-37%20inhibits%20desmoglein-3%20endocytosis%20and%20keratinocyte%20dissociation%20via%20upregulation%20of%20Caveolin-1%20and%20inhibition%20of%20the%20STAT3%20pathway.%20J.%20Eur.%20Acad.%20Dermatol.%20Venereol.37,%201920%E2%80%931927%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR145">
<span class="label">145.</span><cite>Marquina, M., Espana, A., Fernandez-Galar, M. &amp; Lopez-Zabalza, M. J. The role of nitric oxide synthases in pemphigus vulgaris in a mouse model. <em>Br. J. Dermatol.</em><strong>159</strong>, 68–76 (2008).
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.2008.08582.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18476963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marquina,%20M.,%20Espana,%20A.,%20Fernandez-Galar,%20M.%20&amp;%20Lopez-Zabalza,%20M.%20J.%20The%20role%20of%20nitric%20oxide%20synthases%20in%20pemphigus%20vulgaris%20in%20a%20mouse%20model.%20Br.%20J.%20Dermatol.159,%2068%E2%80%9376%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR146">
<span class="label">146.</span><cite>Orlov, M. D., Chernyavsky, A. I., Arredondo, J. &amp; Grando, S. A. Synergistic actions of pemphigus vulgaris IgG, Fas-ligand and tumor necrosis factor-alpha during induction of basal cell shrinkage and acantholysis. <em>Autoimmunity</em><strong>39</strong>, 557–562 (2006).
</cite> [<a href="https://doi.org/10.1080/08916930600971729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17101499/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Orlov,%20M.%20D.,%20Chernyavsky,%20A.%20I.,%20Arredondo,%20J.%20&amp;%20Grando,%20S.%20A.%20Synergistic%20actions%20of%20pemphigus%20vulgaris%20IgG,%20Fas-ligand%20and%20tumor%20necrosis%20factor-alpha%20during%20induction%20of%20basal%20cell%20shrinkage%20and%20acantholysis.%20Autoimmunity39,%20557%E2%80%93562%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR147">
<span class="label">147.</span><cite>Lotti, R. et al. Soluble fas ligand is essential for blister formation in pemphigus. <em>Front. Immunol.</em><strong>9</strong>, 370 (2018).
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.00370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5834757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29535737/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lotti,%20R.%20et%20al.%20Soluble%20fas%20ligand%20is%20essential%20for%20blister%20formation%20in%20pemphigus.%20Front.%20Immunol.9,%20370%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR148">
<span class="label">148.</span><cite>Lotti, R. et al. Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models. <em>Front. Immunol.</em><strong>14</strong>, 1193032 (2023).
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1193032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10368993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37503332/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lotti,%20R.%20et%20al.%20Blocking%20soluble%20Fas%20Ligand%20ameliorates%20pemphigus:%20PC111%20efficacy%20in%20ex-vivo%20human%20pemphigus%20models.%20Front.%20Immunol.14,%201193032%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR149">
<span class="label">149.</span><cite>Schmidt, E. et al. Apoptosis is not required for acantholysis in pemphigus vulgaris. <em>Am. J. Physiol. Cell Physiol.</em><strong>296</strong>, C162–C172 (2009).
</cite> [<a href="https://doi.org/10.1152/ajpcell.00161.2008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18987254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmidt,%20E.%20et%20al.%20Apoptosis%20is%20not%20required%20for%20acantholysis%20in%20pemphigus%20vulgaris.%20Am.%20J.%20Physiol.%20Cell%20Physiol.296,%20C162%E2%80%93C172%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR150">
<span class="label">150.</span><cite>Radeva, M. Y. et al. ST18 Enhances PV-IgG-Induced Loss of Keratinocyte Cohesion in parallel to increased ERK activation. <em>Front. Immunol.</em><strong>10</strong>, 770 (2019).
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.00770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6478701/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31057535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Radeva,%20M.%20Y.%20et%20al.%20ST18%20Enhances%20PV-IgG-Induced%20Loss%20of%20Keratinocyte%20Cohesion%20in%20parallel%20to%20increased%20ERK%20activation.%20Front.%20Immunol.10,%20770%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR151">
<span class="label">151.</span><cite>Assaf, S. et al. Up-regulation of ST18 in pemphigus vulgaris drives a self-amplifying p53-dependent pathomechanism resulting in decreased desmoglein 3 expression. <em>Sci. Rep.</em><strong>12</strong>, 5958 (2022).
</cite> [<a href="https://doi.org/10.1038/s41598-022-09951-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8993920/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35396567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Assaf,%20S.%20et%20al.%20Up-regulation%20of%20ST18%20in%20pemphigus%20vulgaris%20drives%20a%20self-amplifying%20p53-dependent%20pathomechanism%20resulting%20in%20decreased%20desmoglein%203%20expression.%20Sci.%20Rep.12,%205958%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR152">
<span class="label">152.</span><cite>Luan, C. et al. Thalidomide alleviates apoptosis, oxidative damage and inflammation induced by pemphigus vulgaris IgG in HaCat cells and neonatal mice through MyD88. <em>Drug Des. Devel Ther.</em><strong>17</strong>, 2821–2839 (2023).
</cite> [<a href="https://doi.org/10.2147/DDDT.S407242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10504907/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37719363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luan,%20C.%20et%20al.%20Thalidomide%20alleviates%20apoptosis,%20oxidative%20damage%20and%20inflammation%20induced%20by%20pemphigus%20vulgaris%20IgG%20in%20HaCat%20cells%20and%20neonatal%20mice%20through%20MyD88.%20Drug%20Des.%20Devel%20Ther.17,%202821%E2%80%932839%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR153">
<span class="label">153.</span><cite>Schulze, K. et al. An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. <em>J. Investig. Dermatol.</em><strong>132</strong>, 346–355 (2012).
</cite> [<a href="https://doi.org/10.1038/jid.2011.299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3258361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21956125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schulze,%20K.%20et%20al.%20An%20adult%20passive%20transfer%20mouse%20model%20to%20study%20desmoglein%203%20signaling%20in%20pemphigus%20vulgaris.%20J.%20Investig.%20Dermatol.132,%20346%E2%80%93355%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR154">
<span class="label">154.</span><cite>Nguyen, V. T. et al. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. <em>J. Biol. Chem.</em><strong>279</strong>, 2135–2146 (2004).
</cite> [<a href="https://doi.org/10.1074/jbc.M309000200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14600150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen,%20V.%20T.%20et%20al.%20Pemphigus%20vulgaris%20IgG%20and%20methylprednisolone%20exhibit%20reciprocal%20effects%20on%20keratinocytes.%20J.%20Biol.%20Chem.279,%202135%E2%80%932146%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR155">
<span class="label">155.</span><cite>Nguyen, V. T. et al. Pemphigus vulgaris acantholysis ameliorated by cholinergic agonists. <em>Arch. Dermatol.</em><strong>140</strong>, 327–334 (2004).
</cite> [<a href="https://doi.org/10.1001/archderm.140.3.327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15023776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nguyen,%20V.%20T.%20et%20al.%20Pemphigus%20vulgaris%20acantholysis%20ameliorated%20by%20cholinergic%20agonists.%20Arch.%20Dermatol.140,%20327%E2%80%93334%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR156">
<span class="label">156.</span><cite>Lin, X., Chen, M., Li, X., Wang, H. &amp; Bao, Y. Low SOCS3 expression in CD4(+) T cells from pemphigus vulgaris patients enhanced Th1- and Th17-cell differentiation and exacerbated acantholysis via STAT activation. <em>Mol. Immunol.</em><strong>150</strong>, 114–125 (2022).
</cite> [<a href="https://doi.org/10.1016/j.molimm.2022.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36030709/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin,%20X.,%20Chen,%20M.,%20Li,%20X.,%20Wang,%20H.%20&amp;%20Bao,%20Y.%20Low%20SOCS3%20expression%20in%20CD4(+)%20T%20cells%20from%20pemphigus%20vulgaris%20patients%20enhanced%20Th1-%20and%20Th17-cell%20differentiation%20and%20exacerbated%20acantholysis%20via%20STAT%20activation.%20Mol.%20Immunol.150,%20114%E2%80%93125%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR157">
<span class="label">157.</span><cite>Pacheco-Tovar, D., Lopez-Luna, A., Herrera-Esparza, R. &amp; Avalos-Diaz, E. The caspase pathway as a possible therapeutic target in experimental pemphigus. <em>Autoimmune Dis.</em><strong>2011</strong>, 563091 (2011).
</cite> [<a href="https://doi.org/10.4061/2011/563091" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3049334/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21403857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pacheco-Tovar,%20D.,%20Lopez-Luna,%20A.,%20Herrera-Esparza,%20R.%20&amp;%20Avalos-Diaz,%20E.%20The%20caspase%20pathway%20as%20a%20possible%20therapeutic%20target%20in%20experimental%20pemphigus.%20Autoimmune%20Dis.2011,%20563091%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR158">
<span class="label">158.</span><cite>Luyet, C. et al. Preclinical studies identify non-apoptotic low-level caspase-3 as therapeutic target in pemphigus vulgaris. <em>PLoS One</em><strong>10</strong>, e0119809 (2015).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0119809" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4352034/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25748204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luyet,%20C.%20et%20al.%20Preclinical%20studies%20identify%20non-apoptotic%20low-level%20caspase-3%20as%20therapeutic%20target%20in%20pemphigus%20vulgaris.%20PLoS%20One10,%20e0119809%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR159">
<span class="label">159.</span><cite>Hariton, W. V. J. et al. Feasibility study for clinical application of caspase-3 inhibitors in Pemphigus vulgaris. <em>Exp. Dermatol.</em><strong>26</strong>, 1274–1277 (2017).
</cite> [<a href="https://doi.org/10.1111/exd.13458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29105150/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hariton,%20W.%20V.%20J.%20et%20al.%20Feasibility%20study%20for%20clinical%20application%20of%20caspase-3%20inhibitors%20in%20Pemphigus%20vulgaris.%20Exp.%20Dermatol.26,%201274%E2%80%931277%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR160">
<span class="label">160.</span><cite>Wang, X. et al. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. <em>Apoptosis</em><strong>9</strong>, 131–143 (2004).
</cite> [<a href="https://doi.org/10.1023/B:APPT.0000018795.05766.1f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15004510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20X.%20et%20al.%20Possible%20apoptotic%20mechanism%20in%20epidermal%20cell%20acantholysis%20induced%20by%20pemphigus%20vulgaris%20autoimmunoglobulins.%20Apoptosis9,%20131%E2%80%93143%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR161">
<span class="label">161.</span><cite>Eichkorn, R. A. et al. Innate immune activation as cofactor in pemphigus disease manifestation. <em>Front. Immunol.</em><strong>13</strong>, 898819 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.898819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9343989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35928825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eichkorn,%20R.%20A.%20et%20al.%20Innate%20immune%20activation%20as%20cofactor%20in%20pemphigus%20disease%20manifestation.%20Front.%20Immunol.13,%20898819%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR162">
<span class="label">162.</span><cite>Su, T. T. Non-apoptotic roles of apoptotic proteases: new tricks for an old dog. <em>Open Biol.</em><strong>10</strong>, 200130 (2020).
</cite> [<a href="https://doi.org/10.1098/rsob.200130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7479936/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32810419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su,%20T.%20T.%20Non-apoptotic%20roles%20of%20apoptotic%20proteases:%20new%20tricks%20for%20an%20old%20dog.%20Open%20Biol.10,%20200130%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR163">
<span class="label">163.</span><cite>Kuga, T. et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. <em>Sci. Rep.</em><strong>6</strong>, 26557 (2016).
</cite> [<a href="https://doi.org/10.1038/srep26557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4879633/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27222304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuga,%20T.%20et%20al.%20FAM83H%20and%20casein%20kinase%20I%20regulate%20the%20organization%20of%20the%20keratin%20cytoskeleton%20and%20formation%20of%20desmosomes.%20Sci.%20Rep.6,%2026557%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR164">
<span class="label">164.</span><cite>Schiltz, J. R., Hu, C. H. &amp; Michel, B. Corticosteroids, aurothioglucose and soybean trypsin-inhibitor do not prevent pemphigus antibody-induced acantholysis invitro. <em>Br. J. Dermatol.</em><strong>101</strong>, 279–284 (1979).
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.1979.tb05620.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/389269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schiltz,%20J.%20R.,%20Hu,%20C.%20H.%20&amp;%20Michel,%20B.%20Corticosteroids,%20aurothioglucose%20and%20soybean%20trypsin-inhibitor%20do%20not%20prevent%20pemphigus%20antibody-induced%20acantholysis%20invitro.%20Br.%20J.%20Dermatol.101,%20279%E2%80%93284%20(1979)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR165">
<span class="label">165.</span><cite>Anhalt, G. J., Patel, H. P. &amp; Labib, R. S. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. <em>J. Immunol.</em><strong>136</strong>, 113–117 (1986).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3079604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Anhalt,%20G.%20J.,%20Patel,%20H.%20P.%20&amp;%20Labib,%20R.%20S.%20Dexamethasone%20inhibits%20plasminogen%20activator%20activity%20in%20experimental%20pemphigus%20in%20vivo%20but%20does%20not%20block%20acantholysis.%20J.%20Immunol.136,%20113%E2%80%93117%20(1986)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR166">
<span class="label">166.</span><cite>Naito, K., Morioka, S., Nakajima, S. &amp; Ogawa, H. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis. <em>J. Investig Dermatol.</em><strong>93</strong>, 173–177 (1989).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12277395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2526184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Naito,%20K.,%20Morioka,%20S.,%20Nakajima,%20S.%20&amp;%20Ogawa,%20H.%20Proteinase%20inhibitors%20block%20formation%20of%20pemphigus%20acantholysis%20in%20experimental%20models%20of%20neonatal%20mice%20and%20skin%20explants:%20effects%20of%20synthetic%20and%20plasma%20proteinase%20inhibitors%20on%20pemphigus%20acantholysis.%20J.%20Investig%20Dermatol.93,%20173%E2%80%93177%20(1989)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR167">
<span class="label">167.</span><cite>Mao, X., Cho, M. J. T., Ellebrecht, C. T., Mukherjee, E. M. &amp; Payne, A. S. Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes. <em>JCI Insight.</em><strong>2</strong>, e92253 (2017).
</cite> [<a href="https://doi.org/10.1172/jci.insight.92253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5414550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28469076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mao,%20X.,%20Cho,%20M.%20J.%20T.,%20Ellebrecht,%20C.%20T.,%20Mukherjee,%20E.%20M.%20&amp;%20Payne,%20A.%20S.%20Stat3%20regulates%20desmoglein%203%20transcription%20in%20epithelial%20keratinocytes.%20JCI%20Insight.2,%20e92253%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR168">
<span class="label">168.</span><cite>Grando, S. A. &amp; Dahl, M. V. Activation of keratinocyte muscarinic acetylcholine receptors reverses pemphigus acantholysis. <em>J. Eur. Acad. Dermatol. Venereol.</em><strong>2</strong>, 72–86 (2006).</cite> [<a href="https://scholar.google.com/scholar_lookup?Grando,%20S.%20A.%20&amp;%20Dahl,%20M.%20V.%20Activation%20of%20keratinocyte%20muscarinic%20acetylcholine%20receptors%20reverses%20pemphigus%20acantholysis.%20J.%20Eur.%20Acad.%20Dermatol.%20Venereol.2,%2072%E2%80%9386%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR169">
<span class="label">169.</span><cite>Chernyavsky, A. I., Arredondo, J., Piser, T., Karlsson, E. &amp; Grando, S. A. Differential coupling of M1 muscarinic and alpha7 nicotinic receptors to inhibition of pemphigus acantholysis. <em>J. Biol. Chem.</em><strong>283</strong>, 3401–3408 (2008).
</cite> [<a href="https://doi.org/10.1074/jbc.M704956200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18073210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chernyavsky,%20A.%20I.,%20Arredondo,%20J.,%20Piser,%20T.,%20Karlsson,%20E.%20&amp;%20Grando,%20S.%20A.%20Differential%20coupling%20of%20M1%20muscarinic%20and%20alpha7%20nicotinic%20receptors%20to%20inhibition%20of%20pemphigus%20acantholysis.%20J.%20Biol.%20Chem.283,%203401%E2%80%933408%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR170">
<span class="label">170.</span><cite>Spindler, V., Vielmuth, F., Schmidt, E., Rubenstein, D. S. &amp; Waschke, J. Protective endogenous cyclic adenosine 5’-monophosphate signaling triggered by pemphigus autoantibodies. <em>J. Immunol.</em><strong>185</strong>, 6831–6838 (2010).
</cite> [<a href="https://doi.org/10.4049/jimmunol.1002675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3129745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21037102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spindler,%20V.,%20Vielmuth,%20F.,%20Schmidt,%20E.,%20Rubenstein,%20D.%20S.%20&amp;%20Waschke,%20J.%20Protective%20endogenous%20cyclic%20adenosine%205%E2%80%99-monophosphate%20signaling%20triggered%20by%20pemphigus%20autoantibodies.%20J.%20Immunol.185,%206831%E2%80%936838%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR171">
<span class="label">171.</span><cite>Schiltz, J. R. Pemphigus acantholysis: a unique immunological injury. <em>J. Investig. Dermatol.</em><strong>74</strong>, 359–362 (1980).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12543775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6993575/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schiltz,%20J.%20R.%20Pemphigus%20acantholysis:%20a%20unique%20immunological%20injury.%20J.%20Investig.%20Dermatol.74,%20359%E2%80%93362%20(1980)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR172">
<span class="label">172.</span><cite>Kawana, S., Geoghegan, W. D. &amp; Jordon, R. E. Complement fixation by pemphigus antibody. II. Complement enhanced detachment of epidermal cells. <em>Clin. Exp. Immunol.</em><strong>61</strong>, 517–525 (1985).
</cite> [<a href="/articles/PMC1577285/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3907901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kawana,%20S.,%20Geoghegan,%20W.%20D.%20&amp;%20Jordon,%20R.%20E.%20Complement%20fixation%20by%20pemphigus%20antibody.%20II.%20Complement%20enhanced%20detachment%20of%20epidermal%20cells.%20Clin.%20Exp.%20Immunol.61,%20517%E2%80%93525%20(1985)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR173">
<span class="label">173.</span><cite>Anhalt, G. J. et al. Defining the role of complement in experimental pemphigus vulgaris in mice. <em>J. Immunol.</em><strong>137</strong>, 2835–2840 (1986).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3760574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Anhalt,%20G.%20J.%20et%20al.%20Defining%20the%20role%20of%20complement%20in%20experimental%20pemphigus%20vulgaris%20in%20mice.%20J.%20Immunol.137,%202835%E2%80%932840%20(1986)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR174">
<span class="label">174.</span><cite>Mascaro, J. M. Jr et al. Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. <em>Clin. Immunol. Immunopathol.</em><strong>85</strong>, 90–96 (1997).
</cite> [<a href="https://doi.org/10.1006/clin.1997.4408" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9325074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mascaro,%20J.%20M.%20Jr%20et%20al.%20Mechanisms%20of%20acantholysis%20in%20pemphigus%20vulgaris:%20role%20of%20IgG%20valence.%20Clin.%20Immunol.%20Immunopathol.85,%2090%E2%80%9396%20(1997)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR175">
<span class="label">175.</span><cite>Cirillo, N. et al. If pemphigus vulgaris IgG are the cause of acantholysis, new IgG-independent mechanisms are the concause. <em>J. Cell Physiol.</em><strong>212</strong>, 563–567 (2007).
</cite> [<a href="https://doi.org/10.1002/jcp.21111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17474087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cirillo,%20N.%20et%20al.%20If%20pemphigus%20vulgaris%20IgG%20are%20the%20cause%20of%20acantholysis,%20new%20IgG-independent%20mechanisms%20are%20the%20concause.%20J.%20Cell%20Physiol.212,%20563%E2%80%93567%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR176">
<span class="label">176.</span><cite>Mimouni, D. et al. Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris. <em>Clin. Exp. Immunol.</em><strong>142</strong>, 426–432 (2005).
</cite> [<a href="https://doi.org/10.1111/j.1365-2249.2005.02947.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1809530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16297153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mimouni,%20D.%20et%20al.%20Protective%20effect%20of%20intravenous%20immunoglobulin%20(IVIG)%20in%20an%20experimental%20model%20of%20pemphigus%20vulgaris.%20Clin.%20Exp.%20Immunol.142,%20426%E2%80%93432%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR177">
<span class="label">177.</span><cite>Mimouni, D. et al. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris. <em>Clin. Exp. Immunol.</em><strong>162</strong>, 543–549 (2010).
</cite> [<a href="https://doi.org/10.1111/j.1365-2249.2010.04265.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3026558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20964642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mimouni,%20D.%20et%20al.%20Efficacy%20of%20intravenous%20immunoglobulin%20(IVIG)%20affinity-purified%20anti-desmoglein%20anti-idiotypic%20antibodies%20in%20the%20treatment%20of%20an%20experimental%20model%20of%20pemphigus%20vulgaris.%20Clin.%20Exp.%20Immunol.162,%20543%E2%80%93549%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR178">
<span class="label">178.</span><cite>Schmitt, T. et al. Dsg3 epitope-specific signalling in pemphigus. <em>Front. Immunol</em><strong>14</strong>, 1163066 (2023).
</cite> [<a href="https://doi.org/10.3389/fimmu.2023.1163066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10151755/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37143675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt,%20T.%20et%20al.%20Dsg3%20epitope-specific%20signalling%20in%20pemphigus.%20Front.%20Immunol14,%201163066%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR179">
<span class="label">179.</span><cite>Balmer, P. et al. SUV39H2 epigenetic silencing controls fate conversion of epidermal stem and progenitor cells. <em>J. Cell Biol.</em><strong>220</strong>, e201908178 (2021).
</cite> [<a href="https://doi.org/10.1083/jcb.201908178" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7898489/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33604655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Balmer,%20P.%20et%20al.%20SUV39H2%20epigenetic%20silencing%20controls%20fate%20conversion%20of%20epidermal%20stem%20and%20progenitor%20cells.%20J.%20Cell%20Biol.220,%20e201908178%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR180">
<span class="label">180.</span><cite>Bement, W. M., Goryachev, A. B., Miller, A. L. &amp; von Dassow, G. Patterning of the cell cortex by Rho GTPases. <em>Nat. Rev. Mol. Cell Biol.</em><strong>25</strong>, 290–308 (2024).
</cite> [<a href="https://doi.org/10.1038/s41580-023-00682-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38172611/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bement,%20W.%20M.,%20Goryachev,%20A.%20B.,%20Miller,%20A.%20L.%20&amp;%20von%20Dassow,%20G.%20Patterning%20of%20the%20cell%20cortex%20by%20Rho%20GTPases.%20Nat.%20Rev.%20Mol.%20Cell%20Biol.25,%20290%E2%80%93308%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR181">
<span class="label">181.</span><cite>Jin, X. et al. Desmosomal cadherin tension loss in pemphigus vulgaris mediated by the inhibition of active RhoA at cell-cell adhesions. <em>iScience</em><strong>28</strong>, 113081 (2025).
</cite> [<a href="https://doi.org/10.1016/j.isci.2025.113081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12307676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40740498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jin,%20X.%20et%20al.%20Desmosomal%20cadherin%20tension%20loss%20in%20pemphigus%20vulgaris%20mediated%20by%20the%20inhibition%20of%20active%20RhoA%20at%20cell-cell%20adhesions.%20iScience28,%20113081%20(2025)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR182">
<span class="label">182.</span><cite>Williamson, L., Suter, M. M., Olivry, T., Wyder, M. &amp; Müller, E. J. Upregulation of c-Myc may contribute to the pathogenesis of canine pemphigus vulgaris. <em>Vet. Dermatol.</em><strong>18</strong>, 12–17 (2007).
</cite> [<a href="https://doi.org/10.1111/j.1365-3164.2007.00561.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17222234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Williamson,%20L.,%20Suter,%20M.%20M.,%20Olivry,%20T.,%20Wyder,%20M.%20&amp;%20M%C3%BCller,%20E.%20J.%20Upregulation%20of%20c-Myc%20may%20contribute%20to%20the%20pathogenesis%20of%20canine%20pemphigus%20vulgaris.%20Vet.%20Dermatol.18,%2012%E2%80%9317%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR183">
<span class="label">183.</span><cite>Williamson, L., Hunziker, T., Suter, M. M. &amp; Müller, E. J. Nuclear c-Myc: a molecular marker for early stage pemphigus vulgaris. <em>J. Investig. Dermatol.</em><strong>127</strong>, 1549–1555 (2007).
</cite> [<a href="https://doi.org/10.1038/sj.jid.5700735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17315040/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Williamson,%20L.,%20Hunziker,%20T.,%20Suter,%20M.%20M.%20&amp;%20M%C3%BCller,%20E.%20J.%20Nuclear%20c-Myc:%20a%20molecular%20marker%20for%20early%20stage%20pemphigus%20vulgaris.%20J.%20Investig.%20Dermatol.127,%201549%E2%80%931555%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR184">
<span class="label">184.</span><cite>Rotzer, V. et al. Desmoglein 3-dependent signaling regulates keratinocyte migration and wound healing. <em>J. Investig. Dermatol.</em><strong>136</strong>, 301–310 (2016).
</cite> [<a href="https://doi.org/10.1038/JID.2015.380" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26763450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rotzer,%20V.%20et%20al.%20Desmoglein%203-dependent%20signaling%20regulates%20keratinocyte%20migration%20and%20wound%20healing.%20J.%20Investig.%20Dermatol.136,%20301%E2%80%93310%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR185">
<span class="label">185.</span><cite>Hoque Apu, E., Akram, S. U., Rissanen, J., Wan, H. &amp; Salo, T. Desmoglein 3 - Influence on oral carcinoma cell migration and invasion. <em>Exp. Cell Res.</em><strong>370</strong>, 353–364 (2018).
</cite> [<a href="https://doi.org/10.1016/j.yexcr.2018.06.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29969588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hoque%20Apu,%20E.,%20Akram,%20S.%20U.,%20Rissanen,%20J.,%20Wan,%20H.%20&amp;%20Salo,%20T.%20Desmoglein%203%20-%20Influence%20on%20oral%20carcinoma%20cell%20migration%20and%20invasion.%20Exp.%20Cell%20Res.370,%20353%E2%80%93364%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR186">
<span class="label">186.</span><cite>Brown, L. et al. Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation. <em>Oncogene</em><strong>33</strong>, 2363–2374 (2014).
</cite> [<a href="https://doi.org/10.1038/onc.2013.186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23752190/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brown,%20L.%20et%20al.%20Desmoglein%203%20promotes%20cancer%20cell%20migration%20and%20invasion%20by%20regulating%20activator%20protein%201%20and%20protein%20kinase%20C-dependent-Ezrin%20activation.%20Oncogene33,%202363%E2%80%932374%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR187">
<span class="label">187.</span><cite>Chen, Y. J. et al. DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. <em>PLoS One</em><strong>8</strong>, e64088 (2013).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0064088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3667790/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23737966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20Y.%20J.%20et%20al.%20DSG3%20facilitates%20cancer%20cell%20growth%20and%20invasion%20through%20the%20DSG3-plakoglobin-TCF/LEF-Myc/cyclin%20D1/MMP%20signaling%20pathway.%20PLoS%20One8,%20e64088%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR188">
<span class="label">188.</span><cite>Mannan, T., Jing, S., Foroushania, S. H., Fortune, F. &amp; Wan, H. RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. <em>Cell Prolif.</em><strong>44</strong>, 301–310 (2011).
</cite> [<a href="https://doi.org/10.1111/j.1365-2184.2011.00765.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6496163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21702856/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mannan,%20T.,%20Jing,%20S.,%20Foroushania,%20S.%20H.,%20Fortune,%20F.%20&amp;%20Wan,%20H.%20RNAi-mediated%20inhibition%20of%20the%20desmosomal%20cadherin%20(desmoglein%203)%20impairs%20epithelial%20cell%20proliferation.%20Cell%20Prolif.44,%20301%E2%80%93310%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR189">
<span class="label">189.</span><cite>Allen, E., Yu, Q. C. &amp; Fuchs, E. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. <em>J. Cell Biol.</em><strong>133</strong>, 1367–1382 (1996).
</cite> [<a href="https://doi.org/10.1083/jcb.133.6.1367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2120897/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8682871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Allen,%20E.,%20Yu,%20Q.%20C.%20&amp;%20Fuchs,%20E.%20Mice%20expressing%20a%20mutant%20desmosomal%20cadherin%20exhibit%20abnormalities%20in%20desmosomes,%20proliferation,%20and%20epidermal%20differentiation.%20J.%20Cell%20Biol.133,%201367%E2%80%931382%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR190">
<span class="label">190.</span><cite>Merritt, A. J. et al. Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation. <em>Mol. Cell Biol.</em><strong>22</strong>, 5846–5858 (2002).
</cite> [<a href="https://doi.org/10.1128/MCB.22.16.5846-5858.2002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC133994/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12138195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Merritt,%20A.%20J.%20et%20al.%20Suprabasal%20desmoglein%203%20expression%20in%20the%20epidermis%20of%20transgenic%20mice%20results%20in%20hyperproliferation%20and%20abnormal%20differentiation.%20Mol.%20Cell%20Biol.22,%205846%E2%80%935858%20(2002)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR191">
<span class="label">191.</span><cite>Peterson, A. F. et al. Systematic analysis of the MAPK signaling network reveals MAP3K-driven control of cell fate. <em>Cell Syst.</em><strong>13</strong>, 885–894.e884 (2022).
</cite> [<a href="https://doi.org/10.1016/j.cels.2022.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9923805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36356576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peterson,%20A.%20F.%20et%20al.%20Systematic%20analysis%20of%20the%20MAPK%20signaling%20network%20reveals%20MAP3K-driven%20control%20of%20cell%20fate.%20Cell%20Syst.13,%20885%E2%80%93894.e884%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR192">
<span class="label">192.</span><cite>Reimann, A. et al. Embryonic stem cell ERK, AKT, plus STAT3 response dynamics combinatorics are heterogeneous but NANOG state independent. <em>Stem Cell Rep.</em><strong>18</strong>, 1295–1307 (2023).</cite> [<a href="https://doi.org/10.1016/j.stemcr.2023.04.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10277824/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37207650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reimann,%20A.%20et%20al.%20Embryonic%20stem%20cell%20ERK,%20AKT,%20plus%20STAT3%20response%20dynamics%20combinatorics%20are%20heterogeneous%20but%20NANOG%20state%20independent.%20Stem%20Cell%20Rep.18,%201295%E2%80%931307%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR193">
<span class="label">193.</span><cite>Enzo, E. et al. Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells. <em>Nat. Commun.</em><strong>12</strong>, 2505 (2021).
</cite> [<a href="https://doi.org/10.1038/s41467-021-22779-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8097075/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33947848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Enzo,%20E.%20et%20al.%20Single-keratinocyte%20transcriptomic%20analyses%20identify%20different%20clonal%20types%20and%20proliferative%20potential%20mediated%20by%20FOXM1%20in%20human%20epidermal%20stem%20cells.%20Nat.%20Commun.12,%202505%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR194">
<span class="label">194.</span><cite>Hunter, M. G., Iltchev, D., Wang, Y. J. &amp; Marsh, C. B. Rapid and irreversible activation of MAPK kinase pathway during myelopoiesis. <em>Blood</em><strong>106</strong>, 858a (2005).</cite> [<a href="https://scholar.google.com/scholar_lookup?Hunter,%20M.%20G.,%20Iltchev,%20D.,%20Wang,%20Y.%20J.%20&amp;%20Marsh,%20C.%20B.%20Rapid%20and%20irreversible%20activation%20of%20MAPK%20kinase%20pathway%20during%20myelopoiesis.%20Blood106,%20858a%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR195">
<span class="label">195.</span><cite>Loryman, C. &amp; Mansbridge, J. Inhibition of keratinocyte migration by lipopolysaccharide. <em>Wound Repair Regen.</em><strong>16</strong>, 45–51 (2008).
</cite> [<a href="https://doi.org/10.1111/j.1524-475X.2007.00290.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18211578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Loryman,%20C.%20&amp;%20Mansbridge,%20J.%20Inhibition%20of%20keratinocyte%20migration%20by%20lipopolysaccharide.%20Wound%20Repair%20Regen.16,%2045%E2%80%9351%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR196">
<span class="label">196.</span><cite>Gvirtz, R., Ogen-Shtern, N. &amp; Cohen, G. Kinetic Cytokine Secretion Profile of LPS-Induced Inflammation in the Human Skin Organ Culture. <em>Pharmaceutics</em><strong>12</strong>, 299 (2020).
</cite> [<a href="https://doi.org/10.3390/pharmaceutics12040299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7238050/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32218380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gvirtz,%20R.,%20Ogen-Shtern,%20N.%20&amp;%20Cohen,%20G.%20Kinetic%20Cytokine%20Secretion%20Profile%20of%20LPS-Induced%20Inflammation%20in%20the%20Human%20Skin%20Organ%20Culture.%20Pharmaceutics12,%20299%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR197">
<span class="label">197.</span><cite>Zheng, Q. W. et al. p38 mitogen-activated protein kinase: functions and targeted therapy in diseases. <em>Medcomm-Oncol.</em><strong>2</strong>, e53 (2023).</cite> [<a href="https://scholar.google.com/scholar_lookup?Zheng,%20Q.%20W.%20et%20al.%20p38%20mitogen-activated%20protein%20kinase:%20functions%20and%20targeted%20therapy%20in%20diseases.%20Medcomm-Oncol.2,%20e53%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR198">
<span class="label">198.</span><cite>Ellebrecht, C. T., Maseda, D. &amp; Payne, A. S. Pemphigus and pemphigoid: from disease mechanisms to druggable pathways. <em>J. Investig. Dermatol.</em><strong>142</strong>, 907–914 (2022).
</cite> [<a href="https://doi.org/10.1016/j.jid.2021.04.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8860856/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34756581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ellebrecht,%20C.%20T.,%20Maseda,%20D.%20&amp;%20Payne,%20A.%20S.%20Pemphigus%20and%20pemphigoid:%20from%20disease%20mechanisms%20to%20druggable%20pathways.%20J.%20Investig.%20Dermatol.142,%20907%E2%80%93914%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR199">
<span class="label">199.</span><cite>A Phase 2 Open-Label Uncontrolled Pilot Study of KC706 in Patients With Stable, Active Pemphigus Vulgaris. <a href="https://clinicaltrials.gov/study/NCT00606749" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinicaltrials.gov/study/NCT00606749</a> (2008). accessed 16 July 2025.</cite>
</li>
<li id="CR200">
<span class="label">200.</span><cite>Bhattacharjee, D. et al. Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor. <em>Cell Chem. Biol.</em><strong>30</strong>, 1211–1222.e1215 (2023).
</cite> [<a href="https://doi.org/10.1016/j.chembiol.2023.09.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10715717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37827156/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bhattacharjee,%20D.%20et%20al.%20Inhibition%20of%20a%20lower%20potency%20target%20drives%20the%20anticancer%20activity%20of%20a%20clinical%20p38%20inhibitor.%20Cell%20Chem.%20Biol.30,%201211%E2%80%931222.e1215%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR201">
<span class="label">201.</span><cite>Galichet, A., Borradori, L. &amp; Muller, E. J. A new light on an old disease: adhesion signaling in pemphigus vulgaris. <em>J. Investig. Dermatol.</em><strong>134</strong>, 8–10 (2014).
</cite> [<a href="https://doi.org/10.1038/jid.2013.439" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24352077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Galichet,%20A.,%20Borradori,%20L.%20&amp;%20Muller,%20E.%20J.%20A%20new%20light%20on%20an%20old%20disease:%20adhesion%20signaling%20in%20pemphigus%20vulgaris.%20J.%20Investig.%20Dermatol.134,%208%E2%80%9310%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR202">
<span class="label">202.</span><cite>Green, K. J., Roth-Carter, Q., Niessen, C. M. &amp; Nichols, S. A. Tracing the evolutionary origin of desmosomes. <em>Curr. Biol.</em><strong>30</strong>, R535–R543 (2020).
</cite> [<a href="https://doi.org/10.1016/j.cub.2020.03.047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7310670/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32428495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Green,%20K.%20J.,%20Roth-Carter,%20Q.,%20Niessen,%20C.%20M.%20&amp;%20Nichols,%20S.%20A.%20Tracing%20the%20evolutionary%20origin%20of%20desmosomes.%20Curr.%20Biol.30,%20R535%E2%80%93R543%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR203">
<span class="label">203.</span><cite>Hofrichter, M. et al. Immunoadsorption of Desmoglein-3-Specific IgG abolishes the blister-inducing capacity of pemphigus vulgaris IgG in neonatal mice. <em>Front. Immunol.</em><strong>9</strong>, 1935 (2018).
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.01935" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6130267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30233569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hofrichter,%20M.%20et%20al.%20Immunoadsorption%20of%20Desmoglein-3-Specific%20IgG%20abolishes%20the%20blister-inducing%20capacity%20of%20pemphigus%20vulgaris%20IgG%20in%20neonatal%20mice.%20Front.%20Immunol.9,%201935%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR204">
<span class="label">204.</span><cite>Egu, D. T. et al. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus. <em>Br. J. Dermatol.</em><strong>182</strong>, 987–994 (2020).
</cite> [<a href="https://doi.org/10.1111/bjd.18237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31218663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egu,%20D.%20T.%20et%20al.%20A%20new%20ex%20vivo%20human%20oral%20mucosa%20model%20reveals%20that%20p38MAPK%20inhibition%20is%20not%20effective%20in%20preventing%20autoantibody-induced%20mucosal%20blistering%20in%20pemphigus.%20Br.%20J.%20Dermatol.182,%20987%E2%80%93994%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR205">
<span class="label">205.</span><cite>Egu, D. T., Kugelmann, D. &amp; Waschke, J. Role of PKC and ERK signaling in epidermal blistering and desmosome regulation in Pemphigus. <em>Front. Immunol.</em><strong>10</strong>, 2883 (2019).
</cite> [<a href="https://doi.org/10.3389/fimmu.2019.02883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6910072/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31867019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Egu,%20D.%20T.,%20Kugelmann,%20D.%20&amp;%20Waschke,%20J.%20Role%20of%20PKC%20and%20ERK%20signaling%20in%20epidermal%20blistering%20and%20desmosome%20regulation%20in%20Pemphigus.%20Front.%20Immunol.10,%202883%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR206">
<span class="label">206.</span><cite>Hunziker, T. et al. High doses of antigen-nonspecific IgG do not inhibit pemphigus acantholysis in skin organ cultures. <em>Arch. Dermatol. Res.</em><strong>277</strong>, 299–303 (1985).
</cite> [<a href="https://doi.org/10.1007/BF00509084" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3923949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hunziker,%20T.%20et%20al.%20High%20doses%20of%20antigen-nonspecific%20IgG%20do%20not%20inhibit%20pemphigus%20acantholysis%20in%20skin%20organ%20cultures.%20Arch.%20Dermatol.%20Res.277,%20299%E2%80%93303%20(1985)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR207">
<span class="label">207.</span><cite>Zakrzewicz, A. et al. Stabilization of keratinocyte monolayer integrity in the presence of anti-Desmoglein-3 antibodies through FcRn blockade with efgartigimod: novel treatment paradigm for pemphigus?. <em>Cells</em><strong>11</strong>, 942 (2022).
</cite> [<a href="https://doi.org/10.3390/cells11060942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8946243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35326398/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zakrzewicz,%20A.%20et%20al.%20Stabilization%20of%20keratinocyte%20monolayer%20integrity%20in%20the%20presence%20of%20anti-Desmoglein-3%20antibodies%20through%20FcRn%20blockade%20with%20efgartigimod:%20novel%20treatment%20paradigm%20for%20pemphigus?.%20Cells11,%20942%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR208">
<span class="label">208.</span><cite>Lanza, A. et al. Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. <em>J. Biol. Chem.</em><strong>283</strong>, 8736–8745 (2008).
</cite> [<a href="https://doi.org/10.1074/jbc.M702186200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18199752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lanza,%20A.%20et%20al.%20Evidence%20of%20key%20role%20of%20Cdk2%20overexpression%20in%20pemphigus%20vulgaris.%20J.%20Biol.%20Chem.283,%208736%E2%80%938745%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR209">
<span class="label">209.</span><cite>Lanza, A. et al. Deregulation of PERK in the autoimmune disease pemphigus vulgaris occurs via IgG-independent mechanisms. <em>Br. J. Dermatol.</em><strong>164</strong>, 336–343 (2011).
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.2010.10084.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21039404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lanza,%20A.%20et%20al.%20Deregulation%20of%20PERK%20in%20the%20autoimmune%20disease%20pemphigus%20vulgaris%20occurs%20via%20IgG-independent%20mechanisms.%20Br.%20J.%20Dermatol.164,%20336%E2%80%93343%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR210">
<span class="label">210.</span><cite>Kugelmann, D. et al. Role of ADAM10 and ADAM17 in the regulation of keratinocyte adhesion in pemphigus vulgaris. <em>Front. Immunol.</em><strong>13</strong>, 884248 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.884248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9279611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35844545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kugelmann,%20D.%20et%20al.%20Role%20of%20ADAM10%20and%20ADAM17%20in%20the%20regulation%20of%20keratinocyte%20adhesion%20in%20pemphigus%20vulgaris.%20Front.%20Immunol.13,%20884248%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR211">
<span class="label">211.</span><cite>Valentino, A. et al. Plasma exosomal microRNA profile reveals miRNA 148a-3p downregulation in the mucosal-dominant variant of Pemphigus Vulgaris. <em>Int. J. Mol. Sci.</em><strong>24</strong>, 11493 (2023).
</cite> [<a href="https://doi.org/10.3390/ijms241411493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10380621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37511259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Valentino,%20A.%20et%20al.%20Plasma%20exosomal%20microRNA%20profile%20reveals%20miRNA%20148a-3p%20downregulation%20in%20the%20mucosal-dominant%20variant%20of%20Pemphigus%20Vulgaris.%20Int.%20J.%20Mol.%20Sci.24,%2011493%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR212">
<span class="label">212.</span><cite>Michel, B. &amp; Ko, C. S. An organ culture model for the study of pemphigus acantholysis. <em>Br. J. Dermatol.</em><strong>96</strong>, 295–302 (1977).
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.1977.tb06141.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/322692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michel,%20B.%20&amp;%20Ko,%20C.%20S.%20An%20organ%20culture%20model%20for%20the%20study%20of%20pemphigus%20acantholysis.%20Br.%20J.%20Dermatol.96,%20295%E2%80%93302%20(1977)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR213">
<span class="label">213.</span><cite>Farb, R. M., Dykes, R. &amp; Lazarus, G. S. Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. <em>Proc. Natl. Acad. Sci. U.S.A.</em><strong>75</strong>, 459–463 (1978).
</cite> [<a href="https://doi.org/10.1073/pnas.75.1.459" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC411269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/272663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Farb,%20R.%20M.,%20Dykes,%20R.%20&amp;%20Lazarus,%20G.%20S.%20Anti-epidermal-cell-surface%20pemphigus%20antibody%20detaches%20viable%20epidermal%20cells%20from%20culture%20plates%20by%20activation%20of%20proteinase.%20Proc.%20Natl.%20Acad.%20Sci.%20U.S.A.75,%20459%E2%80%93463%20(1978)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR214">
<span class="label">214.</span><cite>Singer, K. H., Sawka, N. J., Samowitz, H. R. &amp; Lazarus, G. S. Proteinase activation: a mechanism for cellular dyshesion in pemphigus. <em>J. Investig. Dermatol.</em><strong>74</strong>, 363–367 (1980).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12543780" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6993576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singer,%20K.%20H.,%20Sawka,%20N.%20J.,%20Samowitz,%20H.%20R.%20&amp;%20Lazarus,%20G.%20S.%20Proteinase%20activation:%20a%20mechanism%20for%20cellular%20dyshesion%20in%20pemphigus.%20J.%20Investig.%20Dermatol.74,%20363%E2%80%93367%20(1980)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR215">
<span class="label">215.</span><cite>Morioka, S., Naito, K. &amp; Ogawa, H. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. <em>J. Investig. Dermatol.</em><strong>76</strong>, 337–341 (1981).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12519988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7014725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morioka,%20S.,%20Naito,%20K.%20&amp;%20Ogawa,%20H.%20The%20pathogenic%20role%20of%20pemphigus%20antibodies%20and%20proteinase%20in%20epidermal%20acantholysis.%20J.%20Investig.%20Dermatol.76,%20337%E2%80%93341%20(1981)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR216">
<span class="label">216.</span><cite>Hashimoto, K., Shafran, K. M., Webber, P. S., Lazarus, G. S. &amp; Singer, K. H. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. <em>J. Exp. Med.</em><strong>157</strong>, 259–272 (1983).
</cite> [<a href="https://doi.org/10.1084/jem.157.1.259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2186905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6681540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hashimoto,%20K.,%20Shafran,%20K.%20M.,%20Webber,%20P.%20S.,%20Lazarus,%20G.%20S.%20&amp;%20Singer,%20K.%20H.%20Anti-cell%20surface%20pemphigus%20autoantibody%20stimulates%20plasminogen%20activator%20activity%20of%20human%20epidermal%20cells.%20A%20mechanism%20for%20the%20loss%20of%20epidermal%20cohesion%20and%20blister%20formation.%20J.%20Exp.%20Med.157,%20259%E2%80%93272%20(1983)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR217">
<span class="label">217.</span><cite>Woo, T. Y. et al. Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. <em>J. Investig. Dermatol.</em><strong>81</strong>, 115s–121s (1983).
</cite> [<a href="https://doi.org/10.1111/1523-1747.ep12540871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6863985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Woo,%20T.%20Y.%20et%20al.%20Specificity%20and%20inhibition%20of%20the%20epidermal%20cell%20detachment%20induced%20by%20pemphigus%20IgG%20in%20vitro.%20J.%20Investig.%20Dermatol.81,%20115s%E2%80%93121s%20(1983)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR218">
<span class="label">218.</span><cite>Kawana, S. &amp; Nishiyama, S. Involvement of membrane attack complex of complement in UV-B-induced acantholysis in pemphigus. <em>Arch. Dermatol.</em><strong>126</strong>, 623–626 (1990).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/2334182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kawana,%20S.%20&amp;%20Nishiyama,%20S.%20Involvement%20of%20membrane%20attack%20complex%20of%20complement%20in%20UV-B-induced%20acantholysis%20in%20pemphigus.%20Arch.%20Dermatol.126,%20623%E2%80%93626%20(1990)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR219">
<span class="label">219.</span><cite>Dobrev, H., Popova, L. &amp; Vlashev, D. Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study. <em>Arch. Dermatol Res.</em><strong>288</strong>, 648–655 (1996).
</cite> [<a href="https://doi.org/10.1007/BF02505273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8931866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dobrev,%20H.,%20Popova,%20L.%20&amp;%20Vlashev,%20D.%20Proteinase%20inhibitors%20and%20pemphigus%20vulgaris.%20An%20in%20vitro%20and%20in%20vivo%20study.%20Arch.%20Dermatol%20Res.288,%20648%E2%80%93655%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR220">
<span class="label">220.</span><cite>Feliciani, C. et al. Tannic acid induces in vitro acantholysis of keratinocytes via IL-1alpha and TNF-alpha. <em>Int. J. Immunopathol. Pharm.</em><strong>20</strong>, 289–299 (2007).</cite> [<a href="https://doi.org/10.1177/039463200702000209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17624241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feliciani,%20C.%20et%20al.%20Tannic%20acid%20induces%20in%20vitro%20acantholysis%20of%20keratinocytes%20via%20IL-1alpha%20and%20TNF-alpha.%20Int.%20J.%20Immunopathol.%20Pharm.20,%20289%E2%80%93299%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR221">
<span class="label">221.</span><cite>Cirillo, N. et al. At least three phosphorylation events induced by pemphigus vulgaris sera are pathogenically involved in keratinocyte acantholysis. <em>Int. J. Immunopathol. Pharm.</em><strong>21</strong>, 189–195 (2008).</cite> [<a href="https://doi.org/10.1177/039463200802100121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18336745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cirillo,%20N.%20et%20al.%20At%20least%20three%20phosphorylation%20events%20induced%20by%20pemphigus%20vulgaris%20sera%20are%20pathogenically%20involved%20in%20keratinocyte%20acantholysis.%20Int.%20J.%20Immunopathol.%20Pharm.21,%20189%E2%80%93195%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR222">
<span class="label">222.</span><cite>Liang, J. et al. Naringenin protects keratinocytes from oxidative stress injury via inhibition of the NOD2-mediated NF-kappaB pathway in pemphigus vulgaris. <em>Biomed. Pharmacother.</em><strong>92</strong>, 796–801 (2017).
</cite> [<a href="https://doi.org/10.1016/j.biopha.2017.05.112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28591691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang,%20J.%20et%20al.%20Naringenin%20protects%20keratinocytes%20from%20oxidative%20stress%20injury%20via%20inhibition%20of%20the%20NOD2-mediated%20NF-kappaB%20pathway%20in%20pemphigus%20vulgaris.%20Biomed.%20Pharmacother.92,%20796%E2%80%93801%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR223">
<span class="label">223.</span><cite>Wei, B. &amp; Li, F. Mechanisms of Trx2/ASK1-mediated mitochondrial injury in Pemphigus Vulgaris. <em>Biomed. Res. Int.</em><strong>2021</strong>, 2471518 (2021).
</cite> [<a href="https://doi.org/10.1155/2021/2471518" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7946479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33763469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei,%20B.%20&amp;%20Li,%20F.%20Mechanisms%20of%20Trx2/ASK1-mediated%20mitochondrial%20injury%20in%20Pemphigus%20Vulgaris.%20Biomed.%20Res.%20Int.2021,%202471518%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373888/bin/41536_2025_426_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (495.3KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373888/bin/41536_2025_426_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 1</a><sup> (31.2KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data utilized in this study are fully detailed and available within the article and its supplementary information files, ensuring transparency and facilitating further open research.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from NPJ Regenerative Medicine are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41536-025-00426-x"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41536_2025_Article_426.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373888/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373888/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373888%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373888/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373888/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373888/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846710/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373888/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846710/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373888/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373888/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Hff9yCGp2vbms5GGjUtn1tjxcwgMVD836Ft4dDExjubUeW4Z3GgnDhmUAXSWMzTs">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
